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ABSTRACT 
A competitive binding technique is described 
for the estimation of the thyroxine (T 4) binding 
properties· of proteins in samples of dilute blood plasma 
and lymph. The assay is performed in physiological media 
at physiological temperature and pH. When the total 
plasma T
4 
concentration is known it is possible to 
obtain estimates of the following parameters: the number 
of functionally different T4 binding proteins (T 4BPs), 
their individual association constants and binding 
capacities for T4 , the amount of total T 4 which is . bound 
to each binding species, and the concentration of unbound 
Both human and sheep serum were shown to have 
three functionally different T4BPs. The mean association 
constants for the binding of T4 to the three human T4BPs 
9 8 5 -1 
were 9.5 x 10 , 1.6 x 10 and 3.1 x 10 M for T 4-
binding globulin (TBG), T 4-binding prealbumin (TBPA) and 
serum albumin respectively. The corresponding sheep 
proteins; TBG, TBP-2 and albumin, had mean association 
constants of 8.9 x 10 9 , 1.4 x 10 8 and 3.5 x 10
5 
M-l 
respectively. Human TBG had a mean T4 binding capacity 
of 21.3 µg/100 ml of plasma while that of sheep TBG was 
12.8 µg/100 ml. The other specific T4BPs (TBPA in the 
human and TBP-2 in the sheep) had mean T 4 binding capacities 
of 307 and 359 µg/100 ml respectively. 
Two functionally different T4BPs were identified 
in rat serum. The specific T 4BP had T4 binding properties 
similar to those of TBPA and TBP-2, i.e. a mean association 
8 -1 
constant for T
4 
of 3.64 x 10 M and a mean T4 binding 
capacity of 317 ~g/100 ml. Rat albumin had an association 
constant of 6.3 x 105 M-
1
. 
Isotope tracer experiments in sheep with 
indwelling lymphatic cannulae demonstrated that T 4 [
125
1] 
disappeared from the circulation and appeared in lymph at 
a greater fractional rate than human serum albumin [
131
1] 
whi ch was injected simultane ously into the circulation. 
The steady state lymph/plasma concentration ratios of the 
three T
4
BPs, albumin and total T4 did not differ signif-
icantly in any sample of lymph studied. Thus the more 
rapid fractional rate of movement of T 4 from blood to 
lymph was attributed mainly to the transfer of the unbound 
T
4 
moiety across capillary endothelium. 
Thyroidectomy and oestrogen administration 
resulted in a decline in the concentration of plasma TBG 
in ewes. 
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CHAPTER 1 
INTRODUCTION 
l 
Many intracellular and extracellular proteins 
are capable of binding steroid and thyroid hormones. The 
physico- chemical nature of the interaction varies according 
to ~he protein and hormone under consideration but can be 
divided arbitrari ly into two distinct types: specific and 
non-specific binding. Specific binding is characterised 
by a high affinity of the protein for the hormone or 
ligand, a low concentration of binding sites, and a high 
degree of specificity of the binding site for the ligand. 
Non-specific binding involves low affinity, high capacity 
binding with no ligand specificity. The plasma proteins 
corticoste roid-binding globulin (CBG) and thyroxine-binding 
globulin (TBG) are examples of specific binding proteins. 
Corticosteroid-binding globulin specifically binds 
cortisol, corticosterone and progesterone while TBG binds 
thyroxine (T 4) and triiodothyronine (T 3). These hormones 
are bound with high affinity having association constants 
of the order of 10 9 litres/mole (M- 1 ). This enables 
appreciable proportions of the hormone to be bound even 
when present at very low concentrations . The binding 
sites are saturated at hormonal concentrations which 
although higher than the normal physiological levels are 
nevertheless of the same order of magnitude. Albumin, 
on the other hand, exhibits non-specific binding since a 
large number of steroid and thyroid hormones are bound 
with low affinity (association constants of the order of 
10 5 M-l) and the protein is unsaturable at hormone 
concentrations several orders of magnitude greater than 
those existing in vivo. 
2 
The interaction of hormone and prot.ein involves 
non-covalent reversible binding, the binding sites are 
assumed to be independent of each other and the system 
obeys the law of mass action. Such reactions are not 
confined to hormone - protein interactions but are 
characteristic of a large number of biological systems. 
Since the discovery of the binding of acid dyes to serum 
proteins, a broad sp~ctrum of low molecular weight 
substances have been observed to bind reversibly to a 
number of different proteins contained within the cells, 
ti·ssues and fluids of the body. Included in this group 
of low molecular weight ligands are: acid dyes, fatty 
acids, enzyme substrates, steroid and thyroid hormones, 
prostaglandins, bile acids, metal ions, vitamins and 
a number of drugs. Antigen-antibody and hapten-antibody 
interactions are characterized by the same type of 
reversible binding and appear to obey the law of mass 
actionQ 
Ligand-protein interactions have been studied 
in a number of scientific disciplines, consequently the 
experimental approach has varied considerably. Enzymologists 
were quick to realize that the interaction of enzyme and 
substrate was an equilibrium reaction. With the advent of 
Michaclis-Menten kinetics a method was available to 
quantitate several aspects of these interactions. It has 
taken several decades however, for similar approaches to 
be adopted by other disciplines studying phenomena based 
on the same physico-chemical principle. Even today some 
3 
authors in th field of endocrinology fail to appreciate 
the dynamic equilibrium which exists between a number of 
ho mones and the proteins to which they bind at the 
cellular and extracellular levels. 
In recent years a large number of specific 
hormone-binding proteins have been purified and their 
binding characteristics determined in vitro. While such 
studies have yielded valuable biochemical information 
the results obtained may have little relevance to binding 
in vivo and have helped little in attributing a functional 
role to such proteins. A more profitable approach to 
the understanding of the role of protein-binding in 
hormone distribution and metabolism in vivo, appears to 
be the use of techniques which quantitate binding in 
complex mixtures of binding proteins, e.g. plasma, under 
conditions mimicking those in vivo. These techniques 
in conjunction with whole animal experiments designed 
to quantitate changes in binding function under varying 
physiological conditions should prove valuable in 
assigning a functional role to specific hormone-binding 
proteins. An approach of this type has been adopted in 
the present study which documents some aspects of thyroid 
hormone-plasma protein interactions. Since these 
interactions are typical of many non-covalent ligand-
protein interactions, the phenomena described in this 
dissertation are likely to be typical of many other 
binding systems and the techniques described may be 
useful in the study of such systems. 
As the u timate aim was to study aspects of 
the physiology of thyroxine-binding proteins (T 4BPs) 
4 
in vivo the initial expe ~imentation involved the develop-
ment of an in vitro te chnique which could yield close 
estimates of the T4 binding constants existing in vivo. 
The principle of the assay system, its advantages and 
disadvantages over other systems, the methods and 
accuracy of data analysis, as well as a description of 
in vitro conditions which influence the T 4 binding 
parameters are discussed in Chapters 3, 4 and 5. Albumin 
binding values derived from assays of whole plasma 
described in Chapters 4 and 5 were checked by using 
purified albumin preparations. These results are summarized 
in Chapter 6. 
The second part of the study describes sheep 
experiments which were conducted to assess the role of 
T
4
BPs in thyroid hormone distribution and metabolism. 
Chapter 7 describes experiments carried out to study the 
role of T
4
BPs in the transfer of thyroid hormones from 
blood to extracellular fluid in sheep with indwelling 
lymphatic cannulae. Results presented in Chapter 8 
illustrate the effect of thyroid hormones and some sex 
steroids on the concentration of circulating T 4BPs in 
sheep. 
CHAPTER 2 
THE THYROXINE-BINDING PROPERTIES 
OF PLASMA PROTEINS. A REVIEW. 
5 
Historical 
The association of iodine with thyroid gland 
function was established in 1896 when Baumann demonstrated 
the presence of iodine in a protein fraction from thyroid 
tissue. On hydrolysis, this fraction yielded a substance, 
iodothyrin, which was capable of rel i eving the symptoms 
and signs of myxoedema produced as a result of thyroid 
insufficiency. It therefore seemed probable that the 
active principle of the thyroid gland contained iodine 
(Baumann, 1896a, b). Almos t two decades later Kendall 
isolated this active iodine containing principle, which 
he called thyroxine (T 4 ), and found it contained as much 
as 65% iodine (Kendall, 1919; Kendall and Osterberg, 
1919). Kendall's work was later repeated by Harington 
(1926a) who, with a modified extraction procedure, was 
able to obtain a one hundred fold increase in the 
extraction efficiency of T4 from thyroid tissue. His 
subsequent synthesis of thyronine (4-(4'-hydroxyphenoxy) 
phenylalanine) (Harington, 1926b)established the 
structure of T4 except for the position of the iodine 
atoms in the aromatic nuclei. However, the fact that 
both T
4 
and diiodotyrosine (DIT) gave reactions 
characteristic of ortho-diiodophenols, together with 
the likelihood that T 4 was synthesized in the thyroid 
from two molecules of DIT, indicated that T 4 would have 
the following formula (Harington and Barger, 1927): 
I I 
HO 
I I 
Thyroxine: a amino-S-[3:5-diiodo-
4-(3':5'-diiodo-4' hydroxy 
phenoxy) phenyl] propionic 
acid. 
6 
Degradation and synthesis studies proved this to be correct 
(Harington and Barge-r, +92 7) and it was later shown that 
L-thyroxine was the active principle (Harington and 
Salter, 1930; Foster, Palmer and Leland, 1936). 
The discovery of iodine compounds in the blood 
quickly followed their demonstration in the thyroid 
gland, but their intimate association with serum proteins 
(Gley and Bourcet, 1900) led to erroneous interpretations. 
Some workers suggested plasma iodine was present as 
thyroglobulin (Hektoen, Carlson and Schulhof, 1923; 
Carlson, Hektoen and Schulhof, 1924; Hektoen and 
Schulhof, 1925; Hicks, 1926; Barnes and Jones, 1933). 
However, the failure of Lerman (1940) to detect 
thyroglobulin in the blood of euthyroid and hyperthyroid 
individuals, when sensitive serological tests were used, 
put an end to this theory. Other workers postulated 
the existence of a circulating peptide or polypeptide 
containing both T4 and DIT (Harington, 1935; Salter, 
1940; Williams and Whittenberger, 1947). In a 
re-examination of previous evidence, Harington (1944) 
concluded that the peptide concept was an unnecessary 
complication and that T 4 itself was probably the
 
7 
circulating hormone. 
The first experimental evidence in favour of 
T
4 
as the circulating hormone came with the work of 
Trevorrow (1939). This study showed that the thyroid 
hormone of blood behaved the same way towards protein 
precipitants, dialysis and ethanol extraction as did 
added T
4
. It was not until nine years later that Taurog 
and Chaikoff ( 19 4 8) demonstrated unequivocally that the 
circulating hormone labelled with 1311, and added T 4 , 
showed identical behaviour in the presence of protein 
precipitants and organic solvents. This work was 
confirmed by Leblond and Gross ( 19 49) and additional 
evidence in favour of T 4 as the circulating hormone was 
presented in the same year when Laidlaw (1949) identified 
T
4 
on paper chromatograms of rat plasma. Numerous 
studies employing a variety of techniques in a number of 
mammalian species have confirmed that over 90% of the 
circulating organic iodine in the normal animal is T 4 
(Rall, Robbins and Lewallen, 1964; Robbins and Rall, 
1967). 
The observation that blood iodine, despite 
its precipitability with plasma proteins (Gley and 
Bourcet, 1900) and inability to pass an ultrafilter 
(Trevorrow, 1939) or a dialysis membrane (Silver, 1942) 
was readily extractable in certain organic solvents 
(Trevorrow, 1939; Riggs, Lavietes and Man, 1942; 
Burger and Member, 1943; Taurog and Chaikoff, 1948), 
lead to the postulate that circulating T 4 is bound in 
8 
some way to one or more plasma proteins. Early attempts 
to identify the binding of T4 to plasma proteins using 
salting out procedures showed that iodine was present in 
most protein fractions. The highest iodine content was 
found in the albumin and a-globulin fractions but the 
latter fraction had the highest iodine to nitrogen 
ratio (Basset, Coons and Salter, 1941; Riggs 
et al. , 19 ,42; Taurog and Chaikoff, 1948; Salter, 1949; 
Silver and Reiner, 1950). The application of zone 
electrophoresis to the prob lem provided clear evidence 
for a specific T 4
-binding protein in serum (Gordon, Gross, 
O'Connor and Pitt-Rivers, 1952). These workers found that 
when serum labelled with a small quantity of radio-thyroxine 
was electrophoresed on paper usin9 barbital buffer at 
pH 8.6, the majority of T4 migrated with the a-globulins. 
The remainder of the label was bound to albumin. Such 
findings were soon confirmed, but it was found that T 4. 
was bound to a protein with an electrophoretic mobility 
between a. 
1 
and a 2-globulins (Robbins . and Rall, 1952; 
Larson, Deiss and Albright, 1952; Winzler and Notrica, 
1952; Larson, Deiss and Albright, 1954). This 
a-globulin fraction, then termed thyroxine-binding 
protein, is now known as thyroxine-binding globulin (TBG) ~ 
Subsequent electrophoretic work at similar 
alkaline pH employing Tris-maleate (Ingbar, 1958; Tata, 
Widnell and Gratzer, 1961) and several other buffer 
systems (Ingbar, 1960; Robbins and Rall, 1960; Blumberg 
and Robbins, 1960; Sterli~g and Tabachnick, 1961a; 
Tata et al., 1961) showed that some of the hormone migrated 
9 
with one of the prealbumins, now termed thyroxine-
binding prealbumin (TBPA). The inability to identify 
binding to this protein in barbital buffer was explained 
by the observation that barbiturate ions compete with T4 
for binding sites on TBPA (Tata et al., 1961; Ingbar , 
1963 ; Woebar and Ingbar, 1964). 
It is now generally accepted that in human 
serum under normal physiological conditions, T 4 is bound 
to three proteins; TBG, TBPA and albumin. This is not 
necessarily true of all mammalian species. Large 
interspecies variations have been demonstrated in the 
electrophoretic mobility of T 4BPs in the plasma of a 
large number of species (Robbins and Rall, 1957, 1960; 
Refetoff, Robin and Fang, 1970). Studies using sheep 
serum have demonstrated T 4 binding in the a-globulin and 
albumin regions using a number of electrophoretic media 
and buffer systems (Robbins and Rall, 1957, 1960; 
Annison and Lewis, 1959; Annison, 1960; Farer et al., 
1962; Refetoff et al., 1970). The subsequent discussion 
will be primarily concerned with human T 4BPs, but species 
differences will be considered where relevant. 
The subject of thyroid hormone-plasma protein 
interactions has been discussed in great detail in 
several expansive reviews (Pitt-Rivers and Tata, 1959; 
Robbins and Rall, 1957, 1960, 1967; Ingbar and 
Freinkel, 1960; Ingbar, 1960; Rall et al., 1964; 
Ingbar and Woebar, 1968). It is not the purpose of this 
treatise to describe in detail the development of 
knowledge on the properties and functions of plasma T4BPs, 
10 
but rather to give a precise summary of the present state 
of knowledge. For a more detailed discussion of the 
deve lopment of curr ent knowledge the reader is referred 
to the above review articles5 
Thyroxine-binding globulin (TBG) 
Some controversy arose ~s to the homogeneity 
of TBG when two TBG bands were identified in human serum 
using starch-gel electr ophoresis (Tata et al., 1961; 
Blumberg, Farer, Rall and Robbins, 1961; Thorson, 
Tauxe ru1d Taswell, 1966; Inada and Sterling, 1970; 
Refe toff et al., 1970). Although both components showed 
TBG-like behaviour, only one band was present when an 
albumin.aemic serum was used, suggesting that the splitting 
represented a protein-protein interaction on a single 
species- of TBG protein (Werner and Nauman, 1968; Inada 
and Sterling, 1970; Refetoff et al., 1970). Despite this 
evidence, only one TBG band was found by other groups 
using a similar buffer system and technique of electro-
phoresis (Britton, Webster, Ezrin and Volpe, 1965) and 
agar gel (Diguilio, Michalak, Weinhold, Hamilton and 
Thomas, 1964) or polyacrylamide gel electrophoresis 
(Marshall and Levy, 1966). These results suggest that 
TBG is a single molecular entity, but the possibility 
of interaction between TBG and albumin cannot be ruled 
out . Studies with purified TBG, using reverse flow 
electrophoresis in glycine-acetate buffer at pH 8.6, 
show that purified TBG has a different mobility to TBG 
11 
of whole serum. On the other hand a TBG-human serum 
albumin (HSA) mixture had a mobility similar to that of 
whole serum TBG (Ste rling, Hamada, Takemura, Brenner, 
Newman and Inada, 19 71.) • This was not confirmed by 
Marshall and Pensky (1971) who demonstrated that. purified 
TBG and TBG of whole serum had identical mobility on 
cellulose acetate electrophoresis in Tris-acetate buffer 
at pH 8.9. More recently a slow moving TBG band has been 
isolated by cellulose acetate electrophoresis of TBG 
fractions prepared on T4 s ubstituted Sepharose columns 
(Marshall, Pensky and Green, 1972). This slow band has 
been attributed to the loss of sialic acid residues from 
the native molecule. 
Although TBG has been identified for over 
twenty years, its purification has proven difficult to 
achieve due to its very low plasma concentration. 
Several groups of workers have now reported the isolation 
of highly purified TBG (Giorgio and Tabachnick, 1968; 
Marshall and Pensky, 1969, 1971; Pensky and Marshall, 
1969; Sterling et al., 1971; Green, Marshall, Pensky 
and Stanbury, 19 72a) . 
Thyroxine-binding globulin is known to be an 
ucidic glycoprotein with an isoelectric point of about 
pll 4 ( l~obb ins, Pc tcrman and Rall, 1955; Ingbar, Dowling 
and Freinkel, 1957; Sterling et al., 1971) and contains 
sialic acid and other carbohydrates (Ingbar, 1958; 
Blumberg and Warren, 1961; Seal and Doe, 1962; Giorgio 
and Tabachnick, 1968; Sterling et al., 1971). Its amino 
acid composition has been assessed in a number of 
laboratories but the estimates show little agreement 
(Seal and Doe, 1964; Giorgio and Tabachnick, 1968; 
12 
Ste rling et al., 1971). Estimates of the molecular weight 
of TBG have also varied widely. Early studies on human 
TBG showed it to be a relatively small molecule with a 
sedimentation coefficient of 3.3 - 3.5 Sand an estimated 
molecular weight of the order of 50,000 (Peterman, Robbins 
and Hamilton, 1954·; Tata, 1961; Seal and Doe, 1962). 
Robbins arid Rall (1957) pointed outi however, that such 
sedimentation coefficients would give molecular weights 
in the range 30,000 - 1,000,000 depending on the shape 
of the molecule. Later studies on highly purified TBG 
reported a sedimentation coefficient of 3. 4 - 3. 9 s and 
a molecular weight of 54,000 - 65,000 (Seal and Doe, 1964; 
Giorgio and Tabachnick, 1968; Marshall and Pensky, 1969, 
1971). A recent publication suggests that TBG is a much 
smaller molecule having a sedimentation coefficient of 
3 .0 Sand an estimated molecular weight of 36,500 
(S terling et al., 1971). While these latter authors 
thought it unlikely that the purified TBG was a dissociation 
product of the native TBG molecule it seems that like the 
composition, the molecular weight of TBG has yet to be 
measured unequivocally. 
The fact that the interaction between T4 and 
TBG is one of reversible equilibrium is evident from 
numerous studies (Robbins and Rall, 1957, 1960, 1967; 
Rall et. al., 1964; Andreoli, Robbins, Rall and Berman, 
1965). Robbins and Rall (1957) calculated the association 
13 
constant to b of the order of 1010 M- 1 . Experimental 
10 -1 
values in the range 1.7 - 4 x 10 M have been reported 
which subst ntiates th concept that TBG has an exceedingly 
high affinity for T4 (Woebar and Ingbar, 1968; Hamada, 
Nakagawa, Mori and Torizuka, 1970; Sterling et al., 197i; 
Green et al., 1972a, b) . . The binding of T 4 to TBG is 
temperature dependent (Green et al., 1972a) however 
exposure to temperatures of 60° for prolonged periods 
abolishes binding due to denaturation of TBG (Takemura, 
Hocman and Sterling, 1971) 5 Various estimates of the 
association constant are summarized in Table 2.1. 
Table 2.1. Reported estimates of the association constant 
between TBG and T4 • 
Association 
(M-1) 
7.9 X 10 9 
8.2 X 10 9 
4 X 1010 
1.7 X 1010 
2.2 X 10lO 
2 . ] X 1010 
J • 7 X 10lQ 
Constant 
( 2 3 °) 
(37°) 
Reference 
Robbins and Rall, 1957 
Oppenheimer and Surks, 1964 
Robbins and Rall, 1967 
Woebar and Ingbar, 1968 
Hamada et al., 1970 
Green cl a]., 1972a, b 
Thyroxine is bound at the rate of one molecule 
of T
4 
per TBG molecule (Seal and Doe, 1962; Marshall and 
14 
Pensky, 1971; Sterling et al., 1971; Green et al., 
1972a) and is strongly bound at moderately alkaline as 
well as neutral pH; the affinity, however, is greatly 
reduced in acid conditions (Robbins and Rall, 1960; 
Korsgaard Christensen, 1961; Marshall and Pensky, 1971). 
The last study, using purified TBG, demonstrated that 
binding of T4 to TBG was maximal over a 
pH range of 
6. 4 - ·10. 4. Below pH 6. 4 the strength of the T 4-TBG 
interaction began to decline and at pH 4.2 binding nearly 
disappeared (Marshall and Pensky, 1971). . It has been 
postulated that changes in the degree of ionization of 
the imidazole group of histidine residues on TBG, artd in 
the phenolic hydroxyl group of T 4 may cause the pH 
dependence of T 4-TBG interactions (Marshall _and Pensky, 
1971). 
The structural requirements on the part of the 
ligand are very strict since closely related analogues of 
T
4 
are bound much less strongly than T 4 (Larson and 
Albright, 1955; Robbins and Rall, 1955, 1957). Thyroxine-
binding globulin has a lower affinity for T 3 than for 
T
4 
(Tanaka and Starr, 1959; Korsgaard Christensen, 1960). 
Some workers have suggested that T3 is bound with about 
one third of the affinity of T 4 (Tata, 1960; Robbins and 
l{ull, 1967) while others conclude that in vivo binding of 
T
3 
by TBG is much lower than this (Zaninovich, Farach, 
Ezrin and Volpe, 1966). 
The binding capacity of TBG for T 4 in normal 
human plasma has been estimated to be 18 - 22 µg T4/100 ml 
15 
of plasma (Robbins and Rall, 1957; Digiulio et ale, 1964, 
Inada and terl..:.ng, 196 7; Ingba and Woebar, 196 8; 
Hamada et al., 1970; Refetoff, Hagan and Selenkow, 
1972) u This binding capacity is considerably altered by 
several physiological and pathological conditions. 
Estimation of the concentration of TBG in normal human 
plasma indicates a much wider range of 1 - 3.4 mg/100 ml 
( Giorgio and Tabachnick, 196 8; Marshall and Pensky, 
1971; sterling et al_. , 1971; Levy, Marshall and Velayo, 
1971; Chopra, Solomon and Ho, 1972). This apparent 
discrepancy between estimates of binding capacity and TBG 
concentration are probably due to the wide variety of 
techniques used to estimate the latter parameter. While 
some estimates of TBG .concentration are derived from the 
binding capacity others have involved competitive binding 
and radioirnmunoassay techniques (Levy et al . , 1971; 
Chopra et al., 1972). 
A summary of various estimates of some of the 
physical properties of TBG is presented in Table 2.2. 
Thyroxine-binding prealbumin (TBPA) 
The higher plasma concentration and the better 
electrophoretic separation of TBPA has made its purification 
a somewhat simpler procedure than the purification of TBG. 
Thyroxine-binding prealbumin has now been isolated in pure 
form in several laboratories (Oppenheimer, Surks, Smith 
and Squef, 1965 ; Purdy, Woebar, Hollaway and Ingbar, 
1965; Raz and Goodman, 1969; Branch, Robbins and 
Edelhoch, 1971). Centrifugal analysis suggested human 
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Table 2.2. Reported estimates of the physical properties 
o f TBG. 
Maximum 
Moles Plasma 
S2 o , w Ass· ciation T4 
(x 1 0- 13 M.Wt. Constant bound Cone. Reference (x 10 3 ) (mg/100 Sec.) ( X 10 1 O M-1) per ml .. ) Mole 
TBG 
3 .3 Peterman et 
-
al. , 1954 
3.5 40-50 1-2 Tata, 1961 
3.3 50±2 1 Seal and 
Doe, 1962 
3.6 59 Seal and 
Doe, 1964 
3 . 92 58 0.1 1.6 Giorgio and 
Tab achni ck , 
196 8 
3. 91 54 Marshall and 
Pensky, 1969 
3. 4 63-65 1 1.5 Marshall and 
Pensky, 1971 
3 .0 36.5 lGO 0.7 1.0 Sterling et 
al. , 1971 
3.4 Levy et al. , 
---1971 
1.7-2.3 0. 85 ( T 4) Green et al. 
0. 91 (T 3) 19 72 a, b 
2. 85 Chopra et 
al. , 1972 
' 
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TBPA had a sed ' mentation coefficient of 4o58 Sand a 
molecular weight of 73,000 (Oppenheimer et al ., 1965). 
A later study indicate that the molecular weight was only 
50,000 ar1d the authors postulated that the discrepanc·y 
between the two estimates was due to the presence of 
retin 1-binding protein in the early preparation (Raz and 
Goodmanv 1969) More recently Branch et al (1971) have 
shown that TBPA has a molecular weight of 54,000 and is 
a stable tetra.mer of identical subunits. The protein also 
binds the retinal-binding protein but binding of T 4 and 
retinol-binding protein are independent (van Jaarsveld, 
Edelhoch, Goodman and Robbins, 1973). 
The affinity of TBPA for T 4 is weaker than the 
corresponding binding to TBG and is strongly pH dependent. 
Binding is most avid at pH 8.6 but decreases with a 
reduction in pH to the physiological range (Ingbar, 1963; 
Lutz and Gregerman, 1969 ). Some workers using paper 
electrophoresis have shown that T 4 binding by TBPA is 
virtually absent at pH 7.4 (Myant and Osorio, 1960; 
Korsgaard Christensen and Litonjua, 1961; Osorio, 1967). 
However recent work employing agarose gel electrophoresis 
and immunoadsorption suggests TBPA is responsible for about 
15 % of T
4 
binding at pH 7.4 in normal serum (Woebar and 
Ingbar, 1968; Lutz and Gregerman, 1969). 
Thyroxine-binding prealbumin has only one T4 
binding site per molecule (Woebar and Ingbar, 1964; 
Oppenhei er et al ., 1965; Oppenheimer, Martinez and 
Bernstein, 1966; Pages, Robbins and Edelhoch, 1973). 
The requirements for hormone binding to this site are 
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quite different from those for binding to the TBG site . 
D-thyroxine and T 3 are bound very weakly 
(Ingbar, 1963; 
Ross and Tapley, 1966; Davis, Handwerger and Gregerman, 
1972; Larsen, 1972; Pages et al., 1973) whereas acidic 
side chain analogues such as tetraiodothyroacetic acid 
are bound more firmly to TBPA than to TBG (Tata et al., 
1961; Ingbar, 1963; Woebar and Ingbar, 1964; Ross and 
Tapley, 1966). 
Despite its lower affinity for T4 , as shown by 
8 -1 
an association constant of 0.16 - 2.3 x 10 M (Woebar 
and Ingbar, 1968; Raz and Goodman, 1969; Hamada et al., 
1970; Pages et al., 1973), TBPA can bind at least ten 
times as much T 4 as TBG due to its higher p
lasma 
concentration of about 30 mg/100 ml (Oppenheimer et al., 
1965, 1966). Although estimates of the binding capacity 
of TBPA for T4 range from 40 - 340 µg/
100 ml (Digiulio 
et al., 1964; Britton et al., . 1965) it is generally 
agreed that the normal mean binding capacity in human 
serum is 230 - 270 µg/100 ml {Oppenheimer et al., 
1963, 1966; Inada and Sterling, 1967; Hamada et al., 
1970; Gordon, Kleinerman, Ehrenfeld and Ehrenfeld, 
1971). Certain types of non-thyroidal illness have 
profound effects on the level of circulating TBPA 
(Ingbar and Woebar, 1968). 
Albumin 
The binding of thyroid hormones to albumin has 
been studied intensively due to the ready availability 
of this protein in a highly purified state. Earlier work 
on human albumin (Sterling and Tabachnick, 1961b; 
Sterling, Rosen and Tabachnick ,. 962) and bovine 
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albumin (Lein, 1952) indicated the existe ce of four T 4 
binding sites per molecule with an association constant 
of 0 .79 - 1.1 x 1 5 M- 1 • Later studies employing 
fluorescen ce quenching (Steiner, Roth and Robbins, 1966) 
or equilibrium dialysis (Steiner et al., 1966; Tabachnick, 
1967) i n dicated that there was a single strong binding 
site with an affinity constant of 1.6 ± Oo4 x 10
6 
M-l at 
pH 7. 4, 26 ° , and an undetermined number of much weaker 
sites . These results are close to the value of 2.5 x 
10 6 M-l obtained earlier by an enzymic assay (Tritsch, 
Rathke, Tritsch and Weiss, 1961). Bovine (BSA) and 
human serum albumin have similar T 4 binding properties 
(Tritsch et al., 1961; Steiner et al., 1966) but chicken 
serum albumin has an eightfold higher affinity at the 
primary site (Tritsch and Tritsch, 1965). 
Because of its high plasma concentration serum 
albumin has an extreme~y high capacity for T 4 , the uppe
r 
limit being governed by the solubility of T4. The 
affinity of albumin for T3 lS about 1/4 - l/6th of that 
for T
4 
at pH 7.4 (Tabachnick, 1964a; Steiner et al., 
1966). This lower affinity for _T 3 is probably due to 
the decreased ionization of the phenolic hydroxyl group 
of that hormone (Sterling and Tabachnick, 1961b; 
Steiner et al., 1966). 
As is the case with TBG and TBPA the interaction 
of thyroid hormones with albumin is temperature and pH 
depen dent. Thyroxine is bound more tightly to albumin at 
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5° than at 38° (Sterling et al., 1962). I vestig~tion 
of the pH dependence of thyroid hormone binding to serum 
albumin has not yielded uniform results. Tabachnick 
( 1964 a) suggests that ·c. e affinity for 1· 4 is constant 
over the pH range 6 .. 8 - 9. 3 while o tside this range 
binding declines rapidly. In contrast, Korsgaard 
Christensen ( 961) found that T4 binding to BSA increased 
with increasing pH between 6.5 and 9o4. Other workers 
reported an increase in the association cons~ant between 
pH 6 and 8 but found little change between pH 8 and 9 
(Trits ch et al., 1961; Steine r et al., 1966). 
The T
4 
binding sites on albumin are considered 
relatively specific for T4 since it has been shown that 
the phenolic hydroxyl group, the iodine atoms in the 3' 
and 5' positions, the diphenyl ether group and the 
carboxy 1 group are all es sen ti.al for high affinity 
binding (Sterling, 1964; Tabachnick and Giorgio, 1964). 
The positively charged £-amino groups of lysine on 
albumin appear to form part of the thyroid hormone binding 
site (Tabachnick, 1964a; Sterling et al., 1962). 
Fatty acids and some other anions are known to 
reduce hormone binding (Sterling et al., 1962; Tabachnick, 
1964 b ; Tab achnick , Downs and Giorgio, 1965; Tabachnick, 
1967). Sodium chloride at a concentration of 0.1 M 
reduces T
4 
binding by 50% at pH 7.4 (Tabachnick, 1967). 
Reported values for the association constants 
of T
4 
with serum albumin are summarized in Table 2.3. 
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Table 2. 3. Reported estimates of the a ssociation constant 
between serum albumin and T 4 
No. of Association 
Binding Constan t 
Sites (M-1 ) 
4 
4 
l 
1 
4 
4 .2 
2 
2 
2 
7. 9 X 10 4 
1.1 X 10 5 
2.5 X 10 6 
2.0 X 10 7 
5 1. 0 7 X 10 
5 1. 6 3 X 10 
5 2.75 X 10 
3.3 X 10 5 
3. 75 X 10 5 
1 1. 6 X 10 
6 
0 • 85 1. 4 X 10 6 
Experimen t al 
Conditions 
BSA, 25° 
pH 9. 75 
HSA, 38° 
pH 7 . 4 
HSA & BSA, 2 3 ° 
pH 7.4 
Chicken SA, 2 3° 
pH 7.4 
HSA, 30 ° 
pH 7.4 
II 
fatty acids 
extracted 
HSA, 30 ° 
pH 7.4 
pH 9.3 
HSA, 30 °, 
pH 7.4 
fatty acids 
extracted 
HSA, BSA, 26° 
pH 7. 4 
HSA, 30° 
pH 7.4 
Reference 
Lein , 1 95 2 
Sterli ng and 
Tabachni ck, 
1961b 
Tritsch et al., 
1961 
Tritsch and 
Tritsch, 1965 
Sterling et al., 
1962 
II 
Tabachnick, 1964a 
II 
Tabachnick, 1964b 
Steiner et al. , 
1966 
Tabachnick, 1967 
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Distribution of endogenous T 3 and T4 between TBG, 1:'~BPA 
and albumin 
The partition of T3 and T4 between their 
individual serum carrier proteins in ivo is dependent on 
the concentration of each binding protein, its respective 
association constant for T 3 and T 4 , the concentration of 
T
3 
and T
4
, and the concentration of any plasma constituent 
that ~ay compete for binding sites on the proteins. 
Studies employing conventional electrophoretic techniques 
have only been able to give approximations of the in vivo 
situation since the distribution of radioactive T 3 and T4 
between the carrier proteins is not only strongly 
influenced by the pH, the ionic composition and the ionic 
strength of the buffer employed, but also by the type of 
medium used, the amount of tracer T 3 and T 4 added, and 
the temperature at whi ch the assay is performed (Tata 
et al., 1961; Marshall and Levy, 1966; Gordon and 
Coutsoftides, 1969; Davis and Gregerman, 1970, 1971) a 
Early estimates indicated that at pH 8.6 TBG 
was responsible for 50-60% of T 4 binding while a large 
proportion (32-37%) was bound to TBPA (Tata et al., 
1961; Oppenheime r et al., 1963). Recent evidence however 
suggests that under physiological conditions TBPA is only 
responsible for 15% of the total bound T 4 (Woebar and 
Ingbar, 1968; Hamada et al., 1970). There is general 
agreement that serum albumin accounts for only 10-15% 
of T
4 
b inding under normal circumstances (Tata et al., 
1961; Oppenhe imer et al., 196 3; Woebar and Ingbar, 
1968; Gordon and Coutsoftides, 1969; Hamada et al., 
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1970). It appears likely that the role of TBG ~n T 4 
binding in vivo is quantitatively much more important, 
and that of TBPA much less important , than was previously 
thought (Woebar and Ingbar, 196 8; Hamada et al. , 19 70) . 
The only estimate of the distribution of T3 
between its c arrier proteins is from results of 
polyacrylamide gel electrophoresis performed at pH 9.0 
(Davis et al., 1972). Whilst the results are unlikely to 
port ray the· true in vivo situation it appears that TBG 
binds over 50% of endogenous T3 • Thyroxine-bindin
g 
prealbumin seems to be only a vecy minor T 3 binding 
protein while a significant portion (30-40%) is bound to 
albumin (Davis et al., 1972) . 
Unbound thyroid hormones 
As the major proportion of plasma T 3 and T 4 is 
strongly bound to plasma proteins it is not surprising 
that the concentration of unb ound (free) thyroid hormones 
in plasma is vecy low. The term unboun d T4 is used in 
preference to free T 4 since free horm
one refers to 
unconjugated hormone in the steroid literature and thus 
does not refer to that portion of circulating hormone that 
is not protein bound. The concentration of unbound hormone 
is so low that direct measurement of unbound T4 has been 
technically very difficult. The earliest estimation of 
unbound T4 was from mathematic
al calculations employing 
data obtained from electrophoretic studies and studies 
using purified serum albumin . This estimate indicated 
that the average concentration of unbound T 4 in the plasma 
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of the euthyroid human was 4 .. 7 ng/100 m1 or appro·:im.::tely 
0 06% of the total plasma T 4 (Robbins and Rall, 9~7). 
Because of the difficulty in direct measurement 
of unbound T 4 
a parameter, the "free thyroxine index", 
was introduced as ·a proportional est_imate o:E unbound T 4 .. 
Such indices are obtained by multiplying- the total T4 
concentration by a factor which is inversely proportional 
to the concen-c.ration of the unoccupied T 4 binding sites. 
Various workers have employed such factors as the T 4 
dialysis rate (Korsgaard Ch~istensen, 1959; Gimlette, 
1965), the erythrocyte T3 uptake (Hamolsky, Stein and 
Freed.berg, 1957) and the resin T3 uptake (Mitchell, Harden 
and O'Rourke, 1960; Gimlette, 1967). These techniques 
give good correlations with clinical findings and more 
sophisticated modifications of the resin method are widely 
employed clinically (Maclagan and Howorth, 19 69; Hamada 
et al. , 1970). 
The first measurement of unbound T 4 was 
described by Sterling and Hegedus (1962). Several 
variations of their basic method, which involves measurement 
of the dialysable portion of serum T 4 after labelling with 
tracer quantities of T 4 (
125 r or 131r), have now been 
described . The concentration of unbound T 4 is the product 
of this dialysable fraction and the total serum T 4 level. 
The major technical problem with this method has been the 
presence of radioactive dialysable impurities in the 
dialysate . These compounds cause an overestimate of 
unbound T 
4 
and a number of methods have been employed to 
remove them. Paper chromatography, Dowex 50 column 
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chromatography, and gel filtrati.or on Sephadex G--25 
co lumns have all been used to sepa.rate T 4 and iodide in 
t he dialysate (Sterling and Hegedus, 1962; Liewendahl and 
Lambe g, 1965). Label]ed T 4 in the dialysat_e has been 
precipitated by MgC12 (Ste~ling and Brenner, 1966) and by 
TCA following addition of whole serum (Oppenheimer et al., 
1963). Ingbar et al. (1965) have added serum to the 
dialysate and then removed labelled iodide by further 
dialysis in the presence o f Amberlite IRA-400 resin. 
Ultrafiltration methods have also been described 
for the measurement of unbound T4 b u t suffer from the same 
p roblems of radioactive impurities in the ultrafiltrate 
(Oppenheimer and Surks, 1964; Schussler and Plager, 
196 7; Thorson, Wi l kins, Schaffr in ,- Morrison and McIntosh, 
1972) . Schussle r and Pla ger (196 7) suggest that more 
accur a t e r esults are obtained if the isotope is purified 
pr ior to use. However, Thorson et al. (1972) obtain 
similar results with purified and unpurified T 4 [
131
r]. 
Although all methods give internally consistent 
results t here are considerable differences between 
laboratories. Table 2.4 summarizes the estimates of 
unboun d T4 conc
entration in normal human serum. 
The effect of dilution of serum on the measurement 
of unbound T 4 has b
een discussed by many authors. 
Oppenheimer and Surks (1964) found that dilution had no 
effe c t on the concentration of free T 4 . This has been 
refute d by others (Ingbar et al., 1965; Sterling and 
Brenner , 1966; Lee and Pileggi, 1971). Spaulding and 
Grege rman ( 19 72) have attributed the decrease in unbound 
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Table 2. 4. Reported estimates of the concentration o[ 
unbound T 4 in normal hu
man serum 
Unbound T 4 
% Unbound T 4 Concentra
tion Reference 
(ng/100 ml) 
0.06 4.7 Robbins and Rall, 1957 
0 . 110 ± 0. 016 1 0 .0 ± 2. 9 . Sterling and Hegedus, 1962 
0 c0 42 ± 00004 2.34 ± 0.28 !Oppenheimer et ale , 19 63 
0.050 + 0.009 4. 0 3 ± 1.08 Ingbar et al. , 1965 
0.0 46 + 0 . 005 2. 76 ± 0.5 Sterling and Brenner, 1966 
0.026 ± 0 . 004 2.1 ± 0.4 Schussler and P lager, 1967 
0.054 ± 0.008 5 .67 ± 0.09 Liewendahl and Lamberg, 1969 
0.038 ± 0 . 00 4 2 .5 ± 0.4 Fang and Selenkow, 1970 
0 . 03 1 + 0 . 004 2 . 64 ± 0.26 Hamada et al. , 1970 
1.9 ± 0.2 Lee and Pileggi, 1971 
0.056 ± 0.007 4 .5 ± 1.1 Liewendahl, Tatterman and 
Lamberg, 1971 
0 . 046 ± 0 .010 4. 2 8 ± 0.78 'Thorson et al. , 1972 
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T 4 concentration 
with dilution to changes in the concen-
tration of phosphate and chloride ions during dialysis 
while Schussler and Plager (1967) suggested that the 
presence of dialysable radioactive contaminants could 
account for these dilution effects. The latter work 
showed that removal of labelled contaminants reduced the 
ultrafiltrable fraction in undiluted serum by about 50%. 
Moreover, when a 1:10 dilution of plasma was made with 
phosphate buffer the ultrafiltrable fraction did not 
decrease (Schussler and Plager, 1967). 
Since it has been demonstrated that pH and 
temperature are important determinants of the binding of 
T 4 to plasma proteins 
it _is not surprising that these 
factors greatly influence the level of unbound T4 
measured in vitro (Fang and Selenkow, 1970; Lee and 
Pileggi, 1971; Thorson et al., 1972; Spaulding and 
Gregerman, 1972). 
Although the electrophoretic pattern of T4 
binding proteins varies greatly ~etween species it is 
interesting to note that the concentrations of unbound 
T 4 in the plasma of m
ost mammalian species studied fall 
within the range reported for normal humans (Refetoff 
et al., 1970). Due to uncertainties in the measurement 
of total T 3 concentration in huma
n serum, it has not 
been possible to arrive at a precise value for unbound 
T 3 . Since T3 is bound less s
trongly to TBG the dialysable 
fraction is 10-15 times greater than that of T 4 (Ingbar 
et al., 1965; Larsen, 1972). This corresponds to a 
normal unbound fraction of 0.26 - 0.46% (Nauman, Nauman 
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and Werner, 1967; Larsen, 1972). If one uses d mean 
value of 0.36% and a mean radioirnmunoassay value for 
total T 3 of 1. 2 ng/ml the mea
n concentration of unbound 
T 3 would be 430 pg/100 
ml, about one-fifth of the absolute 
concentration of unbound T 4 in human serum (Larsen, 1972). 
Factors affecting thyroid hormone-plasma pr~tein 
interactions 
A number of physiological, pathological and 
pharmacological factors alter the interaction of thyroid 
hormone s with plasma proteins. Two types of mechanisms 
are apparent, i.e. those that involve competitive 
interactions for the T 4 binding sites on proteins, 
e.g. 
diphenylhydantoin, and those which cause an alteration 
in the concentration of binding sites by affecting protein 
synthesis and turnover, e.g. pregnancy and oestrogenic 
agents. The influence of such factors on thyroid hormone 
binding to human plasma has been considered in depth in 
two expansive reviews (Robbins and Rall, 1967; Ingbar 
and Woebar, 1968) and the findings are summarized in 
Table 2. 5. 
Species differences may be important, for 
example diphenylhydantoin has no effect on hormone 
binding to rat plasma (Hershman, 1963) but greatly 
reduces T 4 binding to TBG in hu
man plasma (Wolff, 
Standaert and Rall, 1960), while pregnancy which induces 
a significant increase in TBG concentration in the human 
(Robbins and Rall, 1967) has no effect on TBG concentration 
in sheep (Annison, 1960). 
Table 2.5. Fac tors a ffecting thy r o id hormome-plasma 
protein interaction s i n human plasma 
Factors causing a decre ase in h o r mone b inding 
(A) to TBG 
age 
2 9 
1 
2 
3 
4 
5 
6 
7 
an drogeni c and an abolic steroids 
mas cul i nizing di s orders 
idiopathic decrease in TBG 
e x cess glucocorticoids 
acrogmegaly 
diphenylhydantoin 
(B) to TBPA 
1 
2 
3 
salicylates 
dinitrophenol 
some cases of nonspecific illness 
e.g. chronic illness or surgical 
stress 
Factors causing an increase in hormone binding 
(A) to TBG 
1 pregnancy 
2 oestrogenic agents 
3 feminizing tumours 
4 acute hepatoce llular disease 
5 acute intermittent porphyri a 
6 idiopathic increase in TBG 
(B) to TBPA 
1 androgen 
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The physiological role of plasma hormone binding_12,F_oteins 
As a result of their interaction with plasma 
proteins, thyroid and steroid honnones acquire macro-
molecular properties whicn profoundly alter their 
distribution and metabolism. These interactions appear 
to retard the transfer of hormones to extravascular sites 
and although direct experimental ev'dence is lacking 
there is a pos s ibility that the hormonal supply to tissues 
in vivo may be limited by the rate of dissociation of the 
hormone protein complexes ·(Robbins and Rall, 196 7) . 
It is apparent from numerous studies that the 
unbound hormone is freely available to tissues where it 
can induce a metabolic response and undergo degradation 
(Ingbar and Woebar, 1968; Westphal, 1971). When 
considering the t hyroid "status " of individuals it is 
well documented that hyper-, hypo-, and euthyroidism are 
correlated with the unbound rather than the total T 4 
concentration (Sterling and Hegedus, 1962; Ingbar et al., 
1965 ; Thorson et al., 1972). It is also evident that 
abnormally high (Beierwaltes and Robbins, 1959) and low 
(Ingbar , 1961) TBG levels are entirely compatible with 
euthyroidism . In these instances, T 4 production and 
disposal proceed at normal ratese Thus binding of thyroid 
hormones to proteins does not affect either hormone 
action or its steady state production but rather 
determines the level of total T 4 in blood. It thus appears 
that the T4
-protein complex in blood and extracellular 
fluid serves as a hormone reservoir or buffer in that it 
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tends to prevent rapid changes i n unbound T 4 cor1cen tration 
resulting from ab r upt changes in T4 s ecretion and 
degradation. 
Other r oles have been p ostula ted for hormone 
binding proteins. Robbins and Rall (1967) suggest one 
function of T 4BPs may be to establish an Lmbound T 4 
concentration gradient from the ce l ls and e xtra.ce l lular 
fluid of the thyroid gland to the blood streame A similar 
role has been postulated for the steroid ho rmone binding 
pro teins which are also thought to be involved i n the 
active role of transporting hormones into their respective 
target tissues (Baulieu, Raynaud and Mi l grom, 1970) ~ 
CHAPTER 3 
MATERIALS AND METHODS 
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Ex erimental animals 
Sheep. Male and female Merino and Merino cross 
sheep of various breeds and ages were used thro ghout this 
study. Prior to experimentation animals were maintained 
on pasture in small holding paddocks. During the experi-
ments the sheep were hous.ed indoors in individual pens or 
metabolism cages and received lucerne chaff, oats and 
water ad libitum. 
Rats. Adult male rats weighing approximately 
250 g were obtained from a Wistar derived colony maintained 
by the laboratory. Water and a comme rcial rat diet were 
fed ad libitum. 
Rabbits. Adult male rabbits used for the 
production of antisera and as a supply of nonnal rabbit 
sera were obtained from the outbred colony maintained by 
the laboratory. They were housed in individual cages and 
fed a diet of commercial rabbit pellets. 
Human plasma samples 
Nonnal human plasma was obtained from expired 
blood bank whole blood. Plasma was recalcified with 
1 M Cac12 , the clot disrupted
 and removed by centrifugation. 
After dialysis overnight against 0.05 M phosphate, 
0.10 M NaCl, pH 7.4 the serum was frozen in 5 ml portions. 
Plasma from hypothyroid, thyrotoxic and pregnant patients 
was obtained from the Department of Nuclear Medicine, 
The Prince of Wales Hospital, N.S.W. through the kindness 
of Dr I. P. C. Murray. 
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Anaesthetics 
Anaesthetic ether B.P. (Drug Houses of 
Australia, Brooklyn, Victoria) was used to anaesthetise 
rats. 
Thiopentone sodium B .. P. ("Intraval" Sodium, 
May and Baker, Ltd) was used as a 5% solution in distilled 
water for the induction of anaesthesia in sheepa 
Subsequently Halothane B.P. (Fluothane, I.C.I. Ltd) was 
used for maintenance of anaesthesia in a closed circuit . 
Pentobarbi tone sodium B. P. ("Nembutal", 
Abbot Laboratories Pty Ltd) was used for some anaesthetic 
procedures. 
Biological reagents 
Anticoagulant. Heparin (157 I.U./mg, pyrogen 
free, Evans Medical Australia) was used as anti-coagulant 
for lymph and blood samples. 
Radio-Isotopes. L-Thyroxine r125 rJ and 
L-3,3' ,5-Triiodothyronine r125r] in 50% propylene glycol, 
with an initial specific activity of 40-45 mCi/mg, 
containing 4-5 µg hormone/ml were supplied at 2 monthly 
intervals by the Radiochemical Centre, Amersham, England. 
Sodi urn iodide [ 131r] and [ 12 5 I] ( carrier free) 
were obtained as required from the Atomic Energy Commission, 
Lucas Heights, New South Wales and the Radiochemica l 
Centre, Amersham, England. 
Thyroid and steroid hormones. L-Thyroxine sodium 
salt (BDH Chemica l s Ltd, Poole, England) and the correspond-
ing salt of L-3,3' ,5-Triiodothyronine (Schwarz Bioresearch 
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Inc., Orangeburg, N.Y., U.S.A.) were dissolved separately 
in an appropriate volume of 50% propylene glycol 
containing a few drops of 0~l M NaOH, to give a final 
concentration of 1 mg/ml. These stock solutions were 
diluted by weight with 50% propylene glycol to produce 
serial 10 fold dilutions which were used as working 
standards. 
Stilboestrol, 5 mg/ml (Knoll Laboratories Pty 
Ltd, Sydney) and testosterone propionate, 50 mg/ml 
(Troy Laboratories Pty Ltd, N.S.W.) in arachis oil were 
used for intramuscular injection. 
Serum albumin. Human serum albumin, 100% pure 
on electrophoresis was supplied by Hoechst Australia Ltd, 
Sydney . Sheep fraction V (95% . pure) and rat fraction V 
were obtained from Schwarz Bioresearch Inc., Orangeburg, 
N.Y., U.S.A. Crystallised rabbit albumin, 100% pure by 
electrophoresis was obtained from Mann Resea ch 
Laboratories , N.Y., U.S.A. 
Scintillation fluid. Naphthalene 60 gm, 
2,5-diphenyl oxazole (PPO, scintillation grade, Packard) 
4.0 gm, and 100 ml methanol were dissolved in 1,4-dioxane 
to give a final volume of 1 litre. 
Biological solutions. Physiological saline 
was a 0.9% w/v solution of sodium chloride in distilled 
water. 
Tris (hydroxymethyl) aminomethane and barbital 
buffers of varying molarity and pH were prepared by 
titrating an appropriate amount of Tris (Sigma Cnemical 
Company, St Louis, U.S.A.) or sodium barbital t o t he 
desired pH with 1 M HCl. 
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Sodium phosphate buffers of varying molarity 
and pH were prepared as described by Green and Hughes 
( 19 5 5) • 
Statistical methods 
All statistical analyses and mathematical 
computations were carried out using a PDP 8/I computer 
(Digital Equipment Corporation) running a 7 user FOCAL 
system 'LIBRA' . 
Analysis of variance used the program VAIM 
which calculated the means and sum of squared deviations 
about the means of any number of groups of observations. 
For only one group, it calculated the mean, variance, 
standard deviation, and standard deviation of the mean 
(standard error), and it tested whether the mean was 
significantly different from zero. For two or more groups, 
it calculated the mean and sums of squared deviations 
about the mean of each group and the overall mean. The 
variance, standard deviation, and standard error of the 
overall mean were calculated from the aggregate within-
group variation. It tested whether or not the group 
means differed significantly from each other and if the 
overall mean differed significantly from zero. These 
tests were made according to standard methods of analyses 
of variance. 
Program RIIM was used for linear regression 
analysis. It fitted the line of best fit of the form, 
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Y = a + bx 
• • • • • X y • n n It 
calculated the values of a and b, the values fitted for 
each x value, the mean values of x and y, the ,ariance of 
a and b, the variance and standard deviation of y, and 
the standard error of the mean of y. It tested whether a 
and b were significantly different from zero . When 
replicate values of y were available for the various x 
values, it also tested whether the relationship between 
y and x deviated significantly from linearity. These 
analyses were made using standard methods of least squares 
analysis. 
A large number of other programs were used to 
solve specific problems, where relevant such programs 
will be described in detail. 
The majority of graphs in this thesis were 
drawn by a Hewlett-Packard 7200A Graphic Plotter connected 
to the PDP 8/I computer. Data points and axes were 
• 
plotted using two FOCAL programs, PFIM and PLIM, chained 
together. A number of different programs were used to 
draw the graphical solutions to models fitted to the 
experimental data points. 
Surgical procedures 
All sheep undergoing surgery were starved for 
the preceding 12 hours. Anaesthesia was induced by 
intravenously administered thiopentone sodium at a dose 
rate of 0.1 gm per 5.0 kg body weigh t . The sheep were 
then intubated with a cuffed Magill enaotracheal tube and 
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anaesthesia was maintained with a mixtur e of haloth ane 
and oxygen administered in closed c·rcuit by means of a 
Boyle's anaesthetic machine. All operations were carried 
out under strict aseptic conditionsG 
Lymphatic cannulations. Chronic lymphatic 
fistulae were established in sheep in the afferent and 
efferent vessels of the popliteal lymph node , the afferent 
testicular lymphatics, the lumbar lymphatic trunk, the 
intestinal lymphatic trunk, the efferent hepatic lymph 
duct, the deep cervical lymph duct and the efferent 
lymphatics from the prefemoral and prescapular lymph 
nodes. The surgical procedures have previously been 
described by Lascelles and Morris (1961), Hall and Morris 
(1962) and Morris and McIntosh (1971). Lymph was collected 
into plastic bottles or plastic centrifuge tubes tied to 
a plastic holder sutured to the animal's skin. Powdered 
heparin was used as an anticoagulant. Lymph so collected 
was centrifuged for 10 minutes at 2,000 rpm to remove the 
cells. Cell free lymph was separated and frozen at -20° 
until required. Occasionally small volumes of lymph 
were collected without anticoagulant, the lymph was 
allowed to clot and the clot gently disrupted. After 
approximately 6 hours at room temperature the serum was 
rourcd off, centrifuged at 2,000 rpm for 10 minutes and 
stored at -20 °. 
Samples of afferent hepatic and afferent renal 
lymph were kindly supplied by Dr G. G. MacPherson. 
Blood vessel cannulations. Chronic indwelling 
arterial and venous cannulae were placed in either the 
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carotid artery or external jugular vein of sheep~ The 
cannulae were kept patent by flushing out with heparinized 
sterile saline and care was taken to maintain sterility 
at all times. 
Blood was als o obtained from sheep by 
venipuncture of the external jugular vein._ Both serum 
and plasma were prepared as described above. 
Thyroidectomy. The thyroid glands of adult 
sheep were ablated via a mid-line incis ion extending from 
the laryngeal cartilage to the 10th trache al ring. The 
gland was dissected free of its connective tissue attach-
ments, leaving the recurrent laryngeal nerve in situ. The 
gland was remove d following ligation of the thyroid 
arteries and veins. 
Cannulation for terminal bleeding. Adult male 
rats were anaesthetized with ether and the abdominal 
aorta was cannulated. Blood was collected into tubes 
containing powdered heparin and plasma was separated by 
centrifugation . 
Protein estimations 
The total protein and albumin concentrations of 
blood plasma and lymph were measured by the method of 
Lowry, Rosebrough, Farr and Randall (1951) as modified 
by Debro, Tarver and Korner (1957). Bovine serum albumin 
(0-150 µg) was used for preparation of the standard 
curves. 
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Immunization procedure 
Rabbits were injected in multiple intramuscular 
sites with 1 ml of whole serum or appLoximately 5 mg of 
se rum albumin fractions emulsified in 1 ml of Freund' s 
comp lete adjuvant (Difeo Bacto Laboratories, Michigan, 
U.S.A.) e A second course of injections was given 3 weeks 
later and the rabbits bled at weekly intervals from the 
external marginal ear vein. Blood was allowed to clot 
and serum removed, centrifuged and then frozen at -20°. 
Immunoele ctrophoresis 
Agar coated glass slides were prepared using 
a 1% solution of agar (1.0 gm of special Agar-Noble, 
Difeo Bacto Laboratories, Michigan, U.S.A. dissolved by 
boiling in 25 ml of 0.1 M barbital buffer, pH 8.6 and 
75 ml of distilled water containing 1:10,000 merthiolate). 
Samples were electrophoresed for 1 hour in agar plates 
with a current of 50 mA and a voltage of 250 V using an 
LKB 6800 A apparatus (LKB Produktor, Sweden). The antisera 
were allowed to react for 12-24 hours at room temperature 
in humid chambers. Slides were then washed in 1% saline 
for 6 hours , a fresh 1% saline solution for 16 hours and 
finally rinsed in distilled water. The gel was covered 
with strips of wet blotting paper and dried at room 
temperature. When dry the blotting paper was moistened, 
removed and the slides gently washed in tap water. 
The slides were then stained for 10-60 seconds 
with amido black (9 gm of amido black in 1,500 ml of 
40 
rinsing solution) while maintaining a constant rocking 
motion and then ro .ked to and fro for 2 minutes in each 
of 4 separate volumes of rinsing solution (1,500 ml of 
methanol, acetic acid and distilled water in the ratio by 
vo lume 9:2:9). After drying the slides were trimmed and 
labe lled. 
Double diffusion 
Double diffusion in agar was carried out in 
buffered agar on glass slides as des cribed above. Samples 
(5 µ1) were placed in wells punched 5 mm apart in the 
gel and were allowed to react with antiserum for 12-24 
hours, after which the slides were processed as described 
in the preceding section. 
Column chromatography 
Samples of serum, lymph or serum albumin 
labelled with T 4 I
125 rJ and/or serum albumin r131rJ were 
fractionated on G-200 and DEAE (A-50) Sephadex columns. 
G-200. Descending gel filtration was carried 
out using 2.0 x 90 cm glass columns. Fifteen grams of 
Sephadex G-200 (Pharmacia Fine Chemicals , Uppsala, 
Sweden) were allowed to swell in 0.05 M phosphate, 
0.10 M NaCl buffer, pH 7.4 containing 0.02% sodium 
azide for 2-3 days at room temperature~ After washing 
3 times in the buffer to remove fines, the slurry was 
packed into the column under gravity. The column was 
used with the LKB 4900A RecyChrom System at 4°. Samples 
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of serum, lymph (1. 0 - 1 .2 ml) or serum a lbumin (5 0 -
60 mg in 1.0 ml of buffer) were loaded onto the column 
and eluted with the above buffer. A cons tant f l ow rate 
of 5 ml/hour was maintained b y using a p e ris taltic pump 
and effluent fract i on s of 3 ml were co llected using an 
automatic fraction collector. The effluen t was continually 
monitored for protein at 254 nm using a 3 mm light path 
continuous flow cell. Pooled protein fractions were 
concentrated by dialysis at 4° in 10% polyethylene glycol 
containing 0 . 9% sodium chlor ide. 
DEAE Sephadex. Ten grams of DEAE-A50 Sephadex 
(Pharmacia) was allowed to swell in distilled water for 
2-3 hours, then washed 2-3 times with distilled water 
and the starting buffer and finally packed into a 2.5 x 
50 cm glass · column. The column was equilibrated with the 
starting buffer, 0.01 M phosphate pH 8.0. The sample, 
500 mg of sheep fraction Vin 5 ml of starting buffer, was 
introduced on to the top of the column and eluted with a 
phosphate linear gradient system (Fahey, McCoy and 
Goullian, 1958). A flow rate of 15 ml/hour was obtained 
by hydrostatic pressure and consecutive 5 ml volumes of 
eluate were collected. The optical densities of eluate 
fractions were read at 280 nm using a Hitachi 101, 
spectrophotometer. 
The purity of isolated albumin was tested by 
immunoelectrophoresis and double diffusion in agar using 
rabbit anti-sheep serum, rabbit anti-sheep fraction V, 
and monospecific rabbit anti-sheep albumin . Pure fractions 
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from gel filtration were pooled, dialysed for 48 hours 
against several changes of distilled water, lyophilized 
and refrigerated until use. 
Polyacrylamide gel electrophoresis 
Pdlyacrylamide gel electrophoresis was performed 
in the E-C470 Vertical Gel Electrophoresis Cell (E-C 
Apparatus Corporation, Philadelphia, Pennsylvania). A 
water cooled 3 mm thick slab of 5% Cyanogum-41 (95% 
acrylamide and 5% bisacrylamide) was used and the buffer 
system was Tris-Na2 EDTA-boric acid at pH 8.4 (Peacock, 
Bunting and Queen, 1965). Samples were prepared as 
either 2% or 4% protein solutions in 40% sucrose ann 
20 µl portions were loaded into each slot. The separation 
occurred in a uniform electric field of 300 volts at 
100-150 mA for 2 hours at room temperature. All samples 
were electrophoresed in duplicate. Following electro-
phoretic separation the gel was divided in half 
longitudinally; one half was stained for protein while 
the other was retained for autoradiography. 
The gels were stained with a 0.25% solution of 
amide black for 30 minutes. The gel was then washed 
several times in the rinsing solution of methanol, water, 
acetic acid (5:5:1) to remove excess stain. 
Protein labelling with radio-iodide 
Protein samples were labelled with 
131
r or 
125 r according to the method of Helmkamp, Goodland, Bale, 
Spar and Mutschler (1960). A 2 mg/ml solution of 
43 
lyophilized protein was made up in 0.20 M borate buffer 
-• . d'd 1311 12s a·1 d pH 8.0. Soctiurn io i e or 1 was i ute to 
2 mCi/ml with 0.05 M NdOH. Borate buffer (4o0 ml) and 
13} 
an appropriate amount. of I (usually 100 µCi) were mixed 
and allowed to stand in an ice bath. Iodine monochloride 
(5 µl of a 0.02 M solution) was added, mixed and rapidly 
jetted into 4.0 ml of the protein solution. The non-
protein bound radio-iodide was removed by passing the 
protein solution over a column of Dowex l-X4 ion exchange 
resin in the chloride form. 
With 100% incorporation of iodine he above 
reagent mixtures would lead to 1 atom of iodine per 
molecule of protein (MQWt. = 70,000). The normal 
incorporation rate was of the order of 55 - 65%. 
Radioactivity measurements 
Samples containing both 1251 and 1311 labelled 
compounds were counted in a two channel Packard Gamma 
Scintillation Spectrometer, Model 578. Windows were 
chosen such that 1311 counted independent of 125 r while 
a constant proportion of 1311 (16%) counted in the 125 1 
channel. Suitable volumes were chosen such that the 
efficiency of c~unting did not change between samples. 
Thyroxine [125 1] in the T 4BP assay was counted 
either in a Beckman LS200 liquid scintillation counter or 
in a Packard well-type external crystal scintillation 
counter~ 
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Autoradiography 
Electrophoretograms of rat fraction V and rat 
plasma which had been labelled with T4 [
125
r] were held in 
close contact with Kodak rapid processing medical X-ray 
film (RP/554). After a suitable exposure period the film 
was developed using Kodak liquid X-ray developer, type 
2 (Kodak (Australasia) Pty Ltd, Coburg, Victoria). 
Estimation of the thyroxine-binding properties of plasma 
proteins 
Principle of measurement of unbound and protein-
bound T4 . Thyroxine is bound reversibly by Se
phadex. 
When a constant amount of Sephadex is in contact with a 
constant volume of buffer solution containing T4 , at 
equilibrium the amount of T 4 included within the Sephadex 
(I), comprising both Sephadex-bound T 4 and T 4 dissolved 
within the included buffer, is related linearly to the 
amount of unbound T4 (U) in the excluded volume (EV). 
r = au (1) 
When T 4 binding proteins are added to such a system, 
they 
are confined to the excluded volume if the porosity of 
the Sephadex is appropriate, and a greater proportion of 
the total T 4 is present in the excluded volume than when 
no binding proteins are present. The T4 in the excluded 
volume (E) consists of unbound T 4 and protein-bound T 4 
(B) • 
E = U + B (2) 
If the total amount of T 4 present in the system 
(T) , the 
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concen tr at ion of rr 4 in the excluded volume ( [E ] ) , the 
excluded volume, and the constant a in equation (1) are 
all known, then the concentrations of unbound T 4 ([U]) 
and protein-bound T 4 (IB]) can be determined as follows: 
T - I + U + B 
from ( 1) T - (1 + a.)U + B 
solving (2) and (4) for u 
u - (T - E)/a. 
[U] - (T/EV - [E])/a. 
[B] - [E] - [U] 
The partition of the total T4 between the 
( 3) 
( 4) 
(5) 
( 6) 
( 7) 
included and 
excluded volumes is measured most conveniently and 
accurately by using radioactively-labelled T 4 • Equations 
(1) - (7) above are valid for both labelled and unlabelled 
T
4 
and labelled T 4 is distinguished in the following by 
an asterisk. If the total amount of radioactivity added 
to the system (T*) and the concentration of radioactivity 
in the excluded volume ([E*]) are measured, then the 
concentrations of unbound T 4 and protein-bound T4 in the 
excluded volume are given by the following: 
[ U] - [ U * ] T /T * 
- (T*/EV - [E*]) T/a.T* (8) 
I B] - [ B *] T /T * 
- [E*] T/T* - [U] (9) 
Serial additions of T 4 standards result in a progressive 
saturation of the T 4BPs in the EV. The corresponding 
concentrations of [B] and [U] can thus be calculated for 
each T 4 addition. 
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Measurement of radioactivity. Much prelirninury 
experimentation was done using separate tubes to determine 
[U] and [B] for each amount of total T 4 added. One half 
gram portions of Sephadex G25 coarse grade, (Pharmacia) 
were weighed into 5 ml graduated stoppered tubes. 
Four millilitre samples of plasma or lymph diluted 1/160 
with an appropriate buffer and containing the smallest 
. f [125] convenient amount o T4 I , were added to each of the 
tubes, followed by the required amounts of T4 dissolved 
in 50% propylene glycol. The gel swelled quickly and 
the contents of the tubes were mixed thoroughly for 10 
minutes or longer at room temperature. The Sephadex was 
then allowed to settle. Approximately 1 ml of the 
supernatant 1 as judged by the graduations on the tubes, 
was aspirated from each tube in a single portion into a 
disposable transfer pipette, and transferred into a 
scintillator vial containing 10 ml of dioxane-based 
scintillator. A separate pipette was used for each tube 
and was rinsed several times with the scintillator in the 
vial after the sample was delivered. This procedure was 
essential to ensure quantitative transfer of the sample 
into the counting vial and to remove T4 adsorbed onto 
the pipette during transfer. The adsorbed T 4 could 
otherwise be considerable and variable, especially when 
high proportions of T 4 in the supernatant w
ere unbound. 
The exact amount of supernatant taken from each tube was 
determined by weighing the tubes before and after the 
samples were taken. One millilitre samples of the diluted 
l abelled plasma being studied were also pipetted into 
10 ml portions of scinti llator to determine the total 
amount of radioactivity added to the tubes. 
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The constant a in equation (1) was determined 
by the same procedure using buffer alone. Howeve r it was 
t dd the T4 [
125I] ne cessary o a (10 µl in 50% propylene 
g l ycol) directly to the tubes containing the Sephadex 
and buf fer, and to the scintillator v ials used to determine 
the t o tal amount of radioactivity added . In the latter 
c a s e, 1 ml of buffer was a dded to the scintillator to 
e n sure the radioactivity was measured under comparable 
conditions. 
Radioactivity was measured using an automatic 
3 channel liquid scintillation counter. No corrections 
were necess ary for differential quenching. The excluded 
volume was de termined by measuring the concentration of 
added HSA [1 31rJ in the supernatant. 
It wa s possible to demonstrate the value of the 
princi ple by this p r ocedure , and to determine optimal 
proportions o f Sephadex and buffer and optimal dilutions 
of plasma fo r satisfactory analyses. However the procedure 
was considered too tedious for routine use because many 
tubes h a d to be used f o r each sample studied, the Sephadex 
had to be weighed before and after the samples of super-
antant were t aken f or radioassay. Moreover it was 
difficult t o s tudy binding at temperatures other than 
room tempe ratur e. To overcome these difficulties, the 
fol l owing apparatus and procedure were developed. 
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Comp lete a n a lysis of a s ingle sample in the 
same vessel. It was f o und that when various volumes of 
1 . . . [ 1 2 SI ] 1 ab 1 1 d ub t a so ution containi ng e e s s ances we r e 
added to a counti ng tube an d counte d i n a well-type 
external crystal scintillation counter {Packard, Breda, 
The Netherlands), beyond a certain c ri ti c a l volume the 
count rate did not increase with the volume counted. 
Provided this critical volume was exceeded, relative 
concentrations of radioac tivity in different solutions 
could be measured without accurately measuring the 
solutions into the counting tubes. At the same time full 
use was made of the counting potential of the external 
crystal detector. 
An apparatus was devised to exploit this 
phenomenon in studying the binding of T4 to proteins us·ing 
Sephadex as a competitive binding agent as outlined 
above. Using this apparatus the radioactivity in the 
excluded volume could be measured each time the system 
came to equilibrium after additional T 4 was added. 
The vessel used is shown in Figure 3.1. It 
consists of a flat-bottomed round flask of about 85 ml 
capacity, fitted with B10 and B29 ground glass socket. 
A stopper was machined fr om Teflon or Nylon to fit in 
the larger socket , and bored so that a polypropylene 
counting tube could be fitted tightly into it to make a 
water-tight seal. 
To carry out an assay, 3.75 g of Sephadex G25 
was weighed accurately into the flask. Plasma to be 
Fi gure 3.1. The apparatus used for the thyroxine-binding 
protein assay. One flask is in the upright position for 
shaking in the Warburg apparatus at 37°. The separation 
of settled Sephadex and the supernatant is clearly 
demonstrated. The supernatant can then be poured into 
the counting tube which is placed in the scintillation 
detector as shown. 
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studied was diluted 1/150 with suitable buffer 'l' 4 
[125 1] added to give a total initial concentration of 
exogenous T 4 of 0.1 ng/ml dilute
d p l asma (0.01 - 0.02 µCi/ 
ml). Ten millilitres of the diluted plctsma was pipetted 
directly into the counting tube fitted in the la ge 
stopper, and 20 ml added directly to the Sephadex in the 
flask. After the radioactivity of the dilutea plasma in 
the counting tube had been determined, the counting tube 
was attached to the flask and the diluted plasma trans-
ferred into the flask. The smaller socket was stoppered, 
and the flask with the counting tube horizontal, was shaken 
in a Warburg apparatus at 37° for 2 hours. The Sephadex was 
then allowed to settle while the flask remained in the bath, 
and the supernatant then poured into the counting tube 
which was inserted into the scintillation detector and the 
radioactivity in the supernatant measured. The supernatant 
was then poured back into the flask, the next required 
amount of T4 added and the flask
 then shaken in the water 
bath for 7-10 minutes, when the Sephadex was again 
allowed to settle and the radioactivity in the supernatant 
measured as above. This procedure was repeated as many 
times as required. Thyroxine, dissolved in 50% propylene 
glycol, was added by means of micrometer burettes (Agla, 
Burroughs Wellcome, London). 
The large stopper was machined so that it 
supported the weight of the flask on the top of the lead 
castle surrounding the scintillation detector during 
radioassay, with the bottom of the counting tube just 
clear of the bottom of the well. The shielding at the top 
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of the castle, and t he geometry of the flask were s uch 
that radioactivity i n the flask was n ot detecte d during 
radioassay and it was not necessary to remove t he counting 
tube from the flas k . 
The constant a was determined by a ddi ng 
T4 [
125
r] (10 µl in 50% propylene glycol) d i r ectly to 
30 ml of buffer and 3. 75 g Sephadex i n the assay flask, 
and assaying the s upern·atant after equilibrati on in the 
water bath as ou tlined above. The total amount of radio-
activity added was measure d by pipett ing the same volume 
of T 4 [
125rJ into 10 ml of buffer in a counting tube and 
measuring the radioactivity in the same apparatus. The 
mean a value (± standard deviation) was 7.362 ± 0.083 
(n = 6) and was independent of the concentration of added 
cold T 4 • Presumably there was some b
inding of T 4 to 
the glassware but as the count rate in the excluded volume 
did not change with added T 4 this binding to glass forms 
part of the competitive binding system and is accounted 
for by the calculation of alpha. Simulation studies have 
shown that substantial errors in the calculation of a 
result in unchanged estimates of the binding capacities 
of the specific T4BPs. 
The excluded volume was determined by the 
dilution of added HSA [131r] in the supernatant. Twelve 
separate estimates gave a mean (± standard deviation) 
value of 22.32 ± 0.53 ml. This resulted in a final 
dilution of plasma proteins in the excl uded volume of 
1:111.6 when the initial dilution in buffer was 1:150. 
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Calculation of results. In the detector used 
the actual critical volume above which the count rate 
does not increase, lies between 9 and 10 ml. Its true 
value is not required to calculate a, [U] or [B], and 
is o f no importance provided the volume of fluid counted 
exceeds this volume. Then the measured count rate for 
a solution can be used as a measure of the relative 
specific activity (cpm/unit volume) of the fluid. In the 
assay procedure, the actual count rate measured in the 
supern atant can be used in equations (8) and (9) for 
[E* ], as it can also for calculating a according to 
equation (10) below. The total amount of radioactivity 
added, in equivalent units, is calculated by multiplying 
the count rate for the solution added by the total 
volume of solution in which the total added radioactivity 
was contained (viz 30 for the assay procedure, and 10 for 
measuring a). By substituting [E*] for [U*] in equation 
(6) a can be calculated according to: 
a = (T*/EV - [E*]) /IE*] (10) 
Analysis of errors. To reduce the counting 
error to less than 1% at least 100,000 counts were 
counted for each addition of T 4 . Inspection o
f equations 
(8) and (9) indicates that if the precision of radioassay 
does not change during an assay, the precision of 
calculated values of [U] and [BJ is likely to be related 
to the precision with which T 4 is added to the sys
tem 
which would be related to the amount of T 4 added. 
Fitting the binding data. A considerable amount 
of evidence from electrophoretic studies suggests that T 4 
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is bound by a numbe r of proteins. The refore attempts were 
made to fit a model of the form of equat ion (11) t o the 
binding data. 
[B] = L Ci[U] /(Ki + [U]) (11 ) 
This assumes that T4 is bound a ccordi n g to the law of mass 
action by a number of non-interacting p r oteins with 
binding capacities c. a~d dis s o c i at i on constants K . . i i 
Electrophores is indicates the presence of 3 T 4BP s in 
human plasma: TBG, TBPA an d albumin . Moreover t he 
dissociation constant for T 4-albumin is mu ch h igher than 
that for T4-TBG or T 4-TBPA (Robbins an d Rall , 1967; 
Hamada et al., 1970). It should be possible therefore 
to study binding over a r ange of IU] which would contain 
sufficient information to calculate the binding parameters 
for TBG and TBPA , but [U] would remain small relative 
to the dissoci ation constant for T 4-albumin. The 
denominator (K. + [U]) in the term in equation (11) 
i 
corresponding to albumin would not change appreciably from 
Ki, and over this range of [U] albumin-bound T 4 (Balb) 
would be given by: 
[B]alb - Calb [U]/Ka lb 
- Kn [U] 
(12) 
This is equivalent to the non-specific binding in the 
formulation of Baulieu and Raynaud (1970), b ut it should 
be pointed out that for any binding prote i n, even so-called 
specific binding proteins, there is a range o f IU] over 
which such a relationship holds. 
For human plasma the model fitted to the binding 
data is given by (13): 
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[B] = cl [U]/(K l + [U] ) + c2 [U]/( K2 + [U]) + Kn [U] ( 1 3 ) 
The parameters c 1 , K1 , c2 , K2 and Kn were fitted to the 
experimental data using an iterative least s q u ares 
method which has b e e n we ll documented (Drape r and Smith, 
1966; Baulieu and Raynaud, 1970). These accounts have 
been presented in a formal mathemati cal manner , difficult 
for many non-specialis t statisticians to f o l low. Therefore 
the practical appli cation of these methods will be 
described. 
Initial es t imates of the non- l inear parameters 
K1 and K2 were req ui r ed to start the solution, and 
initial values for the linear parameters c1 , c2 and Kn 
were set to zero. Corrections for c1 , c2 , K1 , K2 and Kn 
(c1 , c 2 , k 1 , k 2 and kn respectively) to improve the fit 
were calculated by fitting the multiple regression: 
Y = c 1x1 + c 2x2 + k 1x3 + k 2x4 + knXn (14) 
A 
in which if [BJ is the value of IB] calculated according 
to equation (13) using current values of c1 , c2 , K1 , K2 
and K the dependent variate Y i s given by: 
n 
A 
Y = ( [BJ - [B])/T 
and the independent vari ates x1 , x2 , x3 , x4 and Xn are 
given by: 
Xl - [U]/(K1 + [U]) T x3 - -c1 [U]/(K1 + [U] ) 
2T 
x2 - [U]/(K2 + [U]) T x4 - -c2 [U]/(K 2 + [U] ) 
2T 
X - [U]/T 
n 
The term Tin the denominators of each variate is a 
weight ing f unction, since as outlined above, the likely 
error for any measured [BJ is related to the t otal amount 
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of T4 adde d. Use 
of these weighting functions also makes 
solution numerically possible when [B] and [U] vary over 
a wide range. 
The current estimates of the parameters were 
corrected by adding to them their respective corr ections, 
and the procedure repeated using the corrected estimates 
until the corrections were all les s than some stipulated 
fraction of their last determined respective parameter. 
In practice a tolerance of 1% has proven suitable. If 
convergence did not occur, o r if it occurre d too slowly, 
the solution was stopped and the suitabiiity of the 
model, or the starting values examine d. 
The actual solutions were obtained using a 
PDP 8/I computer. The routine used two separate FOCAL 
programs chained together and could handle a maximum of 
18 pairs of data points. Complete solution takes about 
5 minutes. 
Calculation of unbound T4 concentrations. The 
concentrati on of unbound T4 in plasma or lymph was 
calculated for given values of total T 4 , and the 
dissociation constants and binding capacities of the 
binding proteins. A FOCAL program was used to compute 
the appropriate root of the equation in [U]: 
by means of an iterative procedure. Amounts bound to 
the various proteins were calculated according to: 
B - C[U]/(K + fU]) for specific binding proteins 
or B - K [U] for albumin (non-specific binding) 
n 
where the various parameters have the same meaning as above. 
55 
Estimation of total T 4 concentration 
Total plasma T 4 concentrations were mea
sured 
by a modification of the method of Murphy and Pattee 
(1964 ). Serum or plasma (1.0 ml) was added dropwise to 
2.0 ml of absolute ethanol, shaken and the precipitate 
removed by centrifugation. Duplicate portions (0.2 ml) 
of the supernatant were dried in 5 ml graduated test 
tubes under a stream of nitrogen at 37°. Sephadex G25 
(0.5 00 gm) and 4.0 ml of a 1:150 dilution of a human 
125 
plasma containing tracer T 4 [ I] was added, the tubes 
were shaken for at least 10 minutes at room temperature 
and an accurately weighed portion (approximately 1 ml) 
of the supe rnatant was removed for counting as described 
above. A standard curve was prepared by adding in 
duplicate O, 2, 5, 7, 10 and 15 n_g quantities of T 4 to 
tubes containing Sephadex and the dilute plasma-tracer 
solution. Unknown T 4 concentrations w
ere read from a 
standard curve of% T4 [
125
r] in the excluded volume 
versus T 4 concentration. The result
s were corrected for 
an ethanol extraction efficiency of 75.2% and expressed 
as µg/100 ml of plasma. A typical standard curve is 
shown in Figure 3.2. 
A pooled sheep plasma sample was analysed 6 
times in duplicate in 6 separate assays conducted over 
a period of 2 months. The mean (± SD) total T 4 value was 
5.6 ± 0.4 which gave a coefficient of variation of 7.2%. 
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Figure 3.2. A typical standard curve for the estimation 
of total thyroxine in blood plasma and lymph. 
Transcapillary transfer of thyroxine-binding proteins 
and t hyroid hormones 
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Chroni c lymphatic fistulae were established 
in adult male and female sheep as previously described. 
The cannulae were allowed to flow for 24 hours prior 
to an experiment by which time animals had completely 
re covered f rom surgery and were eating and drinking 
normally. Blood was collected through an indwelling 
j ugular vein cannulae and the plasma separated by 
centrifugation. A volume of plasma, (3 ml), was mixed 
with approximately 15 µCi T 4 [
125
r] and 10 µCi HSA 
[131r]. This mixture was shaken and dialysed overnight 
at 2 ° ag a inst a slurry of Amberlite IRA-400, (Cl) resin 
(BDH Chemicals Ltd, Poole, England) and 0.9% saline 
contained wi t hin a dialysis me mbrane. Such treatment 
removed labelled impurities not firmly bound to proteins. 
The radioactive dose was weighed accurately into a 
sterile syringe and infused into the jugular vein: The 
cannul a wa s rinsed several times with blood and sterile 
heparinized saline. Dose time and dose weight were 
recorde d and a portion of the injected material was 
retained for radio-assay. Blood and lymph samples were 
collect e d at timed intervals after injection and plasma 
was separated in the usual manner. Lymph flow rates 
were r e co r de d. Where volumes permitted 3.0 ml of plasma 
or lymph were counted in a gamma scintillation spectrometer 
system be f o re and after protein precipitation with two 
volumes o f cold 10% trichloroacetic acid (TCA). The 
precipitate was deposited by centrifugation and the 
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supernatant poured off. Results were expressed as the 
percentage of the dose remaining/litre of plasma or lymph 
at any fixed time after injection. 
In some experiments a large dose of T 4 was 
injected at the same time as, or 72-98 hours after the 
tracer injection. L-thyroxine sodium (5 mg) was dissolved 
in 2.0 ml of 0.9% steri e saline containing 2-3 drops of 
1 M NaOH to ensure that the T 4 was completely disso lved. 
Following the administration of this dose, blood and 
lymph samples were collected at short time intervals 
over an appropriate time period. 
125 In experiments where T3 [ I] replaced labelled 
T 4 TCA precipitation was inadeq~ate in separating T3 from 
other labelled plasma iodocompounds. To overcome this 
125 problem T3 [ I] was separated on strong anion exchange 
resin columns as described by Sutherland and Irvine 
(1973 ). A 50% (v/v) slurry of AG1-X2, 200-400 mesh, 
chloride form (Biorad Laboratories , Richmond, California) 
in 0.1 M acetate buffer, pH 5.0 , was prepared and 3 .0 ml 
of this slurry was pipetted into glass columns (0.8 x 
20 cm) to give 0.8 x 2.5 cm resin columns. The columns 
were washed with 8 ml of 0.1 M NaOH. Plasma or lymph 
(2.0 ml) was added to 8.0 ml of 1 M NaOH, shaken, allowed 
to stand for 15 minutes and added to the columns which 
were then eluted sequentially with 8.0 ml of 1% acetic 
acid, 8.0 ml of 18% acetic acid, 0.8 ml of glacial 
aceti c acid and finally with 6.0 ml of 59% acetic acid. 
The last fraction which eluted 82.5% of the T r125 rJ 3 was 
retained for gamma counting. 
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Perfusion of popliteal lymph nodes . An afferent 
popliteal lymphatic accompanying the recurren t tarsal 
ve in was cannulated in the direction of lymph flow. The 
surgical procedure has bee n described in detail by Hay 
(1970) . Sterile Evan ' s Blue dye (0.2 ml) was slowly 
infused up the afferent lymphatic and all efferent 
lymphatics were identified, tied off, and one cannulated 
as described by Hall and Morris (1962). A 24 hour collection 
of sterile lymph was made after clearance of the dye. 
Cells were spun off and the l ymph plasma retained. An 
infusion system was set up whereby the sterile efferent 
lymph l abel led with T 4 [
125 r] or T3 [
125 rJ (0.2 µCi/ 
100 ml) and OSA r131r] (0.2 µCi/100 ml) was infused into 
the afferent lymphatic at the rate of 1 ml/hour. Varying 
concentrations of T 4 (0 - 100 µg/ml) were added to the 
infusion mixture to assess the effect of changes in 
unbound T4 concentration on 
the passage of T 4 through a 
lymph node. Each infusion was continued for 4 hours 
with a 1 hour sterile saline wash between treatments. 
Efferent lymph was collected over half hourly intervals 
and the radioactivi ty counted before and after precipit-
ation with TCA. Results were expres·sed as the T 4 :albumin 
activi ty ratio in efferent lymph/the T 4 :albumin activity 
ratio in the infusion mixture. 
CHAPTER 4 
FACTORS AFFECTING THYROXINE BINDING 
TO PLASMA PROTEINS IN VITRO 
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INTRODUCTION 
Most methods previously described for 
characterizing T4BPs in biologi cal
 fluids have involved 
dilution of these fluids. Electropho resis has been the 
mos t widely used technique for studying thyroid hormone-
protein interactions. With electrophoresis, the sample 
and its constituent p roteins necessarily become diluted 
during separation, often in unphysiological buffers at 
unphysiological temperature and pH. In the competitive 
binding technique developed for the studies reported in 
this thesis, and indeed in most other techniques used 
to meas ure unbound T 4 concentrations, it i
s necessary to 
dilute the samples so that the proportion of the total 
T4 which is unboun d i
s increased and thus measured more 
accurately. It is not possible to dilute plasma without 
changing the ionic composition of the solution since the 
plasma prote ins themselves constitute a considerable 
proportion of the functional anions in undiluted plasma. 
The purpose of the experiments described in 
this chapter was to study some of the effects of ionic 
strength , ionic composition, pH, and temperature on the 
binding of T 4 by plasma proteins, 
so that conditions 
most likely to reflect the in vivo situation could be 
used routinely in vitro. The methods of parameter fitting 
used in subsequent chapters of this thesis had not been 
developed when these experiments were carried out. The 
results were therefore not suitable for that type of 
analysis and the effects of the various treatments are 
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described qualitatively. It was hoped, however, t hat the 
differential effects of some ions, e.g. barbital (Tata 
et al., 1961), and temperature (Takemura et ale, 1971) 
on binding by individual proteins might have a use in 
characterizing the binding system. 
Methods of graphical presentation of binding data 
When specific binding proteins are present as 
homogenous preparations, the binding parameters for a 
particular ligand can be readily calculated from measured 
bound and unboun d ligand concentrations using simple 
linear regression techniques . In the case of blood 
plasma and lymph, non-specific binding proteins are 
present concomitantly with the specific binding proteins 
and the above methods are invalid. Human plasma is known 
to have three T 4BPs and thus the relat
ionship between 
bound and unbound T4 is the sum of 3 hyp
erbolic functions 
and no linearization is theoretically possible. 
Linearization can however be attained over narrow 
concentration ranges but when the range is extended the 
slope of the initial straight line must be modified to 
try and fit all points. Therefore the values for the 
binding parameters are determined rather arbitrarily 
and inaccurately . 
Despite these limitations one such graphical 
technique, the Scatchard plot , has been used widely to 
obtain quantitative estimates of binding parameters in 
mixtures of binding proteins. This type of analysis 
plots the [B]/[U] ratio on the ordinate against [BJ on 
the abscissa. A typical Scatchard plot is shown i n 
Fi gure 4.1. 
Rearrangement of the mass action equation 
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s hows that if there is only one set of independent binding 
sites then 
[B]/[U] = k{C - [B]) 
where k - the associat ion constant 
an d C - the binding capacity for t he ligand under study. 
The plot of [B]/[U] versus [BJ is then a straight line 
wi th a slope of -k an d intercepts on the ordinate and 
abscissa of kC and C, respectively (Scatchard, 1949). 
If there are two or more sets of independent binding 
sites the Scatchard plot is non-linear, and division of 
such plots into two or more linear components can at 
best be only an approximation, s ince even at the very 
lowest concentration of ligand some of the ligand is 
bound t o proteins other than the specific binding 
prote i n o f highest affinity. Quantitative estimates of 
the binding properties of TBG in plasma using extra-
polation o f the initial slope of the Scatchard plot can 
only yield a minimal estimate of the associati on constant 
and a maximal estimate of the binding capacity. 
In most binding experiments it is necessary to 
saturate t he specific binding proteins to gain maximal 
information about the binding system. Logarithmic 
presentati ons are essential to cover the entire 
concentrat ion range studied. One such method is the 
proportional graph of Baulieu and Raynaud (1970 ). In 
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Figure 4.1. A Scatchard plot of data for the binding of 
T 4 by human plasma diluted 1:111.6 in t
he excluded 
volume. The extrapolation technique for the estimation of 
the T 4 binding parameters is dem
onstrated. The slope, -k, 
and the intercept, C, are graphical estimates of the 
association constant and binding capacity respectively of 
human TBG. 
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this presentation the log of the proportion of bound 
([B]/[T ]) or unbound ([U]/[T]) ligand is plotted as a 
funct ion of the log of the total ligand concentration 
([T]) . A proportional graph for the binding of T 4 by 
human plasma is shown in Figure 4.2. Using this type of 
analysis, without concurrent statistical evaluation, it 
is impossible to obtain accurate estimates of the binding 
parameters in such complex mixtures of binding proteins 
as plasma. However, this form of graphical presentation 
is useful in determining the number of specific binding 
proteins present in the plasma of various species. 
Another useful graphical presentation is the 
plot of log [B] versus log [U]. Since this method gives 
some indication of which regions of the graph, and thus 
which binding proteins, are most affected by a particular 
treatment the log [BJ versus log ID] plot has been 
invariably used in the qualitative studies presented 
here. If the assumption that the binding properties of 
T
4
BPs are not changed by dilution is true, it is possible 
to correct [B] for dilution, i.e. multiply by 111.6, and 
estimate the concentration of unbound T 4 in undiluted 
plasma directly from a log IB] versus log IU] plot as 
shown in Figure 4.3. 
RESULTS 
Effect of ionic strength and ionic composition on T 4 
binding to plasma proteins 
A normal human plasma sample was assayed 
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Figure 4.2. A proportional graph (log [U]/[T] versus 
log [T]) of data for the binding of T 4 to human plasma 
diluted 1:111.6 in the excluded volume. 
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Figur e 4. 3. A plot of protein-bound T 4 versus unbound T 4 
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sample diluted 1:111.6 in the excluded volume. The right 
hand ordinate scale has been corrected for a dilution of 
111 . 6 which allows a direct graphical estimate of the 
unbound T 4 concentration in undiluted plasma. 
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following dilution (1:150) in three different buffer 
systems at different con centrations. The systems used 
were : 0.05, 0.10, and 0.15 M sodium phosphate buffer 
pH 7.4; 0.05 M sodium phosphate pH 7.4 to which 0.05, 
0.10, and 0.15 M NaCl was added, and 0.05, 0.10, 0.15 
and 0.20 M barbital pH 8.6. 
Results are summarized g raphically in Figure 
4.4 where the concentration of unbound T4 in undiluted 
plasma, estimated from the results with the diluted 
samples, are plotted against the ionic stre ngth of the 
buffer. The concentration of unbound T4 was increased, 
and hence the binding of T4 to plasma proteins 
was 
decreased, with increased ionic strength in al l three 
buffer systems . The relative effect was greatest at the 
lower ionic strengths studied. Additions of NaCl caused 
a greater reduction in binding than did equimolar 
additions of sodium phosphate buffer. Although, as shown 
below, an increase in pH from 7.4 to 8.6 results in an 
increase in T4 binding to whole plas
ma, the use of 
barbital buffer over a similar ionic strength range at 
pH 8.6 resulted in greatly diminished binding compared 
with the other two buffer systems. 
Effect of temperature on T 4 binding 
A human plasma sample, diluted 1:150 with 
0 . 05 M sodium phosphate, 0.10 M NaCl buffer, pH 7.4, 
was analysed at 25° and 37°. The results are shown in 
Figure 4.5 and clearly indicate that the degree of 
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Figure 4.4. The effect of ionic strength and ionic 
composition of the assay buffer on the unbound T 4 
concentration of a human plasma sample. The composition 
of the buffer systems is described in the text. Unbound 
T 4 concentrations in barbital buffer are presented on a 
different ordinate scale than results obtained with the 
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prote in-binding was greatly affected by temperatur e. At 
any given unbound T4 concentration the sample ass
ayed at 
25° bound considerably more T4 than when analysed at 37°. 
Sheep plasma showed a ·similar response. 
To test the effect of "heat denaturation II of 
TBG on the binding of T4 to plasma proteins a hum
an 
sample, diluted as above , was heated to 60 ° for 1 hour. 
Following cooling the sample was assayed in the normal 
manner. The results for heat t reated compared with 
untreated plasma are shown i n Figure 4 . 6. Thyroxine-
binding globulin activity was removed by heat treatment 
as indicated by the absence of the initial steep slope 
in the Scatchard plot (Figure 4.6). Thyroxine-binding 
pre albumin and albumin binding properties appeared to be 
retained as the Scatchard plot of heat treated plasma did 
not yield a straight line. When sheep plasma was subjected 
to the same protocol similar results were obtained. This 
indicated the presence of more than two T4BPs in sheep 
plasma and demonstrated that sheep TBG and human TBG 
respond simi larly to exposure to elevated temperature. 
Effect of pH on T 4 binding 
Since a large n umber of T4 binding studies have 
employed alkaline buffers, especially at pH 8.6, it was 
important to compare binding at that pH with binding at 
physiological pH. A human and a sheep plasma sample 
were analysed in 0.05 M Tris, 0.10 M NaCl buffer at 
pH 7.4 and pH 8.6. Both samples showed qualitatively 
similar responses to this change in pH. Results for the 
15 
$ 
\ 
$ 
\ 
$ 
10 \ 
B/U \ 
$ 
\ 
5 '-..._ Normal 
~$ ~ -----*---$ 
~
8
- L - L --- . -----$ L---A- ---L---
Heat Treated 
500 1,000 
BOUND T 4 ( ng/ 100 ml) 
Figure 4 . 6 . A Scatchard plot of T 4 binding to a human 
plasma sample before (normal) and after (heat treated) 
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h umc.1n sample are shown in Figure 4. 7. At pH 8. 6 plasma 
bound more T4 at all levels of unbound T 4 tha
n when 
assayed at pH 7.4, however, the differences were smallest 
at the lower unbound T4 concentrationso T
his suggested 
that TBG binding of T4 is less pH sensitive betw
een 7.4 
and 8.6 than the binding of T4 to TBPA and albumin. The 
pH dependence of T 4 binding to TBPA, over 
this pH range, 
lS illustrated in Figure 4.8 where a heat treated ( 6 0 ° 
for 1 hour) human sample was assayed at pH 7.4 and 8. 6. 
Considerably increase d T4 binding , presumably to TBPA 
and a l bumin, was demonstrated at the more alkaline pH. 
Effect o f merthiolate on T4 binding 
Equilibrium dialysis -buffer systems, used for 
the assessment of plasma unbound T4 concentrations, have 
often cont a ined merthiolate as a bacteriostat. Since 
it has been suggested that this substance interferes 
with t hyroid hormone-plasma protein interactions, the 
effect o f various concentrations of merthiolate on T4 
binding was studied using the present assay system. A 
human plasma sample was diluted 1:150 in 0.05 M phosphate, 
0.10 M NaCl buffer, pH 7.4, and increasing concentrations 
-5 -3 
of merthiol ate were added over the range 10 to 10 
gm/ml of buffer. The concentrations of unbound T 4 at 
each mert h i olate concentration are shown in Table 4.1. 
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Table 4.1. Effect of merthiolate concentration on the 
estimation of unbound T4 concentration 
Merthiolate 
Concentration 
(gm/ml of buffer) 
0 
1 X 10-5 
2 X 10-s 
5 X 10-5 
1 X 10-4 
3 X 10- 4 
5 X 10-4 
1 X 10- 3 
Unbound T 4 
Concentration 
{ng/100 ml) 
1.7 
1.9 
2.4 
2.9 
3.6 
5.1 
6.0 
6. 8 
At all concentrations of added merthiolate there was an 
increase in the concentration of unbound T 4 and thus a 
reduction in the affinity of the T 4BPs for T 4 . 
Effect of barbital buffer on T 4 binding 
It has often been suggested that barbiturate 
ions are specific inhibitors of T 4 binding to T
BPA, however, 
the elevated unbound T4 levels found usi
ng barbital buffer 
(Figure 4.4) appeared to be too great to be due entirely 
to the inhibition of TBPA binding. To study this effect 
in more detail a human plasma sample was assayed in 
0.05 M phosphate, 0.10 M NaCl buffer, pH 7.4 and 0.15 M 
barbital buffer, pH 8.6. The relationship between bound 
and unbound T 4 in each buffer syste
m is shown in Figure 4.9. 
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Figure 4.9. The effect of dilution in barbital buffer on 
the binding of T4 by human plasma. The composition of 
the two buffer systems is described in the text. 
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At a ll unbound T 4 concentratio
ns studied the plasma 
sample assayed in phosph te buffer bound considerably 
more T
4 
than when assayed in barbital. The paralle l 
nature of the two binding curves suggested that T 4 
binding to all three T4BPs was affected by the use of 
barbital buffer. 
DISCUSSION 
The results reported in this chapter clearly 
demonstrate that the T 4 binding parameters derived from 
the competitive binding assay described in Chapter 3 are 
dependent on the in vitro conditions under which the 
assay i s performed. For this r eas on it was necessary t o 
choose carefully those conditions most likely to 
approximate the in vivo state and to maintain stringent 
control over these conditions. 
The observation that the ionic strength, the 
ionic composition and the pH of the buffer system, as well 
as the assay temperature, influenced the T4 binding 
properties of plasma proteins is in general agreement wi t h 
a number of studies in the literature (Gordon and 
Coutsoftides , 196 9 ; Coutsoftides and Gordon, 1970; 
Davis and Gre german, 1971 ; Spauldi~g and Gregerman, 
1972). 
In de s igning the routine T 4BP assay system use 
was made o f the present q u alitative information. While 
control of assay temperature and pH at 37° and 7.4 was 
easily attained , choice of an appropriate buffering system 
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posed some problems. Chloride ions at a concentrat ion o f 
0.10 M were included because of their profoun d effect on 
binding and their presence in normal plasma at approximately 
that concentration. The buffering iohs were s upplied by 
sodium phosphate b uffer at a concentration of 0.05 M 
since changes in phosphate concentration had minimal 
effects on the binding of T 4 to plasma prote ins. 
Phosphate is not present at this concentration in plasma 
which may lead to an artefactual situat ion s i nce 
Spaulding and Gregerman (19 72) have shown that T4 
binding by plasma proteins is increas ed with decreases in 
the molarity of phosphate buffer below 0.05 M. Woebar 
and Ingbar (1968) demonstrated that unbound T4 concentration 
was 20% lower in Krebs Ringer bicarbonate buffer than in 
Krebs Ringer phosphate buffer which suggests that the 
use of bicarbonate buffer would be more likely to 
approach the in vivo state. This buffer was not used 
however because of the technical difficulty of keeping 
the assay system continuously supplied with carbon 
dioxide. Whilst it would be naive to postulate that T 4 
binding in a simple buffer system, like 0.05 M sodium 
phosphate, 0.10 M NaCl, pH 7.4, is identical to binding 
in whole plasma it appears likely from the results 
presented here that T4 binding in this buffe
r system 
bears a close approximation to T 4 binding in vivo. 
Merthiolate should be excluded from the buffer 
system because of its profound effect on T4 binding. 
Such an observation is at variance with published data 
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which have shown that merthiolate, when present at 
-4 4 
concentrations of 10 gm/ml of buffer and at 0.5 x 10-
gm/ml, had no effect on the concentrations of unbound T 4 
and T 3 respectively (Sterling and Brenner , 1966; Nauman 
et al. , 1967). This apparent anomaly in results might 
be explained by the use of diluted plasma in the current 
assay s ystem. 
The presence of more than two binding species 
makes graphical interpretation of binding data difficult. 
Since it has been well documented that human plasma 
contains three r 4BPs attempts were made to specifical
ly 
remove one of these binding proteins in the hope of 
simplifying the binding system to make graphical 
interpretation more simple. Two approaches, based on 
phenomena which have been described in the literature, 
were investigated , viz. the specific denaturation of TBG 
by exposure to elevated temperature, and the inhibition 
of T4 binding to TBPA by barbiturate 
ions. 
Scatchard plots of binding data obtained with 
both human and sheep plasma which had been heat treated, 
were very different from those obtained with unheated 
plasma. With both species, heat treatment reduced 
markedly the initial steep slope of the Scatchard plots, 
but the plots were still not linear and indicated the 
presence of at least 2 binding proteins in the heated 
plasma. In the case of human plasma, these 2 proteins 
were probably TBPA and albumin since Takemura et al. 
(1971) have shown that T4 binding to TBG is eliminated by 
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such treatment, while the binding to TBPA is not affected. 
In the case of sheep plasma, the situation might not be 
so s imple since only 2 binding proteins have been 
described. If heat treatment affects sheep TBG the same 
as h uman TBG, then such a result indicates the presence 
of mo r e t h an 2 binding proteins which are not separated 
by e lect rophoresis. Alternatively heat might affe ct 
sheep TBG by reducing its affinity for T4 • 
The attempt to specifically remove the binding 
of T4 to TBPA using barbital 
buffer was clearly unsuccesful 
due to the fact that barbiturate ions reduced T 4 binding 
to all the plasma T4BPs. While such an ob
servation is 
at variance with most published data it can be readily 
explained in t he light of the present results and some 
published data. A change in pH, in Tris-NaCl buffer, 
from 7.4 to 8.6 was accompanied by an increase in the 
ability of human plasma proteins to bind T 4 . Differences 
were greatest at the higher unbound T 4 concentrations wh
ere 
TBG was saturated (Figure 4.7). This indicated that the 
binding of T 4 to TBPA and albumin w
as more sensitive to 
changes in p H over this range, than was the binding of 
T 4 to TBG. Such obs
ervations are in agreement with 
published data (Steiner et al., 1966; Lutz and Gregerman, 
1969; Marshall and Pensky, 1971). When the same pH 
change was acc ompanied by a change in composition with 
respect to o ther ions, 
. i.e. phosphate-NaCl at pH 7.4 and 
barbital at pH 8.6, the results were considerably 
different. Binding at the more alkaline pH was severely 
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reduced and the two graphs were essentially parallel 
suggesting that each of the binding proteins was influenced 
to a similar extent (Figure 4.9) 8 However if barbital 
had an identical effect on all three T4BPs one would 
expect graphs of the fonn shown in Figure 4.7 and not of 
a paralle l nature as shown in Figure 4.9e The latter 
graphical result indicates that the interaction between 
T4 and TBG is less affected by barbiturate ions than is 
the binding of T4 to TBPA and albumin. This inhibitory 
effect of barbital on T4 binding to plasma proteins is 
probably due to competitive inhibition at the T4 binding 
sites which results in a reduction in the apparent 
association constant between these sites and T4 . The 
apparent associ ation constant for TBPA is reduced to a 
greater extent than that for TBG. Such an hypothesis is 
supported by the following observations reported in the 
literature: 
1. T4 is bound to TBPA when barbital buffer concentrations 
are lower than those normally employed (Ingbar, 1960; 
Davis and Gregerman, 1970). 
2. The use of barbital buffer increases the proportion 
of T4 bound to TBG over that seen in other buffer systems 
(Ingbar, 1963; Davis and Gregerman, 1970). 
3. Tetraiodothyroacetic acid, which is bound more firmly 
to TBPA than is T4 , has been shown to bind to TBPA even 
in the presence of barbiturate ions at a concentration 
where no binding of T4 is evident. The amount bound, 
however, is considerab ly less than when other buffer 
systems are used (Ingbar, 1960, 1963). 
72 
4. When a mixture of purified TBPA and HSA was subjected 
to electrophoresis in barbital buffer both proteins were 
shown to bind T4 (Ingbar, 1960). 
While the qualitative information reported in 
this chapter was of considerable value in designing an 
in vitro assay system which approximated T 4 binding 
in vivo, it was virtually valueless in assessing the 
physiological binding properties of plasma T4BPs. For 
this reason attempts were made to attain quantitative 
estimates of the thyroid ' ·hormone binding properties of 
plasma proteins by using the present technique in 
conjunction with a mathematical technique for fitting 
non- linear regressions. The quantitative data obtained 
using these techniques is presented in the following 
chapter. 
CHAPTER 5 
THE THYROXINE-BINDING PROPERTIES OF 
PLASMA PROTEINS. QUANTITATIVE ESTIMATES. 
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INTRODUCTION 
The major requirement for unambiguous 
dete rminations of hormone-protein binding parameters is 
that measurements of protein-bound and unbound hormone 
concentration be made when the system is in a state of 
thermodynamic equilibrium (Westphal, 1971). Since 
hormone -protein complexes are held together by dissociable 
non-covalent bonds the need for equilibrium techniques 
can not be ove rstressed. Currently available electro-
phoretic methods, and competitive bin.ding techniques 
employing ion exchange resins, dextran coate d charcoal 
and Sephadex columns do not fulfil this requirement 
(Robbins and Rall, 1957; Inada and Sterling, 1967; 
Keane, Pegg and Johnson, 1969; Roberts and Nikolai, 
1969; Refetoff et al., 1972; Elewaut, 1973). 
The competitive bindi~g technique described in 
Chapter 3 allows estimation of the concentration of 
protein-bound and unbound T4 at equilibrium under 
conditions closely approximati ng those existing in vivo. 
If sufficient data points are avai lable, mathematical 
analysis of the binding data allows estimation of the 
number of specific binding proteins, their individual 
association constants and binding capacities together 
with an assessment of the unbound hormone concentration. 
Quantitative results obtained using this technique are 
summarized in this chapter. 
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RESULTS 
Thyroxine -binding proteins in human serum 
Computer simulation studies demonstrated that 
an appropriate mathematical analysis of binding data 
could be attained if values of [BJ and [U] covered a 
range of concentrations, from a point where TBG was less 
than 50% saturated to a concentration where TBPA was 
gre ater than 90% saturated. A standard protocol was 
adopted to ensure this and a typical set of results are 
shown in Table 5.1. Using such data it was possible to 
get a seemingly adequate fit to a model consisting of two 
specific binding proteins (TBG and TBPA) and one non-
specifi c binding protein (albumin) as described in 
equation 13 of Chapter 3. 
Six replicate analyses of the same human plasma 
samp le were subjected to mathematical analysis and the 
bindin g parameters calculated. The results are summarized 
in Tab le 5.2. The standard deviation for each of the 
' 
fitted parameters was calculated and expressed as a 
percentage of the mean {i.e. % coefficient of variation). 
The coe fficient of variation was 10.8% for K1 and 10%, 
13%, 15.6% and 6.0% for c1 , K2 , c2 and Kn respectively. 
Because of the method of fitting, individual estimates of 
Kand C for each of the specific binding proteins were 
significantly correlated, i.e. an estimate of K1 or K2 
above (or below) the mean value was accompanied by a c1 
or c2 value above (or below) the corresponding mean C 
value. With replicate analyses the mean value of K is 
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Table 5.1 . A typical results table for the analysis of 
a human plasma sample di luted 1:150 with 0.05 M phosphate, 
0. 10 M NaCl buffer, pH 7.4. 
Background Counts - 2,500/400 sec 
Excluded Volume - 22.32 ml 
a - 7.362 
Endogenous T4 - 19.24 ng 
Total Counts/10 ml 
dilute plasma - 267,564/400 sec 
Count rate 
Total in the Unbound T4 Protein-bound T4 
Added T4 excluded Concentration concentration 
volume [U] [B] (ng) (Counts/ (ng/100 ml) (ng/100 ml) 
400 sec) 
0 271 , 185 2 . 878 62.131 
10 26 3,874 4.740 91. 3 70 
20 256,816 6.834 118.662 
40 248,419 11.167 172. 0 3 7 
80 231,070 21.647 263.608 
120 219,152 33.208 346.151 
200 202,025 58.701 491. 404 
300 191,713 91.098 668.521 
500 180,574 158.050 1,004.730 
700 173,407 22 7. 7 33 1,318.100 
1, 000 165,114 337.160 1,747.150 
2,000 146,535 732.039 2,925.460 
4,500 131,188 1,756.840 5,556.760 
7,000 126,973 2,779.250 8,208.100 
10,000 123,395 4,028.330 11,204.200 
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Table 5.2 . Six replicate estimates of the thyroxine-
binding properties of a normal human plasma sample 
diluted 1 : 111.6 in the excluded volume. K1 , c 1 , K2 , c 2 
and K , the p a rameters previously described were not 
n 
corrected fo r dilution. c1 , c2 and Kn values calculated 
from the me an K1 and K2 values are s
hown in parentheses. 
Sample Kl Cl K2 c2 K 
No. (n g/l00ml) (ng/l00ml) (ng/l00ml) (ng/l00ml) n 
1 9.70 193 475 2609 1.44 
( 1 76) ( 300 7) ( 1. 31) 
2 7. 9 7 166 620 2 839 1.47 
(173) ( 2 3 46) (1.61) 
3 8 .10 164 591 2817 1.39 
(169) ( 2 46 4) (1 . 49) 
4 9 . 42 196 511 2103 1 . 6 3 
( 182) (2273) (1.57) 
5 7 .26 161 444 2039 1.56 ( 184) (2211) (1.52) 
6 8.77 200 513 2109 1.46 (19 6 ) ( 2189) ( 1. 43 ) 
Mean 8.54 180 526 2419 1.49 
(180) ( 2 416) ( 1. 49 ) 
SD 0.93 18 68 377 0 . 09 
(10) ( 30 7) ( 0. 11) 
% c.v. 10 . 8 10.0 13.0 15.6 6.0 
( 5 . 6) ( 12. 7) ( 7. 4) 
-
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likely to be a more precise estimate of the true value of 
K than any individual estimate of K. For this reason 
c1 , c2 and Kn were recalculated using the m
ean values of 
K1 and K2 . These values are sh
own in parentheses in 
Table 5.2. While the mean values of c1 , c2 and Kn were 
unaffected by the use of mean K1 and K2 values the 
coefficients of variation for c1 and c2 were reduce d to 
5.6% and 12.7% respectively while that for K was slightly n 
increased to 7.4%. 
Insofar as it is valid to extrapolate from 
diluted to undiluted plasma the association constants 
and binding capacities of the two specific binding 
proteins and the association constant of the non-spe cific 
binding protein were calculated using the mean values in 
Table 5.2. The association constant of the most avid 
T P bl G 9 4 lo g -l d. b' d' 4B, presuma y TB was . x M an its in ing 
capacity was 20 µg/100 ml of plasma. The association 
constant of the other specific binding protein (TBPA) was 
1.5 x 10 8 M-l with a binding capacity of 270 µg/100 ml 
of plasma. The association constant of human albumin 
calculated from Kn' using the measured albumin concentration 
of 3.7 g/100 ml, and assuming one binding site per albumin 
molecule was 3.07 x 10 5 M- 1 . From the values of K1 and K2 , 
and the values of c1 , c2 and Kn corrected for dilution, 
it was possible to calculate the unbound T4 concentration 
in undiluted serum. Using the six replicate measurements 
of these parameters a mean unbound concentration of 
2.20 ± 0.07 ng/100 ml was calculated which was identi cal 
to the unbound T4 concentration calculated from the mean 
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estimates of K1 , c1 , K2 , c2 and Kn corrected for di
lution. 
Properties o f plasma T 4BPs in subjects of differing 
clinical thyroid states 
Plasma samples from 3 normal, 2 hypothyroid, 
2 hyperthyroid and l pregnant human subject were analysed 
as described in Chapter 3. The results extrapol ated to 
undi luted plasma are Slli'11ffiarized in Table 5.3. 
The variance in the estimates of the mean 
association constants for TBG and TBPA was not signif-
icantly different from the variance obtained with 
replicate estimates on the one plasma sample. It is 
conceivable that the association constants of the T4BPs 
vary between individuals and for this reason it was not 
valid to use the mean association constants for the 
calculation of individual binding capacities. The mean 
values for the association constants of TBG, TBPA and 
9 8 
albumin in these samples were 9.5 x 10 , 1.6 x 10 and 
5 - 1 3.06 x 10 M respectively. The TBG binding capacity 
in the one pregnant subject was 44.5 µg/100 ml which was 
significantly higher than the mean value of 21.3 ± 3.2 µg/ 
100 ml for the other seven subjects. The mean value for 
the plasma TBPA binding capacity was 307 ± 78 µg/100 ml. 
Using the estimated values of K1 , c1 , K2 , c2 
and K and correcting for dilution the concentration of 
n 
unbound T 4 and the distribution of bound T4 betwee
n its 
three binding proteins in undiluted plasma was calculated. 
These are shown in Table 5.3. The unbound T4 concentrations 
agreed well with the clinical status, the mean unbound T 4 
Table 5.3. The thyroxine-binding properties of human plasma pro t eins from subj ect s of differing 
clinical t hyro i d status. 
TBG TBPA Albumin % Distribution of Total T4 
Total Unbound 
Thyroid T4 Ti+ Cone 
Status (µg/ K B.C.* K B. C. Cone. K (ng/ 
100ml) assoc assoc K assoc TBG TBPA Albumin Unbound 100ml) (M- 1 X (µg/ (M- 1 X (µg/ n (g/100 (M- 1 X 
10 9 ) 100ml) 10 8 ) 100ml) ml) 10 5 ) 
Normal 5.6 9.4 20.0 1.52 270 166.2 3.7 3.07 73.3 20.1 6.5 0. 0 39 2.2 
8.0 8.5 24.8 1 .72 202 256.8 4.2 4.22 74.4 16 .1 9.6 0.0 37 3.0 
4.7 10. 7 19. 0 1. 5 8 302 215. 6 4.3 3.44 72 .1 20.4 7.4 0. 0 34 1. 6 
Hypo- 3.5 11.3 17.3 1.65 457 212.8 5.6 2.62 64.7 2 8. 8 6.5 0.031 1.1 
thyroid 2.8 9.8 25 .7 1. 5 8 355 233.6 6.0 2. 36 75 . 5 18.4 6 .. 1 0 .. 026 0.7 
Hyper- 9.2 8.8 22.9 1.02 304 170.0 4.3 2. 74 76.0 16.6 7.3 0 .. 043 4.0 
thyroid 8.6 9. 8 19. 4 1. 86 240 218.4 4.3 3.50 6 8. 2 22.8 9.0 0.041 3.5 
Pregnant 7.3 7.9 44.5 1.92 326 16 3. 2 4.5 2.52 80 .1 16 .. 4 3 .. 4 0.021 1.5 
Mean 9.5 21. 3** 1.61 307 204.6 4.6 3.06 73.0 20.0 6.97 
SD 1.1 3.2 0. 2 8 78 3 4. 5 0.8 0.63 4.8 4.3 1.90 
* B.C. - binding capacity 
** Pregnant sample excluded from mean estimate. 
.....J 
'° 
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concentration in normal human pl as ma was 2.3 ng/100 ml 
while that in the plasma of hypothyroid and h ype rthyroid 
subjects was 0.9 and 3. 8 ng/100 ml respective ly. The 
latter level is lower than reported v alues for the 
concentration of unbound T4 in hyperthyroi d patients. 
This may be due to the small number of p atients studied, 
the degree of hyperthyroidism or it may b e accounted for 
by an incorrect diagnosis. The sample from the pregnant 
subject had an unbound T4 concentration of 1.5 n g/100 ml 
which was at the lower end o f the range s e en i n the 3 normal 
subjects. The mean percentage distribution o f total T4 
between TBG-bound, TBPA-bound, albumin- bound and the unbound 
state was 73.0:20.0:6.97:0.03. 
Thyroxine-binding proteins in sheep serum 
Sera collected from 16 male and non-pregnant 
female sheep of various ages were subjected to the same 
protocol as the human samples. Although data in the 
literature suggests that there are only two T4BPs in 
sheep serum (TBG and albumin) fitting a model with one 
specific and one non-specific binding protein (s 1 + NS) 
gave very poor fits over the concentration range used. 
However, the model used for analysis of human sera, i.e. 
two specific and one non-specific binding protein (s 1 + 
s2 + NS) gave a good fit to the data as is demonstrated 
in Figure 5.1. The binding parameters extrapolated to 
undiluted serum are shown in Table 5.4. In all samples 
studied there appeared to be at least three T4BPs. The 
most avid T 4BP which probably corresponds t o TBG of 
electrophoresis , had a mean association c on stant of 
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Figure 5 . 1 . Thyroxine-binding by sheep serum diluted 
1 : 111 . 6 in the excluded volume. The experimental data 
points were fitted to a two (S 1 + NS) and three 
(s 1 + s 2 + NS) binding protein model. 
Table 5.4. The thyroxine-binding propertie s of sheep and rat serum proteins 
Total TBG 
TBP-2 Albumin % Distribution of Total T4 
T4 
(µg/ 
Kassoc B.C. * K B. C. 
K 
100ml) assoc Cone. assoc (M- 1 X (µg/ (M- 1 X (µg/ K (g/100 (M- 1 X TBG TBP-2 Albumin Unbound 
10 9 ) 100ml) 10 8 ) 10 0ml) n ml) 10 
5 ) 
Sheep 
(n = 16) 
Mean 6.2 8.9 12. 8 1.39 359 161 2.81 3.52 5
3 .1 35.6 11.3 0.056 
SD 2.7 2.9 4.8 0.62 99 49 0.60 0. 86 
8.6 7.5 2.3 0.019 
Rat 
(n = 7) 
Mean 4.0 3. 6 4 317 228 2.41 6.25 
85.l 14.8 0.066 
SD 2.3 0.69 114 33 0.55 2.11 
4.9 4.9 0. 023 
* 
B.C. - binding capacity. 
Unbound 
T .. Cone 
(ng/ 
100ml) 
3.54 
2.04 
2. 42 
1. 0 8 
• 
00 
I--' 
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8.9 x 10 9 M-l which was not significantly different from 
that of human TBG, however the mean binding capacity of 
this protein was significantly lower than that of human 
TBG. The association constant and binding capacity of 
sheep T4BP-2 were not significant
ly different from those 
of human TBPA, nor was the association constant of sheep 
albumin significantly different from that of human 
albumin. The mean estimated concentration of unbound T 4 
in sheep plasma was 3.5 ± 2.0 ng/100 ml, and many of the 
sheep had unboun d T4 concentrations greater tha
n those . 
estimated in two hyperthyroid humans. The distribution 
of total T 4 between the various bin
ding proteins was 
different from the human, due to the lower binding 
capacity of sheep TBG. The mean percentage ratio of 
TBG-bound:T4BP-2-bound:albumin-bound
:unbound in the sheep 
was 53.1:35.6:11.3 :0.06. 
Thyroxine-binding proteins in rat serum 
The binding of T4 by rat serum was considera
bly 
different from that seen with human and sheep serum 
(Figure 5.2). Data was best fitted by a model consisting 
of one specific and one non-specific binding protein. The 
specific binding protein had a mean association constant 
8 -1 
of 3.64 x 10 M and a mean capacity of 317 µg/100 ml 
(Table 5.4). Non-specific binding was probably due to 
albumin. The association constant of rat albumin for T4 
was 6.25 ± 2.11 x 10 5 M-l which is twice the corresponding 
value found for sheep and human albumin. 
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Figure 5 . 2. Thyroxine-binding by rat serum diluted 
1 : 111 . 6 in the excluded volume. 
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Since the results obtained with rat p lasma 
were at variance wi th t hose in the literature attempts 
were made to confirm the present findings using normal 
biochemical separation t echniques. 
Rat Cohn f r action V (1 mg/ml), which was pure 
on immunoelectrophoresis (Figure 5. 4) , was assayed by the 
present technique and shown to contain two T4BPs. The 
association constants of the specific binding proteins in 
fraction V and whole plas a were identical. The Cohn 
fractionation procedure, however, resulted in a greater 
degree of purification of albumin than of the specific 
binding protein as is show in Table 5.5. 
Table 5.5. The thyroxine-binding properties of rat plasma 
diluted 1:111.6 in the excluded volume and rat fraction V 
at a concentration of 1.34 mg/ml in the excluded volume. 
Kl Cl 
K 
(~g/100 ml) (ng/100 ml) n 
Rat Plasma 219.3 2839 2.04 (n = 7) 
Rat Fraction V 205.5 7686 10. 74 (n = 2) 
Fraction V/Plasma 2.71 5.26 
From the data presented in Table 5.5 it was possible to 
calculate the molar ratios of the two T4BPs in the rat 
fraction V. The specific binding protein was present at 
less than 1% of the albumin concentration. Assuming that 
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rat albumin has one binding site pe r mole c ule the 
association constant of purifi e d rat a l bumin for T 4 was 
calculated to be 5.5 4 x 10 5 M-1 . 
Radio-thyroxine [125 r ] and rat fraction V 
[131r] were added t o 1 ml of pooled rat plasma and a 
50 mg/ml solution of rat f r action V. Each sample was 
separated in duplicate on the s ame Sephadex G-200 column. 
The distribution of protein and radioactivity in the 
col umn effluent i s s hown in Figure 5 .3. The optical 
density peaks for albumin in whole plasma an d f raction V 
. . d d . h h f . 1131 ] d · · · coinci e wit t e rat raction V I ra i o acti vi ty 
peak at tube 39. Thyrox ine r125r] radioactivity peaked 
three tubes later indicating the presence of a protein of 
smaller molecular size than albumin which was present in 
low concentration but had the ability to bind considerable 
T4 presumably due to its high association constan
t. 
Tubes from the ascending (34-39) and the des cending 
(40-45) sides of t he optical density peak of the rat 
fracti on V separation were pooled and concentrated. A 
portion of each sample was electrophoresed and reacted 
against rabbit anti-whole rat plasma. One protein band 
corresponding to albumin was found in the ascending 
fraction and two protein bands were found in the descending 
fraction (Figure 5.4). The latter fraction contained 
both albumin and a 8-globulin. Autoradiographic studies 
of these immunoelectrophoretograms were unable to 
demonstrate T 4 [
125
r] binding to any plasma protein other 
than albumin. 
Attempts were then made to separate these two 
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Figur e 5 . 3. Separation of rat T 4BPs by gel filtration 
on Sephadex G- 200 columns. Rat plasma and rat fraction 
V were labelled with tracer T 4 [
125 1] and rat fraction 
V [ 1311 J • h . . f. h . Te protein elution pro iles ares own in 
the upper diagram. 
A 
B 
C 
D 
Figure 5.4. Identification of two proteins in rat 
fraction V following gel filtration of a 50 mg/ml solution 
of fraction V. The centre wells contained the following 
material: 
A & B - the starting material, rat fraction V 
C - a concentrate of the ascending side of the O.D. 
peak 
D - a concentrate of the descending side of the O.D. 
peak. 
The precipitin arcs were developed using rabbit anti-rat 
serum. D shows two precipitin lines while A, Band C have 
only an albumin line. 
85 
T BPs by polyacrylamide gel electrophoresis. Rat serum, 
4 
rat fraction Vanda concentrate of tubes 40-45 above were 
labelled with T4 [
125
r] and subjected to electrophoretic 
separation in polyacrylamide gel. A number of protein 
bands were identified in all samples . Autoradiographic 
studies using these electrophoretograms demonstrated 
strong T 4 [
125
r] binding in the albumin region as shown 
in Figure 5.5. Occasionally small amounts of radio-
activity were present in the immediate postalbumin region •. 
Since the majority of T4 [
125
r] would be associated with 
the specific T 4BP it was concluded
 that this protein 
demonstrates electrophoretic mobility similar to that of 
serum albumin. For this reason it could not be separated 
from albumin by the electrophoretic techniques employed. 
Effect of the added T4 concentration r
ange on estimates 
of the T4 binding parameters 
Preliminary results indicated that good solutions 
could be obtained when sheep binding data were fitted to 
a two binding protein model (s 1 +NS). This situation 
arises when the concentration of added T 4 is insufficient 
to saturate the specific binding proteins. To test the 
optimum additions of T 4 a human plasma was
 assayed using 
18 additions of T 4 over a 10,000 fold
 concentration 
range of added T 4 . Identical estim
ates of the binding 
parameters were obtained when 14 to 18 data points were 
used. A 1,000 fold unbound T 4 concentration range 
was 
therefore adequate to saturate the specific binding 
proteins and obtain a solution. When the concentra tion 
A B C D A B C 
Figure 5.5. Polyacrylamide gel electrophoretograms of 
rat serum and rat fraction V labelled with T 4 r
125 rJ. 
Electrophoretograms stained for protein and auto-
radiographs are shown. The samples studied were 2% 
protein solutions of the following: 
A rat fraction V 
B rat serum (4% solution) 
C rat serum 
D a concentrate of the descending side (tubes 
40-45) of the OD peak for a Sephadex G-200 
separation of rat fraction V. 
D 
, 
. f 
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range of added T 4 was further red
uced a solution with 
three T 4BPs (S 1 + s2 + NS) could not be att
ained, however, 
a two binding protein model could be used with the 
adequacy of fit increasing as the number of data points 
diminished. This is illustrated in Table 5.6. When the 
first 10 data points were fitted to a two protein model 
(s 1 + NS) a seemingly good fit was att
ained over the 
concentration range fitted. However the solution deviated 
consi derably from the experimental points when extrapolated 
beyon d that range as is demonstrated in Figure 5.6. 
It was of interest to note that when the first 
5 data points were fitted, the binding parameters for 
TBG binding were close to the correct result. At these 
low unbound T 4 concentrations 
TBPA probably acts as a 
non-specific binder, i.e. the relationship between [BJ and 
[U] is linear which would explain the accuracy of the 
result. 
DISCUSSION 
Conventional methods of measuring the T 4 binding 
properties of proteins in who le serum have mainly 
involved electrophoretic separation techniques. The 
distribution of T4 in such electroph
oretograms has been 
' 
measured using radioactively labelled T 4 and the binding 
capacities of the saturable binding proteins (TBG and 
TBPA) estimated from the maximum amounts of added T 4 that 
they can bind. Gordon and Coutsoftides (1969) have shown 
that the distribution of labelled T 4 is a function o
f the 
Table 5.6. The effect of the added T 4 concentration range on estimates of the T 4 binding 
parameters of human plasma 
Sl s 2 NS 
No . of Maximum 
Model Data [U] K Binding K Binding assoc. assoc. 
Points (ng/100 ml) M-l X lOlO Capacity M-l X 10 8 Capacity K n 
(µg/100 ml) ( µg/100 ml) 
18 40,445 1.77 11.7 1.84 274 303 
S l + s 2 + NS 15 3, 827 1.76 11.8 1.78 2 83 298 
18 40 ,-445 0. 2 8 59.2 - - 383 
15 3,827 0.38 44 .9 - - 457 
s 1 + NS 10 204 1.21 16.5 772 - -
5 21 1.72 11.9 - - 938 
Residual 
Variance 
0.00025 
0. 0 0 0 32 
0 .. 00553 
0.00499 
0.00029 
0.00037 
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Figure 5 . 6. The effect of the added T 4 concentration 
range on estimates of the thyroxine-binding parameters 
of a human plasma sample diluted 1:111.6 in the excluded 
volume. A three binding protein model (s 1 + s 2 + NS) 
gave an excellent fit over the entire concentration range. 
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ionic strength, composition, pH and temperature of the 
system used for the electrophoretic separation. These 
factors have also been shown to influence binding in the 
present assay system probably by affecting the avidity 
with which T 4 is bound. Electro
phoresis suffers from the 
addit ional disadvantage that it is a non-equilibrium 
system, under such conditions the proteins are continually 
dilute d during the separation which leads to the 
dissociation of T4 from them. The f
inal distribution of 
T4 in the ele
ctrophoretograrns therefore depends on the 
relative rates of movement of unbound T4 and T4 bound to 
the various proteins as well as on the extent to which 
unbound T4 interacts wi
th the supporting medium. Some 
allowance has been made for these various factors in the 
development of clinically useful methods of measuring the 
binding capacities of TBG and TBPA. While these techniques 
are very useful clinically and adequate as research tools 
where comparative estimates of T4 binding capacit
ies are 
required, they are of limited use in assessing the 
relative import ance of the T 4BPs in the tra
nsport of 
thyroid hormones in vivo. Estimates of the association 
constants for TBG and TBPA, necessary to do this, could 
only be derived from electrophoretic data when values 
for the association constant of albumin were derived by 
other means, e.g. equilibrium dialysis studies (Robbins 
and Rall , 1967; Hamada et al., 1970). In order to 
measure association constants relevant to the in vivo 
situation it is necessary to use equilibrium te chniques 
under conditions which closely mimic the normal 
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physiological state. It was found in the present studies 
that plasma diluted in 0.05 M phosphate, 0.10 M NaCl 
buffer, pH 7.4 and assayed at 37° was a convenient 
system and appeared likely to closely approximate T4 
binding in vivo. 
It has long been realised that if the 
concentration of protein-bound and unbound ligand can be 
measured over a wide range of added ligand concentration 
then considerable information can be obtained about the 
binding properties of the proteins involved (Scatchard, 
1949). A large number of methods have been applied to 
that end in the study of steroid hormone-plasma protein 
interactions . These methods, which have been evaluated in 
a recent review by Westphal (1971), tend to be more 
sophisticated than methods currently used for the study 
of T 4 binding propert
ies in that greater efforts have 
been made to maintain equilibrium. The method described 
in this thesis is similar in principle to one previously 
used for the study of testosterone-plasma protein binding 
in that Sephadex was used as a competitive binding agent 
(Pearlman and Crepy, 1967; Pearlman, 1970). With this 
system, equilibrium concentrations of protein-bound and 
unbound T4 could be measure
d over a 1,000 fold range, 
enabling accurate statistical estimation of the T4 
binding parameters. 
Previously, analysis of binding data relied on 
linear transformations and graphical techniques (Lineweaver 
and Burk, 1934; Eadie, 1942; Scatchard, 1949). These 
methods are liable to systematic errors and are not 
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adequately suited to situations involving a number of 
binding species (Baulieu et al., 1970; Westphal, 1971). 
With the availability of modern computer techniques it 
is now possible to fit non-linear functions over a wide 
concentrat ion range. Such a technique has been described 
in detail by Baulieu and Raynaud (1970). While the 
present method of analysis is similar to that of Baulieu 
and Raynaud (1970) the proportional graph was not used 
for initial estimates of binding affinities; these were 
found by trial and error using values in the literature 
as a bas is. The proportional graph however has been 
useful on occasions for assessing the number of saturable 
binding proteins present and to indicate whether the 
range of concentrations was sufficient to permit an 
adequate solution. The plot of log B vs log Uhas also 
proven useful for these purposes and has the added 
advantage o f allowing graphical estimates of the concen-
tration of unbound T 4 in undiluted plasma. 
The parameter fitting technique described in 
Chapter 3 relies on the assumption that the relationship 
between albumin-bound T4 and unbound T4 concentrations 
1s linear over the range of unbound T4 concentration 
used in the assay. When the estimated association 
constants for albumin are used, albumin can be shown to 
be less than 2% saturated at the highest unbound T4 
concentration found in the assay. If there is more than 
one binding site per molecule of albumin, it would be 
proportionately less saturated. Thus the approximation 
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derived in equation (12) in Chapter 3 for non-specific 
(albumin) binding, and used in fitting the model used in 
this chapter is an accurate one. 
The results presented here demonstrate the 
applicability of this technique to sera of different 
species and to individuals of different clinical states. 
Because of the small numbers in each group it is unlikely 
that the data is truly representative of the group as a 
whole however certain trends are evident. The fitting of 
a three binding protein model to the human data is 
consistent with recent published information using 
electrophoretic techniques (Hamada et al., 1970). The 
values derived for the association constants of human 
TBG, TBPA and albumin are close to published figures 
using purified protein preparations when it is realised 
that the various estimates were made under varying 
conditions of pH, temperature and buffer composition 
(Tabachnick, 1964a, 1967; Green et al., 1972a; Pages 
et al., 1973). Present observations agree with previous 
publications which showed that the binding capacity of 
TBG is substantially increased during pregnancy (Refetoff 
et al., 1972) but is little affected by hypothyroidism 
(Inada and Sterling, 1967), and that the unbound T4 
concentration is at the lower end of the normal range 
during pregnancy, is lowered in hypothyroidism and elevated 
in hyperthyroidism (Sterling and Brenner, 1966; Thorson 
et al., 1972). The present estimates of the distribution 
of T4 between its binding proteins do not diffe
r greatly 
from those of Woebar and Ingbar (1968) and Hamada et al. 
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(1970) but are considerably different from earlier e stimate s 
(Oppenhe imer and Surks, 1964; Robb i ns and Ral l, 1967). 
The observation that sheep serum contains three 
function a lly distinguishable T4BPs is a t var ian ce with 
elect rophoretic data which has demonstrated only two 
T4BPs (Fare r et al., 1962; Refetoff et a
l., 1970). 
Statisti c a l analysis of the data presented i n the preceding 
chapter for heat treated sheep and human plas ma, showed 
that h e at treatment removed TBG binding in both species, 
an d that sheep T4BP-2, like human TB
PA, was unaffected by 
the heat. This illustrates the ability of the present 
technique to detect functionally different T4BPs and 
measure their a ffinities and capacities for T4 . 
Electrophoresis can only distinguish classes of binding 
proteins with diffe r ent e lect rophor e tic mobilities and 
only the binding capacities of these classes of proteins 
can be determined. It is conceivable that proteins of 
widely differing T4 binding prope rties c
ould have similar 
electrophore t i c mobility. Similarly the present method 
has shown two f unctionally different T4BPs in the rat 
which disagree s with findi ngs using a number of electro-
phoretic media and buffer systems (Farer et al., 1962; 
Refetoff et al ., 1970). However, these are minimal 
estimates of the number of specific binding proteins 
since this te chnique is not capable of distinguishing 
between di f f e r ent proteins with similar T4 binding 
properties. 
Further support for the existence of two T 4BPs 
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in rat serum was obtained with gel fi l t r ation studies 
(Figure 5.3). The existence of two such proteins, however, 
could not be substantiated using agar o r polyacrylamide 
gel electrophoresis. Davi s, Spaldin g and Gre germa~ 
(1970) have demonstrated that the majo r T4BP of rat serum 
migrates slightly anodal to albumin on polyacrylamide gel 
electrophoresis and has T4 binding propert
ies s imilar to 
those of human TBPA. The present estimates o f the 
association constant and binding capaci t y of the most avid 
T4BP in rat se
rum are similar to those of human TBPA 
(Tables 5.3 and 5.4). It appeared likely that the major 
T4BP observed in b
oth studies was the same protein. The 
inability to separate this protein from albumin in the 
present study was attributed to the use of a different 
polyacrylamide gel and buffer system than that employed 
by Davis et al. (1970). The latter authors also demon-
strated T 4 binding to 
a protein in the immediate 
postalbumin region. While they suggested that such 
binding was due to a rat "TBG-like" protein the competitive 
binding technique was unable to detect a protein with T4 
binding properties similar to those of human or sheep TBG. 
It appeared more likely that this protein, which has also 
been isolated in the present polyacrylamide gel separations 
(Figure 5.5), is a second non-specific T4BP which binds 
only tracer quantities of T4 . 
The competitive binding technique described 
here is essentially analogous to the widely used technique 
of equilibrium dialysis. In both methods bindi~g systems 
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can be studied at equilibrium under closely controlled 
conditions but the present technique has the added 
advantages of reaching equilibrium more rapidly, of being 
less troubled by contaminating radio-iodide and of being 
technically more simple. It could be used for all those 
purposes for which equilibrium dialysis has been used 
tradi tionally such as measuring concentrations of unbound 
ligand or studying the binding of purified proteins. With 
the methods of data analysis described, this technique 
can be used for the study of binding in complex mixtures 
of binding proteins. Since the controlled conditions can 
be readily varied these can be selected to mimic the 
situation pertaining in vivo or altered to yield information 
about mechanisms underlying the binding reactions. 
Seemingly similar competitive binding methods which have 
been described previously have employed ion exchange 
resins, Dextran coated charcoal, and Sephadex columns 
(Keane et al., 1969; Roberts and Nikolai, 1969; 
Refetoff et al., 1972; Elewaut, 1973). Ion exchange 
resins have been found to take too long to reach 
equilibrium, bind T4 too strongly and bind T4BPs 
themselves. 
Sephadex columns yield data under non-
equilibrium conditions due to the dissociation of protein-
bound hormone during its passage through the column. To 
illustrate the erroneous results obtained from such a 
technique and to demonstrate the inaccuracy of graphical 
analys i s a recent paper by Elewaut (1973) was studied in 
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detail. This author used Sephadex G25 columns for 
separating two forms of T 4 ; "protein-bound" T 4 passed
 
directly through the columns, while "unbound" T 4 was bound 
tightly to the Sephadex and could only be eluted with an 
excess of plasma. The binding parameters for the various 
proteins were determined from the data obtained, by a 
graphical method. 
Elewaut claimed the unbound T 4 values were too 
high, the error being due to T4 which was bound to album
in 
in the plasma being stripped off the albumin during passage 
through the column. He estimated the unbound values were 
34 times too high. Nevertheless he estimated the binding 
parameters using these uncorrected values, but corrected 
the estimated binding parameters subsequently. It seemed 
unlikely that Elewaut's explanation for his erroneously 
high estimates of unbound T4 in his non-equilibrium
 system 
could be as simp le as he claimed. 
Firstly, it seemed unlikely that the amount of 
T4 bound to albumin in plasma di
luted 1:10 would be 33 
times the amount unbound. Second, the speed with which 
T4 equilibrates between plasma a
nd Sephadex in the 
equilibrium technique described in this thesis suggests 
it likely that T4 would be stripped off pr
oteins other 
than albumin during passage through Sephadex columns. 
Third, in the example shown in Figure 1 of Elewaut's 
publication (Figure 5.7), the binding curve obtained from 
the estimated binding parameters fitted the data points 
very badly, suggesting that either the model fitted, or 
the method of parameter estimation was incorrect. Fourth, 
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in the same publication it was suggested that binding of 
T4 to TBPA 
as well as to TBG, is destroyed by heating 
plasma to 60° and this is at variance with data presented 
in Chapter 4 and other published observations (Takemura 
et al., 1971). 
To test the adequacy of the model fitted by 
Elewaut, i.e. 2 specific binding proteins (S 1 + s2 ) 
supposedly corresponding to TBG and TBPA, and to evaluate 
the validity of the graphical method of parameter fitting 
used, the data was reanalysed using the computer least 
squares routine of non-linear parameter estimation 
described in Chapter 3. 
When an (s 1 + s2 ) model was used with the 
uncorrected bound and unbound T4 values plotted in Figur
e 
1 of Elewaut's paper, an almost perfect fit was obtained 
which is in marked contrast with that obtained by Elewaut 
(models 1 and 2, Figure 5.7). The TBPA binding parameters 
were quite similar to those estimated by Elewaut, but 
those for TBG were very different. These estimates, 
together with those of Elewaut and for fits described 
below, are shown in Table 5.7. When a model which also 
allowed for albumin binding (s1 + s2 + NS) was fitted to 
the same data, an unreal solution was obtained (a 
negative value for K indicating either a negative n 
association constant or binding capacity for albumin) 
even though the fit to the actual data points was improved 
(model 3, Figure 5.7). 
Since the use of the erroneously high unbound 
T4 values weights the 
data points incorrectly, the two 
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Figure 5.7. A Scatchard plot of T4 binding to human 
serum as assessed by the Sephadex column chromatographic 
procedure of Elewaut (1973). The data points were taken 
from Elewaut (1973) - see Appendix 1. The four models 
fitted to the data are described in Table 5.7. 
Table 5.7. Estimates of the thyroxine-binding properties of human serum proteins using binding 
data obtained from Sephadex G25 column chromatography. 
TBG TBPA Albumin 
Model No. K B.C.* K B.C. 
Values Used** Method o f Fit 
assoc assoc K 
(M- 1xl0 9 ) (Mxl0- 8 ) (M- 1x10 8r (Mxl0- 8 ) 
n 
s1+s2 1 7.5 35. 7 8 3.3 
391 - ) Gr aphical )B and U 
s1+s2 2 16. 2 21.6 2.86 
394 - ) Least Squares )uncorrected 
s 1+s 2+NS 3 
15. 7 22.1 1.49 776 -19. 0 ) 
II II 
_ , 
Sl+S2 4 16. 7 21.0 2.18 
457 )U corrected Le as t Squares 
) 
sl+s2+NS 5 14.7 23.6 0.90 1630 
-54.8 )B uncorrected " II 
sl+s2+NS 6 14.6 23.6 0.90 1450 
-14.6 B and U Least Square s 
corrected 
* 
B.C. - binding capacity 
** Uncorrected Band U values were taken from Elewaut (1973) - Appendix 1. 
I..D 
....i 
98 
models fitte d above were fitted again using unbound T 4 
values corrected as suggested by Elewaut. Fitting the 
model (No. 4, Table 5.7) for 2 binding proteins (s 1 + 
s2 ) resulted in appreciably different parameters for 
TBPA, but those for TBG were very similar. The model 
(No. 5, Table 5.7) which also allows for albumin binding 
(S1 + s2 + NS) still could not be fitted. 
If the excess T4 taken up by the Sephadex 
(excess over the true unbound) is T4 originally bound to 
albumin, then correcting the bound T4 concentrations by 
adding to them the amount of T4 which was subtracted from 
the unbound concentrations should reproduce the distrib-
ution of T4 present in the diluted plasma before chromat-
ography. It should b e possible there fore to fit the model 
allowing for albumin binding (s1 + s2 + NS) to such 
corrected bound and unbound values. However, it can be 
seen from model 6, Table 5.7 that such a fit was still 
not possible. 
Sephadex chromatography carried out under the 
conditions employed by Elewaut disturbs the equilibrium 
between T4 and its binding proteins. Not only is T4 
removed from albumin by the Sephadex, as claimed by 
Elewaut, but a lmost certainly from other binding proteins. 
The proportions removed from the individual species 
would depend on the distribution of T 4 between the 
various species of binding proteins. Since this would 
vary with the amount of added T4 , no simple correction, 
such as that suggested by Elewaut, can be applied to data 
so obtained. Similarly, if T4 dissociates from proteins 
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during chromatography, no simple correction f or di lution 
can be applied to the calculated binding parameters. 
This is because the plasma is progressively diluted during 
chromatography. It should also be pointed out that the 
actual dilution of plasma applied to the Sephadex columns 
by Elewaut was 1/14 not 1/10. This was brought about 
by the addition of 200 µl of various T4 solutions to 
500 µl of the plasma diluted 1/10. 
Thus, the analyses presented in Table 5.7 and 
Figure 5.7 indicate that the data obtained by the 
procedure of Elewaut is not suitable for kinetic analysis. 
Without prior knowledge of the binding parameters which 
are to be measured, this would only be possible if the 
procedure is carried out at such a low temperature that 
dissociation of protein-bound T4 during chromatography 
is negligible. However, association constants calculated 
from such data would have little relevance to the 
situation in vivo. 
The deficiencies of graphical methods for 
estimating binding parameters are clearly shown. Unless 
the binding parameters so calculated are progressively 
altered by trial and error to obtain a good fit to the 
½ 
data, as suggested by Berson and Yalow (1959), they are 
of little value. A simpler and more accurate procedure 
is to use the least squares method presented in this 
study. 
' 
CHAPTER 6 
THE THYROID HORMONE BINDING PROPERTIES 
OF HUMAN AND OVINE ALBUMIN 
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INTRODUCTION 
The competitive binding technique described in 
this thesis has supplied the first estimates of the T4 
binding properties of human and ovine albumin in samples 
of dilute plasma. It was therefore important to compare 
such estimates with those derived from studies using 
purified human and sheep serum albumin. 
The ready availability of human and bovine 
serum albumin as Cohn fraction V made albumin, until 
recently, the most extensively studied pure T 4BP. Most 
workers used human Cohn fraction V and there was general 
agreement that it was not contaminated, to any large 
extent, with other T 4BPs (Sterling, 1964; Steiner et al., 
1966) . While results in this laboratory confirm that 
observation, we have found that sheep, rat and rabbit 
Cohn fraction V preparations are contaminated with T 
4 
binding moieties other than albumin (Sutherland and 
Brandon, unpublished observations). For this reason 
sheep fraction V was purified on DEAE Sephadex prior to 
experimentation . 
With the availability of pure human and ovine 
serum albumin (OSA) experiments were conducted to assess 
the T4 binding properties of these proteins under varying 
conditions of ionic strength, ionic composition, pH and 
temperature. 
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Experimental procedure 
The assays were performed as described in 
Chapter 3 with the following modifications. The relation-
ship between albumin-bound T4 and unbound T4 was 
estab lished by making serial additions of T 4 (O - 500 ng) 
to albumin diluted 1 mg/ml in an appropriate buffer at 
37°. Data was plotted as albumin-bound T 4 , [BJ, against 
unbound T 4 concentration, IU], and the relationship 
was linear over the concentration range studied (4.4 x 
10-6 - 7.1 x 10- 4M T 4 bound per mole of albumin). It 
should be pointed out however, that the relationship 
between [B] and [U] maintains linearity over a much 
greater concentration range than this. If normal human 
plasma has a mean total T4 concentration of 8.0 µg/100 ml 
and 7% of this is bound to albumin present at 4 g/100 ml, 
then human albumin in normal whole plasma would bind 
T4 at the rate of approximately 1.2 x 1
0-SM T 4 per mole 
of albumin. Therefore over a range of albumin bound 
T 4 concentrations likely to be encount
ered in vivo the 
relationship between IB] and [U] is linear and can be 
expressed by the following equation: 
[B]alb = Calb [U]/Kalb See Equation (12) Chapter 3 
This formulation assumes 1 strong binding site 
per albumin molecule. It is generally agreed however, 
that albumin has more than one type of T 4 binding site 
(Tri tsch et al., 1961; Tabachnick, 1964a) and if this is 
the case equation (12) becomes 
where n. is the number of each type of binding site/molecule 
l 
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and k. is the association constant of the i th site. For 
l 
this to be dimensionally correct [B], [U] and [Calb] must 
be expressed in molar concentrations and k. in reciprocal l 
molar concentrations. Since [Calb] is a constant, 
changes in E n.k. will reflect changes in the ability of 
l l 
albumin to bind hormone. Because of the limited 
concentration range of added T 4 used in the present study 
it was not possible to detect whether changes in 
L n.k. were due to changes inn. or to changes ink .. 
l l l l 
Estimates of E n.k. were made under various 
l l 
experimental conditions by calculating the linear 
regression of [B] on [U], using least squares methods, 
under those conditions. The regression coefficient was 
equal to E n. k. [ C lb] . l l a 
RESULTS 
Effect of ionic strength and ionic composition on the 
T4 binding properties of serum albumin 
Increasing the buffer concentration from 
0.05 M to 0.20 Min both phosphate at pH 7.4 and barbital 
at pH 8.6 resulted in a reduction in the affinity of 
albumin for T4 , as assessed by changes in r n.k. l l 
(Table 6.1). The rate of decline in binding affinity 
was greatest between 0.05 Mand 0.10 M, and changed 
little between 0.15 Mand 0.20 M. A similar reduction 
in binding affinity was observed when increasing 
concentrations of NaCl (0.05 - 0.15 M) were added to 
0.05 M phosphate buffer, pH 7.4. When 0.05 M NaCl, 
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0.05 M sodium phosphate buffer, pH 7.4 was used the 
binding affinity was 4.76 x 10
5 M-l which is significantly 
(P < 0.01) lower than the value of 5.45 x 10 5 M-l found 
using 0.10 M phosphate pH 7.4 (Figure 6.1). Similarly 
0.05 M phosphate, pH 7.4, containing 0.10 M (3.90 x 
10 5 M-l) and 0.15 M (3.28 x 10 5 M-l) NaCl resulted in 
significantly (P < 0.01) lower binding affinities than 
5 -1 5 -1 
when 0.15 M (5.02 x 10 M ) and 0.20 M (4.96 x 10 M ) 
phosphate buffer, pH 7 .. 4, was used. These results 
indicate that the observed reduction in binding affinity 
with increased concentration of buffer was not due 
entirely to changes in ionic strength but was also 
dependent on the ionic species present (Figure 6.2). 
This is further exemplified in the case of barbital 
buffer. Assays performed in barbital buffer, pH 8.6, 
resulted in a diminished binding affinity when compared 
with phosphate and phosphate-NaCl buffers at pH 7.4 
(Table 6.1 and Figure 6.2). Since a change in pH from 
7.4 to 8.6 causes an increase in the binding affinity 
in phosphate buffer (Table 6.2 and Figure 6.3) the 
reduced binding observed with barbital at pH 8.6 would 
seem to be a direct effect of the barbiturate ions. 
Human and ovine serum albumin showed essentially the 
same responses to changes in buffer ionic strength and 
ionic composition. 
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Figure 6 .2. The effect of ionic strength and ionic 
composition of the assay buffer on the binding affinity 
of HSA for T 4 . The composition of the buffer systems 
is described in the text. 
Table 6.1. Effect o f buffer concentration on the 
binding of T 4 to HSA. 
Buffer Ion 
Concentration 
(moles/litre) 
0.05 
0 .10 
0 .15 
0.20 
Binding Af f i n i ty 
E n.k . x 10 5 M-l 
l l 
Phosphate 
pH 7.4 
6.63 
5. 45 
5.02 
4.96 
Bar b ital 
p H 8.6 
3.2 2 
1 . 81 
1. 35 
1 . 2 4 
Effect of pH on T 4 binding 
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The effect of pH on the binding of T4 to HSA 
is shown in Figure 6.3 . Two different buffer systems 
were used: 0.05 M sodium phosphate, 0.10 M NaCl, 
pH 6.0, 7.0, 7.4 and 8.0; and 0.05 M Tris, 0.10 M NaCl, 
pH 8.0, 8.6 and 9.0. At the same pH, Tris buffer 
resulted in a slightly greater E n.k . value than the l l 
corresponding phosphate buffer. This may be due to the 
lower ionic strength of the Tris-NaCl buffer. Over the 
pH range studied the affinity of albumin for T 4 
increased seven fold from 1.43 x 10 5 M-l at pH 6.0 to 
1.01 x 10 6 M-l at pH 9.0. Human and she ep albumin 
behaved similarly (Table 6.2). 
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Figure 6 . 3 . The effect of pH on the T4 binding properties 
of HSA . 
Table 6.2. Effect of pH on the binding of T4 by HSA 
and OSA. 0.05 M sodium phosphate buffer in 0.10 M 
NaCl was used at pH 6.0, 7.0, 7.4 and 8.0 while 
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0.05 M Tris in 0.10 M NaCl was employed at pH 8.0, 8.6 
and 9.0. The assays were performed at 37°. 
pH 
6.0 
7.0 
7.4 
8.0 
8.6 
9.0 
Binding Affinity 
r n.k. x 10 5 M-l 1. 1. 
HSA OSA 
1.43 1.62 
2. 80 
3.90 4.11 
5.68 
9.41 9.66 
10. 0 8 
Effect of temperature on T 4 binding 
The binding affinity of albumin for T4 was 
measured at 25° and 37° 1.n a buffer of 0.05 M sodium 
phosphate, 0.10 M NaCl, pH 7.4. At these two temperatures 
a significant difference 1.n the degree of protein binding 
was observed (P < 0.01). A decrease of 12° in temperature 
resulted in an increase in I n.k. from 3.90 x 10 5 M-l 1. 1. 
at 37° to a value of 5.45 x 10 5 M-l at 25°. 
Binding of T 4 and T 3 to serum albumin unde
r "physiological 
conditions" 
The routine assay system used for the study of 
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the thy roid hormone binding properties of plasma proteins 
employs a 0.05 M sodium phosphate, 0.10 M NaCl buffer, 
pH 7.4 a t 37°. When T4 binding to 1 mg/ml 
solutions of 
HSA an d OSA was studied under such conditions the 
L n . k . v a lues were 3.90 x 10
5 
and 4.11 x 10 5 M-l 
l l 
respe c t i ve ly. Triiodothyronine was bound with lower 
affinity than T 4 . These E n.k. va
lues were 1.15 x 10 5 
l l 
and 1.26 x 10 5 M-l for human and sheep albumin respectively. 
DISCUSSION 
Th e ready availability of serum albumin in 
relatively p ure form, its good stability, the availability 
of considerab l e info rmation on its b in ding affinity for 
a wide range of compounds , as we l l as the relative 
scarcity of othe r p urified T4BPs probably explains th
e 
wide use of albumin as a mode l f o r the study of thyroid 
hormone-plasma protein interaction s. Most studies have 
investigated t he nat ure of T 4 and T3 binding sites.
 The 
number of sites , the ir amino a c id composition, their 
affinity for T4 and i ts anal ogues, have
 been the main 
parameters s tudie d . 
Unti l the de ve lopment of the present competitive 
binding assay t here were no techniques available which 
allowed e s t i mation of the thyroid hormone binding 
prope rties of albumin in samples of whole plasma. With 
the adve nt o f s uch a technique it was important to 
compare e s timates of albumin binding in whole plasma with 
those derived from experiments using purified serum 
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albumin. Preliminary results which were reported in 
. . 
Chapter 4, indicated that a number o f factors: ionic 
strength, ionic composition, pH and temperature, had a 
profound effect on estimates of hormone binding parameters 
derived from in vitro assay systems. The effect of these 
factors on estimates of T4 binding to serum albumin was 
studied, firstly , to determine whether the observed 
changes in albumin binding seen in the whole plasma 
assay system were accompanied by similar changes in the 
binding properties of purified albumin, and secondly, 
to allow comparison of albumin binding parameters 
calculated using the present technique with those 
derived under different experimental conditions. 
The effect of changes in ionic strength on 
the binding activity of serum albumin has received 
little attention. Tritsch et al. (1961) noted that the 
ability of HSA to bind T4 was influenced by the ion
ic 
strength below values of 0.3 in phosphate buffer at 
pH 7.35. Increases in ionic strength above 0.3, however, 
had no significant effect on the binding activity. In 
contrast Tabachnick (1967) reported that there was no 
difference in T 4 binding to human albumin when either, 
a 0.03 M potassium phosphate buffer, pH 7.4., 
. . ionic 
strength 0.064, or a similar phosphate buffer of ionic 
strength 0.175 was used. Data presented in this chapter 
clearly demonstate that increases in ionic strength 
reduce T 4 binding to human and shee
p serum albumin in 
three buffer systems at two pHs. Changes were minimal 
with increases in ionic strength above 0.2 except in the 
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case of phosphate - Na Cl buffer. A s i milar phenomenon 
has been described for the binding of estrone t o HSA. 
Increas ing the concentration o f phos pha te buffer f rom 
0.05 M to 0.10 M resulted in a s l ight de cline i n the 
amount of estrone that was protein-bound (Sandberg, 
Slaunwhite and Antoniades, 1957). 
Inhibition of binding by NaCl is o f p articular 
interest in view of its high plasma concentration and 
its normal omission from buffers used i n bindin g studies. 
Tabachni ck (1967) found a decline in T 4 binding to HSA 
of 41% and 47% when 0.05 Mand 0.10 M NaCl was added to 
0.03 M potassium phosphate buffer, pH 7.4. The present 
experiments demonstrate a similar decline. Thyroxine 
binding was reduced by 28%, 41% and 51% with addition of 
0.05, 0.10 and 0.15 M NaCl respectively to a 0.05 M 
sodium phosphate buffer at pH 7.4. This decline was 
considerably greater than that observed with equimolar 
increases in the concentration of sodium phosphate 
buffer , despite the greater ionic strength of the 
latter buffer. 
The results obtained with barbital buffer, 
pH 8.6 are interesting because veronal ions were 
previously thought to be specific inhibitors of T 4 
binding to TBPA (Tata et al., 1961; Ingbar, 1963). 
Results presented in Table 6.1 show that barbital also 
inhibits T4 binding to serum albumin.
 It now appears 
likely that barbital buffers inhibit the binding of T 4 
to all plasma T 4 binding sites since r
esults presented 
in Chapte r 4 demonstrated inhibition of T4 binding to TBG 
in barbital buffer. Whilst it is only recently that 
the effects of ionic strength and ionic composition 
have been discussed with respect to thyroid hormone 
binding they have long been known to influence the 
binding of many small anions to HSA. As early as 
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1953 Klotz stated that phosphate buffers cause minimal 
interference to anion binding by HSA while veronal 
buffers produce a significant decrease in binding 
affinity . 
Data presented here show that pH has a profound 
effect on the affinity of albumin for T 4 . The marked 
increase in binding affinity as pH is increased from 
6 - 8.6 is in general agreement with the results of a 
number of other workers (Tritsch et al., 1961; Tritsch 
and Tritsch, 1963; Steiner et al., 1966). In view of 
this agreement , using a number of different techniques, 
it is difficult to understand why Sterling et al. (1962) 
and Tabachnick (1964a) were unable to detect changes in 
the affinity of T4 binding to HSA between pH 6.8 and 
9.8. The pH dependence of thyroid hormone binding to 
serum albumin has been attributed to changes in the 
degree of ionization of ionizable groups on both the 
hormone and the protein (Tritsch and Tritsch, 1963; 
Steiner et al., 1966). Such changes may be accompanied 
by conformational changes in albumin which expose new 
or auxillary binding sites (Klotz, 1953). 
Thyroxine binding to serum albumin is known to 
be temperature dependent although previously reported 
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results do not show the magnitude of change reported 
here. Sterling et al. (1962) found no difference in 
the binding affinity at 30° and 38°, however, binding 
was stronger at 5°. Similarly, Tabachnick (1967) 
demonstrated no difference in r n.k. between 30° and l l 
37° although this value was increased by 25% with a 
decline in assay temperature to 6 °. 
Previously reported estimates of the affinity 
of HSA for T 4 , expressed as E n.k. values, are summarized l l 
in Table 6.3. The present estimate of 3.90 x 10 5 M-l 
for r n.k. in 0.05 M phosphate, 0.10 M NaCl, pH 7.4 
l l 
at 37° is in close agreement with the early estimates of 
Sterling and Tabachnick (1961b) and Sterling et al. 
(19 62) but is somewhat lower than more recent estimates 
of E n.k. (Tabachnick, 1964a, b, 1967; Tabachnick and 
l l 
Giorgio, 1964; Steiner et al., 1966). These differences 
can be largely explained by the effects of NaCl 
concentration and temperature on T 4 binding to albumin 
currently reported. Thyroxine binding by OSA differed 
little from the binding activity of HSA. Although the 
binding of thyroid hormones by OSA has not been reported 
previously, Tritsch et al. (1961) and Steiner et al. 
(1966) have shown that HSA and bovine serum albumin have 
similar T 4 binding properties. 
Triiodothyronine was bound with l/3rd of 
the affinity of T 4 by both human and ovine serum 
albumin. Such a binding affinity is greater than 
Table 6.3. Reported estimates of r n.k. for the binding of T 4 to HSA. l l 
-1 ~ n.k. (M ) 
l l 
2.8 X 10 6 
4.4 X 10 5 
5 4. 2 X 10 
7. 0 X 10 5 
7.0 X 10 5 
5 7. 5 X 10 
6 1.6 X 10 
6 1. 6 X 10 
Experimental Conditions 
0.03 M Phosphate buffer, pH 7.35, 25° 
Phosphate buffer, ionic strength 0.15, 
pH 7.4, 38° 
Phosphate buffer, ionic strength 0.15; 
0.05 M Tris-0.10 M NaCl; pH 7.4, 38° 
Phosphate buffer, ionic strength 0.15, 
pH 7.4, 38° 
0.06 M Phosphate buffer, pH 7.4 , 30° 
0.06 M Phosphate buffer, pH 7.4, 30° 
Fatty acids extracted 
0.10 M Phosphate buffer, pH 7.4, 24° 
0.06 M Phosphate buffer, pH 7.4, 30° 
Reference 
Tritsch et al ., 1961 
Sterling and Tabachnick, 
1961b 
Sterling et al., 1962 
Tabachnick, 1964a 
Tabachnick and Giorgio, 
1964 
Tabachnick, 1964b 
Steiner et a l., 1966 
Tabachnick, 1967 
I--' 
I--' 
f-J 
previously reported values which i n dicate d that T 3 
was boun d to HSA with 1/4 to l/6th the affinity of 
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T 4 (T ab a chnick , 1964a; Steiner et al., 1966) but th
is 
might be due to the use of different b u ffers. This 
decreased affinity for T 3 has been attributed to the 
decreased ioni zati on of the phenolic h ydroxyl g roup 
of this hormone (Sterling and Tabachnick, 196 1b ; 
Steiner et al., 1966). 
The E n . k. values , 3.90 and 4.11 x 10 5 
l l 
M- 1 , for the binding of T 4 to purified human an
d 
ovine se r um albumin respectively, were greater than 
the mean K v alues of 3.06 and 3.52 x 10
5 M- 1 , found 
n 
for the corresp onding binding affinities in whole plasma 
assayed unde r identical conditions. However, in both 
species estimates of K varied considerably between n 
in dividuals an d the range of values included the 
correspondin g E n.k. values estimated with purified 
l l 
albumin. Thus the assumption that non-specific 
binding measure d in samples of plasma was due to 
albumin would s e em to be valid. 
CHAPTER 7 
THE TRANSCAPILLARY EXCHANGE OF THYROID HORMONES 
AND THYROXINE-BINDING PROTEINS BETWEEN 
BLOOD AND TISSUE FLUIDS 
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INTRODUCTION 
The first barrier that the thyroid hormones 
must surmount on leaving the blood to enter the tissue 
fluids, and hence the tissue cells, is the endothelial 
lining of the blood capillaries. Data presented in 
Chapter 5 and that of many other workers (Robbins and 
Rall, 1967) demonstrate that the majority of plasma T4 
is tightly but reversibly bound to protein, while only 
a minute proportion, 0.06% in sheep, circulates in the 
unbound state. Clearly, protein-binding must have a 
profound effect on the passage of hormone across the 
endothelium, however, few experiments have been 
conducted to elucidate this phenomenon. 
It has long been thought that unbound T 4 is 
the freely diffusible, metabolically active component 
of plasma T4 (Ingbar and Freinkel, 1960; Ingbar and 
Woebar, 1968). This interpretation has been based on a 
number of clinical and experimental observations. 
Clinical thyroid status is known to be more highly 
correlated with unbound plasma T4 concentration than 
with total plasma T4 concentration (Ingbar and Woebar, 
1968). Recent experimental evidence indicates that 
unbound T 4 is the form in which T 4 is captured by tissue 
cells (Hillier, 1968a, b, 1969, 1971). Inherent in this 
interpretation is the concept that unbound T4 is freely 
diffusible across the capillary endothelium while the 
diffusion of protein-bound T 4 is severely restricted due 
to the molecular size of its binding proteins. In 
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contradiction to this "free thyroxine theory", Oppenheimer, 
Surks and Schwartz (1969) have postulated that the escape 
of T 4 from the blood vascul
ar system is due entirely to 
the diffusion of T 4-protein complexes and t
hat the uptake 
of T4 by tissues results from d
irect interaction between 
protein-bound T 4 and tissue binding sites.
 This has been 
called "the collision theory". 
Earlier work in this laboratory has provided 
evidence that unbound T 4 is removed from the circu
lation 
at a greater fractional rate than protein-bound T4 • Such 
an interpretation was based on the observation that 
radioactively labelled T4 appeared more rapidly in 
the 
lymph of chronically cannulated sheep than did labelled 
albumin when both isotopes were injected simultaneously 
into the blood circulation (Simpson-Morgan and Irvine, 
1972; Irvine and Simpson-Morgan, 1974). 
The aim of the work described in this chapter 
was to extend that initiated by Irvine and Simpson-Morgan 
(1974) by sampling lymphatics afferent to a lymph node, 
and by sampling lymph from a large number of different 
drainage areas throughout the body of sheep. Two main 
approaches were adopted. Firstly, the rate of equilibration 
of radioactively labelled T 4 and albumin was me
asured 
in a number of different tissue fluid pools following the 
simultaneous injection of both labelled compounds into 
the circulation, and secondly, the steady state concentra-
tions of T4 and the T 4BPs w
ere measured in plasma and 
in lymph draining many different regions of the body. In 
addition, distribution experiments were performed in 
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animals in which the proportion of unbound thyroid 
hormone was higher than is normal fo r T4 . This was 
achieved either by administering large doses of T 4 or 
by using tracer doses of labelled T 3 • The removal o
f 
T4 from lymph durin
g its passage through a lymph node 
was also studied. 
RESULTS 
The rate of movement of tracer T4 and serum albumin fro
m 
blood to lymph 
Chronic lymphatic fistulae were established in 
lymphatics efferent to the popliteal, prefemoral and 
prescapular lymph nodes, the lumbar lymph trunk, the 
intestinal lymph trunk and the afferent testicular 
lymphatics. Following simultaneous intravenous injection 
125 131 
of T4 [ I] and HSA [ I] samples of p
lasma and lymph 
were collected at appropriate time intervals. Since 
Irvine and Simpson-Morgan (1974) were unable to detect 
labelled compounds other than T4 and iodide in any
 of 
the body fluids studied in similar experiments, the TCA 
. . d 125 d 131 . . . t k t precipitate I an I activities were a en o 
represent T4 and HSA respectively. 
In all animals studied 
labelled T4 was removed from 
the plasma and appeared in 
the lymph at a greater fractional rate than did labelled 
albumin. Representative experiments illustrating the 
equilibration of labelled T4 and albumin between p
lasma 
and lymph in four different tissue fluid pools are shown 
in Figures 7.1 - 7.4. The rate of transfer of labelled 
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Figure 7.1. The disappearance of T 4 [
1251] and HSA [1311] 
from plasma and their appearance in afferent testicular 
lymph following simultaneous intravenous injection of the 
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from plasma and their appearance in efferent popliteal 
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T4 and HSA from blood 
to lymph during a given collection 
period were estimated from the ratios of the activities 
in the lymph to the activities in plasma at the mid-point 
of that collection period. These ratios which are 
expressed as percentages in Table 7.1, varied considerably 
when lymph was collected from different lymphatics in the 
same animal, or from the same lymphatic in different 
animals. However, in any lymphatic the nett relative 
rate of movement of T4 from blood to lymph, estim
ated 
this way, was greater than that of HSA during the first 
1/2 hour collection period. This difference was relatively 
constant for any particular lymph pool but differed 
significantly between different tissue fluid pools due 
possibly to differences in capillary permeability. The 
results from six different capillary beds are summarized 
in Table 7. 1. 
The lymph/plasma concentration ratios for total T4 and 
the thyroxine-binding proteins 
The greater relative rate of movement of 
labelled T4 than of HSA from blood to
 tissue fluids could 
be explained either by the rapid diffusion of unbound T 4 
or by the preferential transfer of T 4 bound to protein. 
To test the latter possibility, assays were performed to 
quantitate the T 4 binding properties of
 proteins in 
various samples of plasma and lymph. In all samples 
studied three T 4BPs were identified with
 association 
constants corresponding to TBG, TBP-2 and albumin of 
sheep plasma. 
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Table 7.1. The relative rates of movement of T 4 [
125
r] 
and HSA [131r] from blood to lymph during the first 1/2 
hour after injection of the labelled dose. 
No. Lymph/Plasma Activity Relative Rate of 
Lymph of Ratios (%) Transfer** 
Sample ani-
mals T4 [1251] HSA [1311] T 4/HSA 
Lumbar 1 8.18 6.61 1.25 Trunk 
Afferent 4 7.92 ± 6.32* 6.33 ± 5.74 1.31 ± 0.13 Testicular 
Efferent 1 1.38 0.416 3.32 Prescapular 
Efferent 4 2.73 ± 1.92 Popli teal 0. 76 8 +
 0.389 3. 42 ± 1.85 
Intestinal 1 4.81 0.91 5.29 Trunk 
Efferent 1 8.35 1.56 5.35 Pre femoral 
* Mean ± SD 
** A ratio greater than 1 indicates more rapid trans-
capillary exchange of T 4 relative to HSA. 
Plasma and lymph samples from 24 animals, 
representing 10 different tissue fluid pools were analysed 
for total T 4 , albumin and T4BP concentrations. The 
results are summarized in Table 7.2 where the lymph/ 
plasma concentration ratios of those substances are 
given. In the cases of afferent testicular or efferent 
popliteal lymph, which were studied in a number of 
animals, there were no significant differen ces between 
Table 7.2. Lymph/ plasma concentration ratios for total thyroxine and thyroxine-binding proteins 
in samples o f lymph from several tissue fluid pools. 
Albumin Albumin 
Lymph Sample No. 
of Total TBG Con e . TBP-2 Cone . Cone. 
Con e . 
samp l es T 4 Con e. ( K ) 
(by De bro 
n et al. , 1957 
Afferent Hepatic 1 0. 7 80 0.9 0 9 0. 9 79 0. 820 0. 9 35 
Efferent Hepatic 1 0. 6 6-7- - - -- 0. 85 8 0. 85 8 0. 82 8 0. 8 80 
Afferent Testicular 9 0. 757±0.187 0. 7 82 ±0. 13 3 0.792±0.163 0.841±0.141 0.774±0.139 
Efferent Prescapular 1 0 . 5 08 0. 7 32 0 .7 81 0 .77 4 0. 879 
Efferent Prefemoral 1 0 .55 7 0. 66 3 0.683 0.773 0.688 
Cervical Lymph Duct 1 0.775 0. 5 9 8 0. 6 86 0.558 0.655 
Lumbar Lymph Trunk 1 0.400 0.662 0.674 0.635 0.716 
Afferent Renal 1 0. 39 0 - 0.418 0 . 572 0. 5 49 0.730 
Efferent Popliteal 8 0.503±0.188 0.418±0.160 0.482±0.226 0.473±0.167 0.483±0.090 
Intestinal Lymph Trunk 1 0.250 0.487 0. 425 0. 415 0. 490 
; 
) 
f-J 
f-J 
ex,· 
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the mean lymph/plasma concentration ratios of total T 4 , 
albumin, and the three T 4BPs. These resul
ts suggest 
that the lymph/plasma ratio for total T 4 is governed by
 
the l ymph/plasma ratio of its binding proteins, and that 
the molecular size of the two specific T4BPs in sheep 
plasma differ little from that of sheep albumin. The 
data from the other 8 tissue fluid pools are consistent 
with such hypotheses. If preferential transport of the 
speci fic T 4BPs occurred, ei
ther by an active process or 
due to their smaller molecular size relative to albumin, 
one would expect a high lymph/plasma concentration ratio 
for the specific T4BPs relative t
o albumin. Since this 
was not so it is likely that the more rapid movement of 
T 4 than of album
in from blood to interstitial ·fluid is 
due to considerable transcapillary movement of unbound 
Gel filtration studies on sheep thyroxine-binding proteins 
Since the measured lymph/plasma concentration 
ratios for the three T 4BPs of sheep 
serum indicated that 
these proteins were of similar molecular size attempts 
we re made to confirm this using gel filtration. Samples 
of sheep plasma containing tracer amounts of T 4 r
125
rJ 
and OSA [131rJ were fractionated in triplicate on a 
Sephadex G-200 column. The protein and radioactivity 
elution profiles of a typical separation are shown in 
Figure 7.5. Both the optical density and the radioactivity 
peaks for albumin coincided at tube 32 while the T 4 [
125
r] 
peak occurred one tube earlier. Since it has been shown 
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in Chapter 5 that sheep TBG binds approximately 5
5% 
of endogenous T4 this result w
as taken to indicate that 
sheep TBG and OSA were of similar molecular size
. 
The binding of T 4 to sheep
 TBG was then 
destroyed by subjecting sheep serum to 60° for 1 hour. 
125 131 
Tracer T 4 [ I] and OSA [ 
I] were added and the sample 
fractionated in triplicate on a different G-200 
column. 
A typical separation is shown in Figure 7.6. Th
e optical 
density and the radioactivity peaks for albumin 
coincided 
at tube 36 while the T 4 r
125 I] peak occurred one tube 
later. In the absence of TBG the second specifi
c T 4BP 
of sheep serum (TBP-2) binds approximately 70% of the 
endogenous T4 . The colum
n fractionation of heat treated 
sheep serum therefore indicated that TBP-2 and O
SA were 
of similar molecular size. 
The observation that sheep TBG, TBP-2 and 
albumin had similar elution profiles on gel filtr
ation 
agrees with the lymph/plasma concentration ratio
 data 
which indicated that the three T4BPs of sheep 
serum were 
of similar molecular size. It could therefore b
e expected 
that these three molecules would have similar di
stribution 
kinetics thus validating the use of albUIPin as a
 model 
to study the distribution of the specific T4BPs 
in the 
sheep. 
Gel filtration studies also demonstrated that 
HSA and OSA had identical elution profiles which
 indicated 
that the use of tracer HSA r
131I] in sheep was a valid 
marker for endogenous albumin distribution in th
at species. 
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Unbound T
4 
concentrations in plasma and lymph 
Although the total T 4 concentration varied 
appreciably between plasma and various samples of lymph 
from the one animal the concentration of unbound T4 was 
relatively constant from sample to sample. Hence the 
proportion of t o t al T 4 that was unbound was inversely 
proportional to the total T 4 concentration and varied 
from 0.056 ± 0. 019% in plasma to 0.125 ± 0.066% in 
popliteal lymph. 
The b inding curves (log IB] vs log IU]) for 
various samples of lymph from the on e animal were 
essentially parallel to the plasma curve indicating that 
the T
4
BPs of lymph we re a s imple physiological dilution 
of those in plasma . A typical s e t o f binding curves for 
plasma, testicul a r and popliteal lymph are shown in 
Figure 7.7. 
Th e rate of movement of tra cer T 3 and serum albumin from 
b lood to l ymph 
Trii o dothy ronine is less firmly bound to human 
plasma proteins than is T 4 . The proportion of unbound 
T
3 
has been estimat ed to be of the order of 0.35% 
(Larsen, 1972 ) . St udies using the present competitive 
b i nding technique have shown that in the sheep T 3 is 
also less firmly bound to protein than is T 4 (Figure 
7.8). Th e binding data was best fitted by a two binding 
p rotein model (S
1 
+ NS) presumably TBG and albumin. The 
ass ociat i on constant of TBG for T3 was approximately 
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1/lOth of that for T 4 . This may unde
restimate the true 
value since no allowance was made for the endogenous T 4 
in the assay. If the normal sheep has a total T 3 
concentration of 80 ng/100 ml (Dussault, Hobel, Distefano, 
Erenberg and Fisher, 1972) the unbound T 3 concentration 
would be approximately 0.2 ng/100 ml or 0.25% of the 
total. This is 4 - 5 times greater than the proportion 
of T4 which is unbo
und and therefore from the results 
presented above one would predict that the fractional 
rate of movement of T 3 from blood t
o interstitial fluid 
would be considerably greater than that of T 4 . Experiments 
were performed to test this hypothesis. 
A ram with afferent testicular and efferent 
popliteal lymphatic fistulae was injected at zero time 
125 131 
with tracer T 3 [ I] and HSA I I]. The
 jsotope 
equilibration curves are shown in Figures 7.9 and 7.10. 
Tracer T3 was removed f
rom the circulation and equilibrated 
with both testicular and popliteal lymph much more 
rapidly than was the case with tracer T4 in the precedin
g 
experiments. Although the relative rates of movement of 
T3 and HSA from bl
ood to testicular lymph did not differ 
from those observed with tracer T 4 (the T 3 :HSA lymph/ 
plasma activity ratio during the first 1/2 hour was 
1.23), the T3 appeared in popliteal lymp
h at more than 
twice the relative rate recorded for tracer T 4 . In this 
latter case the T3 :HSA lymph/plasm
a activity ratio during 
the first 1/2 hour after injection was 7.84. 
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125 131 The disappearance of T 3 [ I] and HSA [ I] 
from plasma and their appearance in afferent testicular 
lymph following simultaneous intravenous injection of 
the two isotopes. 
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TIME (hours) 
The disappearance of T [ 125 1] an c1 HSA 3 
[1311] from plasma and their appearance in efferent 
popliteal lymph following simultaneous intravenous 
injection of the two isotopes. 
24 
12 3 
The effect of elevated unbound thyroid hormone concen-
trations on the rate of movement of labelled hormone 
from blood to lymph 
A ewe with an efferent popliteal lymphatic 
125 
fistula was injected sequentially with tracer T4 I l], 
125 tracer T3 [ l] and a loading dose of T 4 at 72 hour 
intervals. The loading dose contained 5 mg of T 4 in 
addition to the tracer T 4 • This treatment was estimated
 
to raise the plasma T4 concentration to about 300 µg/
100 ml 
and the percentage unbound to 0.23%. The isotopic 
equilibration curves for the 12 hours following injection 
of each dose are shown in Figure 7.11. 
The loading dose of T4 when compared with the 
tracer T 4 dose resulted in the
 more rapid movement of 
T4 [
1251] out of the circulation during the first hour. 
This was accompanied by the more rapid appearance of 
T [1251] in popliteal lymph during the first hour 4 
following the loading dose. 
125 Subsequently T 4 I l] was 
removed from the circulation at the same fractional rate 
with both treatments. Equilibration between plasma and 
lymph occurred earlier following the loading dose but 
following equilibration the lymph/plasma ratios for 
radioactive T4 were the same in both cases. 
Despite the fact that almost identical 
proportions of hormone in the circulation were unbound 
following the loading T 4 (0.23%} and tracer T 3 (0.25%) 
doses the equilibration curves were vastly different. 
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Figure 7.11. The disappearance of radioactively labelled 
thyroid hormones from plasma and their appearance in 
popliteal lymph following sequential intravenous 
· · · f r125 ] 1 d' d T d 1nJect1ons o tracer T4 I , oa ing ose 4 , an 
tracer T3 r
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r] at 72 hour intervals. 
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at a significantly greater fractional rate than both T4 
treatments over the entire time period studied. 
Equilibration of T 3 between plasma and poplitea
l lymph 
occurred during the first 1/2 hour collection interval. 
The effect of a loading dose of T 4 during isotopic 
equilibrium on the distribution of tracer T4 and serum 
albumin between blood and lymph 
Four rams which had received tracer T4 at zero 
time were injected intravenously with 5 mg of T 4 at 
72 - 96 hours. At this time the T 4 and HSA labels had 
attained equilibrium as judged by parallel isotope 
disappearance slopes in plasma, testicular and popliteal 
lymph . Plasma and lymph radioactivity was monitored 
over the ensuing 4 - 8 hours. 
The plasma concentration of labelled T 4 fell 
at over 100 times the preinjection rate during the first 
5 - 30 minutes following the loading injection. This 
125 
rapid rate of removal was followed by a T 4 I I] 
disappearance rate which appeared to differ little from 
the preinjection removal rate. The rate of removal of 
labelled T4 from testicular and po
pliteal lymph followed 
that of plasma in 3 of the 4 animals studied. Typical 
disappearance curves for one such animal are shown in 
Figure 7.12. In one animal however, the initial rapid 
removal of T 4 [
125 1] from plasma during the first 1/2 
hour after injection was accompanied by a rapid rise in 
the level of T4 [
1251] in testicular lymph. This elevated 
T 4 level fell equally as r
apidly during the next 1/2 hour 
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Figure 7.12. The effect of an intravenous loading dose 
of T
4 
at isotopic equilibrium on the distribution of 
T
4 
[125 1] and HSA [1311] between plasma and afferent 
testicular lymph. The loading dose was injected at 
98 hours after tracer T 4 [
125
r] and HSA r
131
r]. 
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and subsequently showed a parallel decline to t
he 
disappearance of T 4 from plasma
 (Figure 7.1 3). No 
comparable chan ges in the rate of removal of HS
A from 
plasma or lymph were observed. 
The removal of thyroid hormones from lymph dur
ing passage 
through a lymph node 
Since all preceding experiments suggested that 
T 4 and T 3 cro
ssed capillary membranes independent of 
their binding proteins it was expected that as 
is the 
case with other molecules of similar size, thi
s movement 
would be bidirectional. An experiment was car
ried out 
to see if T 4 and T 3 w
ere lost from lymph during passage 
of lymph through the popliteal lymph node. Th
is 
experimental model was chosen because unpublish
ed results 
of other worke rs in this laboratory have shown 
that low 
molecular weight substances which are not bound
 to 
protein, are almost totally removed from lymph 
during 
passage through the popliteal node and readily 
enter the 
blood stream. 
The recovery of T 4 [
125 rJ during passage through 
a popliteal node was compared with that of OSA 
r131r] at 
four concentrations of T 4 in the ly
mph. These were 
compared with the loss of tracer T3 . The r
esults are 
summarized in Table 7.3 where it can be seen t
hat 
significant portions of T 4 were los
t during passage 
through the node and these increased with incre
asing 
concentrations of T4 . Triiodo
thyronine loss at tracer 
concentrations was greater than that at the hi
ghest 
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Figure 7.13. The effect of an intravenous loading dose 
of T 4 at isotopic equilibrium on the d
istribution of 
T4 [
125 1] and HSA [1311] between plasma and afferent 
testicular lymph. The loading dose was injected 96 hours 
after tracer T4 [
125 1] and HSA [1311]. 
Table 7.3. The effect of changes in the proportion of unbound thyroid hormones on their rate of 
loss from lymph during perfusion of a popliteal lymph node. 
Total* Unbound* Proportion 
T 4 :OSA Activity** 
T 4 :OSA Activity*** 
Hormone Hormone Unbound 
Ratio in Ratio in Efferent E/I 
Concentration Con cen tr a ti on ( % ) Infusion 
Lymph (%) 
(µg/100 ml) (ng/100 ml) (I) (E) 
1.8 2 .10 0.117 0. 85 8 ± 0 • 001 
0.851 ± 0.003 99.2 
11.8 2.0. 9 8 0 .17 8 1.022 ± 0.003 
0.967 ± 0.004 94.6 
101.8 32 8. 92 0. 32 3 0 • 9 80 ± 0 • 0 13 
0.845 ± 0.024 86. 2 
1,001.8 5,970. 35 0 ·• 5 96 0 • 95 6 ± 0 . 0 14 
0.777 ± 0.047 81.3 
0.04**** 0 .196 0. 489 1.110 ± 0. 0 0 8 
0.795 ± 0.023 71.6 
* 
Concentrations of hormone in the infusion administered at 1 ml/hr. The mean efferen t lymph 
flow rate was 7.9 ml/hr. Samples containing exogenous T 4 would be diluted almost six fo l d i n 
the node. 
** Mean± SD values for triplicate analysis on 1 ml of infusion 
*** 
Mean± SD values for 1/2 hourly collections of efferent lymph during the infusion period. 
** ** 
Triiodothyronine. 
f--' 
rv 
a, 
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concentration of T 4 . Because of the large amounts of T 4 
removed at h igh T4 concentr ations and since the material 
removed from the lymph was no t r ecovered during the 
period of saline perfusion be t we en treatments, these 
results are un likely to be e xp lai ned by tissue uptake in 
the node. They are more likely to indicate transfer into 
the blood str e am. Unfortunate ly the amounts of radio-
activity used were t oo low to allow reliable radioassay 
of the circulating blood. 
DISCUSSION 
The experiments des c ribed in this chapter supply 
convincing evidence that labelled thyroid hormones are 
removed from the circulat ion and appear in interstitial 
fluid at a greater fr acti onal rate than labelled human 
serum albumin. This was t r ue for all tissue fluid pools 
sampled and at a ll levels of hor mone studied. If it is 
assumed that HSA h as i denti c al distribution kinetics to 
the specific T 4BP o f sheep serum, these results indicate 
that thyroid hormones are removed from the circulation 
mainly as the unboun d moiety. 
A systemati c study of samples of lymph from 
various regi on s o f the body demonstrated that the three 
T 4BPs present in sheep p lasma were also present in all 
sample s of lymph . In addition the lymph/plasma concen-
tration ratios for these three proteins were the same in 
any sample o f lymph and similar to the corresponding 
lymph/plasma ratios for total T4 and serum albumin. 
The se r e sults indicate that there is no preferential 
transcapillary movement of any of the T 4BPs compared with 
albumin, or each other, and suggest that the T 4BPs of 
sheep are a ll of similar molecular size. The latter 
suggestion i s at variance with recent estimates in the 
literature which indicate that the molecular weights of 
human TBG and TBPA are significantly lower than that of 
human serum albumin (Raz and Goodman, 1969; Marshall 
and Pensky , 1971; Sterling et al., 1971; Branch et al., 
1971). Ge l filtration chromatography however, confirmed 
that the T 4BPs of sheep ser
um had molecular sizes similar 
to h uman an d sheep albumin; if anything TBG was slightly 
larger and TBP -2 slightly smaller than serum albumin. 
Similar chromatographic separations of normal and heat 
treated human s erum have shown that TBG, TBPA and albumin 
have similar elution profiles to sheep TBG, TBP-2 and 
a l bumin respectively (Sutherland and Brandon, unpublished 
observations) . It should be pointed out however, that 
gel fi l trati on results are markedly affected by molecular 
shape as we ll as mole cular weight. While such a technique 
is a good model for assessing comparative transcapillary 
diffusion, it is diffi cult to make accurate comment on 
molecular weights. 
The concentration of unbound T4 was similar in 
plasma an d any sample of lymph from the same animal. 
Such a s ituation would arise whether T 4 and its binding 
proteins moved independently, or if T 4 crossed capillary 
memb r ane s bound only to proteins. In the former case an 
unmeasurable transcapillary concentration gradient would 
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be expected for a substance with molecules as small as 
those of T 4 even if there was considerable transcapill
ary 
transport of that substance (Landis and Pappenheimer, 
1963). If lymph is produced just as a simple filtrate of 
plasma with the proteins being reduced in concentration, 
then T4 would dissociate from its binding prote
ins in the 
interstitial fluid so that the concentration of unbound 
T 4 would be very similar to that in the blood
 (Oppenheimer 
and Surks, 1964). In either case the concentration of 
total T 4 in blood or interstitial fluid would b
e determined 
by the concentration of the T 4BPs. Such a transcapillary 
gradient for total T4 has previously been suggested as
 
providing evidence that T 4 leaves the circulation bound 
to its binding proteins (Ismail, El-Ridi, Badran, 
Khalifa, Abel-Hay and Talaat, 1967) but by itself such 
an observation is insufficient for this purpose. 
In experiments where the proportion of unbound 
T 4 was elevated, equilibration of l
abelled hormone between 
plasma and lymph occurred more rapidly, supporting the 
thesis that T 4 exchanges between these pools as un
bound 
T 4 . Following equilibration in 
the extracellular fluid, 
the proportion of labelled T 4 in plasma and lymph relative 
to each other was no different from that with tracer doses. 
This would be expected from consideration of the binding 
properties of plasma and lymph as plotted in Figure 7.7. 
However, the proportion of total labelled T 4 present in 
these pools was reduced. Since the fractional rate of 
elimination of T 4 from the body was not increased,
 lower 
concentrations in the extracellular fluid most likely 
1~ 
indicate higher concentrations within cells. Thyroxine 
is known to be bound intracellularly (Oppenheimer et al., 
1969) but the relationship between intracellular bound 
T 4 and unbound T 4 must be 
different from that for plasma 
and lymph and would seem t o favour cellular uptake when 
T 4 concentrations are elevate
d. 
Triiodothyronine equilibrated more rapidly 
between plasma and lymph than did T 4 due most likely to 
the higher proportion of T3 which is unbound. The 
equilibration curves for labelled T3 were quite different 
from those for T 4 , even when a loading do
se of T 4 was 
used. This most likely represents different fractional 
rates of destruction, or different steady state distribution 
between intrace llular and extracellular pools. 
Expe riments in which T 4 loading doses were 
administered at isotopic equilibrium in general support 
the above arguments. Plasma levels of labelled T 4 declined 
abruptly following the loading dose. In three experiments 
out of four, lymph levels declined similarly. These results 
suggest that the loading dose was distributed very rapidly. 
After re-estab lishment of equilibrium a smaller proportion 
of T 4 was present in the e
xtracellular fluid and a larger 
proportion presumably in the intracellular fluid. In only 
one experiment was the reduction in plasma T 4 followed by 
an increase in labelled T 4 in the lymph. This
 was 
transitory and lymph levels soon fell to parallel the 
plasma levels as in the other experiments. If this result 
was not artefactual it could reflect T 4 en route from 
blood to tissues but this is thought more likely to be due 
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to experimental error. Similar effects o f l oading doses 
of T4 in the h uman have been reported (Ingbar and 
Freinkel, 1960) and the effects similarly interpreted 
as here. However, since all such loading experiments 
disturb the steady state profoundly, it is difficult to 
derive useful quantitative data from them, and they are 
difficult to interpret critically. 
If T 4 does move across capillaries in the 
unbound form then like other molecules of similar size, 
it would move in both directions with equal facility. 
Experiments carried out in a perfused lymph node indicated 
that T 4 and T3 move from interstitial fluid to blood 
and 
the extent to which this occurs is related to the prop-
ortion of the hormones which is unbound. 
Thus the experiments reported in this chapter 
support earlier claims that unbound T4 is the freely 
diffusible form of T 4 (Ingbar and Freinkel, 1960; 
Robbins and Rall, 1967) and that cellular uptake of T 4 is 
related to the proportion of T 4 in the unbound state 
(Hillier, 1969). Unbound T 4 captured by the tissue cells 
is supplied by the circulating unbound T4 pool and by 
dissociation of T 4 from the circulating binding proteins 
during passage through the capillaries (Hillier, 1969, 1971). 
The present results do not support the claim that T 4 is 
distributed in the body bound to its binding proteins 
(Oppenheimer et al., 1969). It should be pointed out that 
because of movement of T 4 in both directions across 
capillaries, and possible cellular uptake of T 4 , the 
relative rates of movement of T 4 and protein from plasma 
132 
to lymph wi ll tend to under-estimate the rate of trans-
capillary movement of T4 relative to that of its binding 
proteins. 
Even though most T 4 seemed to cross capillarie
s 
in most tissues as unbound T 4 , in all tissues a 
proportion of T 4 which crossed the capillaries must 
have 
done so bound to protein. Those differences which were 
observed in the transcapillary exchange of both T 4 and 
protein between various tissues can be explained in terms 
of known di fferences in capillary permeability of the 
tissues (Yoffey and Courtice, 1970). Certainly no 
evidence was found to suggest that T4BPs had a functional 
role in the facilitated transport of T 4 into any tissue. 
CHAPTER 8 
THE EFFECT OF THYROIDECTOMY AND 
ADMINISTRATION OF SEX STEROIDS ON PLASMA 
THYROXINE-BINDING PROTEIN CONCENTRATIONS IN SHEEP 
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INTRODUCTION 
Despite the vast amount of knowledge that has 
been accumulated with respect to the thyroid hormone 
binding properties of plasma proteins, no definite 
functional role has yet been assigned to the specific 
T 4BPs. It was hoped that some insight into such a 
functional role for the T 4BPs might be attained by 
studying factors which affect their concentrations in 
the body. Two different experimental treatments, namely, 
surgical thyroidectomy and administration of sex steroids 
were employed in an attempt to alter the levels of 
specific T 4BP s in sheep. 
The concentration of circulating plasma T 4 
appears to have little effect on the maximal binding 
capacity of human TBG. Several studies have shown that 
in humans thyrotoxicosis might slightly lower, and 
hypothyroidism might slightly elevate TBG binding 
capacity (Oppenheimer et al., 1963; Inada and Sterling, 
1967; Gordon et al., 1971). Preliminary experiments 
with sheep, however, suggested that surgical 
thyroidectomy resulted in the reduction of plasma TBG 
concentrations (Sutherland and Simpson-Morgan, 1974). 
The binding capacities of two other specific binding 
proteins; corticosteroid-binding globulin in the rat 
and sex steroid-binding globulin in the human have also 
been shown to be affected markedly by the level of 
circulating T 4 (Labrie, Raynaud and Fortier, 1965; 
Dray, Mowszowicz, Ledru, Crepy, Delzant and Sebaoun, 
1969; De Moor, Steeno, Heyns and Van Baelen, 1969; 
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Crepy, Dray and Sebaoun, 1972). 
The effects of the administration of stilboestrol 
and tes tosterone propionate were also studied since these 
two hormones have previously been shown to cause changes 
in the plasma concentration of TBG in the human, a species 
which h as functionally similar specific plasma T 4BPs to 
the s heep (Dowling, Freinkel and Ingbar, 1956; Engbring 
and Engs trom, 1959; Robbins and Rall, 1967). 
RESULTS 
The e f fe ct of thyroidectomy on the concentration of 
plasma T 4BP s in the sheep 
Four adult female sheep were subjected to 
surgical t hy r oidectomy. Plasma T4 was undetectable 10 
days afte r surgery. The animals tolerated the operation 
well and were eating and drinking normally within a few 
hours . De spite complete absence of thyroid hormones, 
these an i mals remained in good health over the ensuing 
3 months and showed no obvious behavioural differences to 
normal con trol animals housed under identical conditions. 
Ten weeks after surgery the four thyroidectomized animals 
and two normal contro ls were injected with 100 µCi of 
NaI [125 r] and the subsequent disappearance of total 
(125 1) and protein precipitable (125 1) was monitored 
over the following 3 weeks. Typical disappearance curves 
f or a t hyroidectomized and a normal control animal are 
shown i n Figure 8.1. Plasma proteins were precipitated 
with 2 v olumes of 10% TCA, the precipitate spun down and 
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131 d' f igure . . asma I isappearance curves or a 
normal and a thyroidectomized ewe. 
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subsequently washed 3 times with 10% TCA. No appreciable 
protein-bound radioactivity could be demonstrated when 
the plasma of thyroidectomized animals was so treated. 
It should be pointed out however, that in other studies 
using supposedly thyroidectomized animals, appreciable 
synthesis of protein-bound (125 r) sometimes occurred. This 
was due to incomplete thyroidectomy as shown by anatomical 
and histological examination at post mortem. The use of 
radioactive iodide as a check on the completeness of 
surgical thyroidectomy is therefore recommended. 
Plasma samples were collected from the four 
thyroidectomized and two control animals at fortnightly 
intervals over a 2 month period. The T 4 binding 
properties of the plasma proteins were assayed in the 
usual manner and the concentration of TBG was found to 
fall slightly during the sampling period. Eight weeks 
after thyroidectomy the mean TBG binding capacity was 
reduced to about 2/3rds of its pre-treatment value. This 
difference was significant (P < 0.05). The TBG binding 
capacity of the two control animals increased slightly 
during the sample period (Figure 8.2). 
Thyroidectomy had virtually no effect on the 
binding of T 4 to TBP-2 and albu
min as assessed by changes 
in the TBP-2 binding capacity and K (Figure 8.2). The n 
latter finding was confirmed by measurement of plasma 
albumin concentrations which did not change significantly. 
The effect of administration of sex steroids on the 
concentration of plasma T 4BPs in sheep 
In a preliminary exp eriment designed to assess 
2.5 
2.0 
1.5 
650 
. 
u E . 
co 8 
< - 550 '---... c... O> 
co ~ 
t-- -
450 
18 
-
. 
u E 
co 0 0 
0 - 1.4 '---... 0) co ~ t--
10 
Figure 8 . 2 . 
••• ,,,,, 
v#L 
0 
••• ,,,,,, 
~ C  v 
~ v-----------------
........ 
TX 
'A A A Ll' I I I I 1 1 1 1 11 1 11 11 111111111 II Ll'''''' '' ''''' '' '' '''''''''''II I I 11111111111111111111111 If l..:.Jl 
,,,,,, 
2 4 
TIME (weeks) 
,,,,,, 
,,,,,, 
,,, 
,,,, "-
,,, /..:.J.., 
6 
C v 
,,,,,, 
,,, TX ,,,,,, 
,,,,,, 
,,,, A. 
,,, b 
8 
The effect of thyroidectomy on the 
concentration of plasma thyroxine binding proteins in 
sheep . Data points are the mean values of four thyroid-
ectomized (TX) and two normal control (C) animals. 
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the effects of oestrogen on plasma T 4BP concentrations in 
sheep, one ewe received a series of intramuscular 
injections of stilboestrol over a four week period. The 
experimental protocol used is indicated in Figure 8.3. 
Such a course of oestrogenic injections had no effect on 
either the level of circulating plasma T 4 or the T 4 
binding properties of the plasma proteins. The association 
constants of TBG and TBP-2 were unaffected as was the 
binding of T4 to serum albumin. Serum albumin conce
ntrations 
remained unaltered. Thyroxine-binding globulin and TBP-2 
binding capacities showed no systematic changes which 
could be related to the injections (Figure 8.3). 
Because the results of this preliminary experiment 
were quite different from what might have been expected 
from results in humans, large daily doses of stilboestrol 
(10 mg) were administered to two ewes over a period of 4 
weeks. Blood samples were collected at weekly intervals 
and the T 4 binding properties of the plasma prote
ins were 
assayed. A similar experiment was performed with two 
ewes which were given daily injections of 50 mg of 
testosterone propionate. Administration of such large 
doses of steroid was associated with a slight decline in 
the total plasma T 4 levels in oestrogen treated shee
p but 
not in testosterone treated animals (Table 8.1). 
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shown on the abscissa . 
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Table 8.1. Total plasma T 4 concentrations in four sheep 
receiving daily doses of 10 mg stilboestrol or 50 mg 
testosterone propionate. 
Total Plasma T 4 (µg/100 ml) 
Duration 
of Stilboestrol Testosterone 
Treatment Propionate 
(weeks) 
l 2 3 4 
0 9. 8 8.4 6.3 7.4 
1 8.4 8.4 5.7 6.6 
2 7.2 8.0 5.5 6.6 
3 7.7 6.3 5.4 4.4 
4 7.2 6.5 6.6 7. 8 
Results from the T 4BP assay are summarized in 
Tables 8.2 and 8.3 and show that the TBG plasma concentrations 
in oestrogen treated sheep fell to very low levels. These 
levels are in fact considerably lower than any which had been 
encountered previously in the study of large numbers of 
normal sheep. Because the binding capacity of TBG was 
decreased proportionately greater than total T 4 concentration, 
the lowest concentration of unbound T 4 measured in the 
assay, and subsequently used in the fitting procedure, was 
much higher than had been measured previously. This probably 
made the fitting procedure less reliable, particularly with 
respect to TBG binding. Nevertheless, the association 
constants for TBG rose to levels higher than those 
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Table 8.2. The thyroxine-binding properties of plasma 
proteins in samples collected at weekly intervals from 
two sheep receiving daily intramuscular injections of 
10 mg stilboestrol. 
Dura- TBG TBP-2 
Albu-
tion 
min 
of 
treat- K Binding K Binding 
ment 
assoc Capacity assoc Capacity K 
(M- 1xl0 9 ) (M-1 xl0 8 ) (weeks) (µg/lOOml) (µg/lOOml) n 
Sheep 1 
0 10.0 22.0 1.70 460 2.63 
1 11.3 15.9 1.78 514 2. 5 3 
2 29.9 4.0 0.92 439 1. 9 4 
3 41. 0 4.6 1. 5 4 582 2.18 
4 69.0 2.0 0.71 440 2.63 
Sheep 2 
0 13.5 16.6 2.14 412 3.04 
l 13.4 13.3 1.96 633 2.51 
2 14.3 8.5 1.15 782 2.27 
3 33.4 4.7 1. 70 650 2.13 
4 22.6 3.1 1.10 427 3.02 
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Table 8.3. The thyroxine-binding properties of plasma 
proteins in samples collected at weekly intervals from 
two sheep receiving daily intramuscular injections of 
50 mg testosterone propionate. 
Dura- TBG TBP-2 
Albu-
tion 
min 
of 
treat- K Binding K Binding 
ment 
assoc Capacity assoc Capacity K 
(M-1xl0 9 ) (M-1xl0 8 ) (weeks) (µg/lOOml) (µg/lOOml) n 
Sheep 3 
0 11.1 17.1 3. 51 2 89 2.81 
1 10.0 16 .9 2.07 43 8 2.65 
2 9. 7 13.1 0.99 486 1. 46 
3 8.9 13.6 1. 41 500 2.55 
4 12.6 9.6 1.02 477 2.05 
Sheep 4 
0 6.1 29.7 2.02 40 8 2.58 
1 7. 8 22.2 1.81 481 2.57 
2 12.0 12.0 1.18 420 1.74 
3 5.5 17.3 1.31 516 2.92 
4 10.0 11. 2 0.87 542 2.27 
de t ermined in any other samples of sheep plasma (Table 
8. 2) . 
This situation should be contrasted with that 
in testos terone treated sheep where the concentration of 
TBG declined to a lesser extent during the course of the 
treatment but the association constants remained within 
the previ ously measured range for untreated sheep as 
can be seen in Table 8.3. Neither of the sex hormones 
used had any appreciable effect on T4 binding to either 
TBP-2 or a lbumin. 
The interpretation of changes in TBG binding 
capacities was complicated by the fact that during the 
period when these experiments were carried out, the mean 
binding capacity of TBG in two normal control sheep 
declined f rom 17.0 to 7. 3 µg / 100 ml and this period 
coincided with the onset of regular oestrous cycles in 
other ewes h oused in the same area. 
DISCUSSION 
The results presented in this chapter suggest 
that thyroidectomized sheep could be useful experimental 
animals. Despite the total absence of circulating thyroid 
hormones s u ch animals remained healthy for several months 
when kept indoors. The plasma concentration of TBG was 
cons i stently reduced following thyroidectomy but the 
other t wo T
4
BPs (TBP-2 and albumin) were unaffected. 
This result is at variance with results reported in humans 
where hypothyroidism leads to unchanged or increased TBG 
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levels in the blood (Oppenheimer et al., 1963; Inada 
and Sterling, 1967; Gordon et al., 1971). 
It might be thought that thyroidectomy with its 
consequent depletion of thyroid hormones, would be a 
useful way of decreasing the proportion of unbound T 4 
in experiments similar to those reported in Chapter 7. 
However the proportion of T4 which would be unbound 
following its injection into thyroidectomized sheep would 
not be very different from that in normal sheep if the 
levels of the three T4BPs remained unchanged. With the 
decrease in TBG concentration following thyroidectomy 
the proportion of tracer doses of T4 which would be unbound 
following injection would be higher than those in normal 
animals. 
The apparent effects of oestrogenic hormones 
on the levels of TBG in sheep are also different from 
those reported in humans. When injections of 5 mg 
stilboestrol were given at various intervals to a ewe 
there was no consistent effect on the plasma concentration 
of TBG or the other T 4BPs. However, when stilboestrol 
was given in massive daily injections the concentration 
of TBG fell drastically. This result is very different 
from those reported in humans where it has been shown 
that administration of oestrogens to men as well as women 
consistently increased plasma levels of TBG (Dowling et 
al., 1956). It is interesting that concomitant with the 
fall in TBG concentration following oestrogen admini-
stration to sheep, the affinity of TBG for T4 appeared 
to increase. There is no comparable data for the effects 
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of oestrogens on TBG affinity in humans but this phenomenon 
is worthy of further investigation. 
Similarly the apparent effect of testosterone 
propionate when given to ewes was to decrease the 
concentration of TBG while the levels of plasma T4 were 
unchanged. These results were difficult to interpret as 
normal untreated animals showed a similar reduction in 
TBG concentration over the same period. The latter 
decline in TBG levels was accompanied by a reduction in 
total plasma T 4 concentration. There
 is some uncertainty 
as to the effect of androgens on thyroxine binding protein 
concentrations in the human. Engbring and Engstrom (1959) 
reported that testosterone propionate decreased PBI 
levels in humans. This decline in PBI was accompanied 
by a fall in TBG concentration in only 3 of 9 euthyroid 
males studied. Recently Barbosa, Seal and Doe (1971) 
reported that testosterone propionate had no effect on 
TBG concentration whereas other anabolic steroids, e.g. 
17a-methyl-testosterone reduced the level of TBG to about 
50% of the normal level. It seems likely that testosterone 
propionate has a negligible effect on the concentration 
of plasma TBG in both humans and sheep. 
The experiments reported in this chapter have 
contributed nothing to an understanding of the role of 
plasma T 4BPs as it was hoped they m
ight. Results 
presented in earlier chapters have indicated that the 
differences between species, with regard to the T4BPs of 
plasma, are somewhat less than would be suggested by 
earlier electrophoretic studies (e.g. Refetoff et al., 
1970). Thus by using the method of ass a y developed during 
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the course of the work reported in this thesis, it was 
possible to show that in all species studied so far 
(human, sheep, rat and rabbit), the protein most constant 
between species is one which has properties similar to 
those of human thyroxine-binding prealbumin but which in 
other species could not be resolved electrophoretically. 
Sheep plasma was shown to contain T4BPs which are 
functionally very similar to those of human plasma. This 
similarity between the two species applies only to the 
number of specific binding proteins and their affinity for 
T4 . Mechanisms involved in the contro
l of thyroxine-
binding protein concentrations in the two species 
appeared to vary considerably as was exemplified by the 
differential effects of thyroid and oestrogenic hormones 
on the plasma concentrations of human and sheep TBG. 
SUMMARY OF 
EXPERIMENTAL RESULTS 
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1. Sephadex G-25 has a high affinity for thyroxine 
(T 4) and triiodothyronine (T 3) which makes it an ideal 
competitive binding agent for studying thyroid hormone-
protein interactions at thermodynamic equilibrium. 
2. With pairs of protein-bound and unbound T 4 
concentrations over a suitable range, the affinities and 
binding capacities of T4 binding proteins (T 4BPs) in 
mixtures such as plasma and lymph can be estimated. 
Graphical methods used previously for this purpose can 
lead to erroneous results. 
3. Human plasma was shown to have three functionally 
different T 4BPs namely; TBG, TBPA and serum albumin. 
Their mean association constants for T 4 were 
9 8 5 -1 9.5 x 10 , 1.6 x 10 and 3.1 x 10 M respectively. 
The mean T 4 binding capacity of TBG was 21.3 µg/ 
100 ml of plasma and that of TBPA was 307 µg/100 ml. 
Sheep plasma was also found to have three 
functionally different T4BPs even though only two can 
be shown on electrophoresis. Sheep TBG, TBP-2 and 
albumin had mean association constants for T 4 of 
8.9 9 1.4 10 8 and 3.5 X 10 5 -1
 
respectively. X 10 1 X M 
The mean T 4 binding capacity of TBG was 1
2. 8 µg/ 
100 ml and that of TBP-2 was 359 µg/100 ml. 
Rat plasma had two functionally different 
T 4BPs. The mean association constants for T 4 were 
8 5 -1 3.6 x 10 and 6.3 x 10 M and the mean T 4 binding 
capacity of the most avid binding protein was 
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317 µg/100 ml. The existence of two different T 4BPs 
in rat plasma was confirmed by gel filtration studies. 
4. The binding of T 4 to plasma proteins is affected 
by the ionic strength, ionic composition, pH and tem-
perature of the assay medium. A diluent for plasma in 
which binding is not likely to differ greatly from that 
in vivo was determined to be 0.05 M sodium phosphate, 
0.10 M sodium chloride, pH 7.4 at 37°. 
5. The presence of merthiolate in the assay medium 
inhibits the binding of T4 to plasma proteins causing 
an increase in the concentration of unbound T 4 . 
6. Barbiturate ions inhibit the binding of T 4 to all 
three T 4BPs in human plasma. Binding of T 4 to 
TBG is 
less affected than T4 binding to TBPA and albumin. 
Barbital is not a specific inhibitor of T 4 binding to 
TBPA as was previously thought. 
7. Exposure of both human and sheep plasma to 60° for 
1 hour destroyed the ability of TBG to bind T 4 . 
8. Binding of T 4 to pure ovine serum albumin (OSA) and 
human serum albumin (HSA) was found to be affected by 
similar factors to those affecting binding in whole 
plasma. Affinities of purified OSA and HSA for T4 were 
similar to those determined for albumin in analyses of 
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whole ovine and human plasma. 
Triiodothyronine was bound to OSA and HSA with 
l/3rd of the affinity of T 4 . 
9. In sheep T 4 was found to pass across cap
illaries 
more rapidly than albumin; this was not due to prefer-
ential transcapillary movement of T4BPs. The same 
T 4BPs present in sheep plasm
a were found in all samples 
of lymph collected from various regions of the body. 
Lymph/plasma concentration ratios for all T 4BPs were 
similar to each other and to those for albumin and T 4 . 
Concentrations of unbound T4 in plasma and lymph were 
similar. It was concluded that T 4 moved across capillary
 
endothelium primarily as the unbound moiety. 
10. Increasing the proportion of thyroid hormone that 
was unbound, either by administration of loading doses 
of T 4 or by using tracer T 3 res
ulted in an increased 
rate of equilibration between plasma and lymph. The 
final distribution of T4 between plasma and inter
stitial 
fluid was unaffected by the level of T 4 injected but the 
distribution between the extracellular and intracellular 
pools was affected by the total amount of hormone 
administered. 
11. Surgical thyroidectomy resulted in a significant 
decline in plasma TBG concentration in sheep. Eight 
weeks after surgery the TBG levels had fallen to 
approximately 2/3rds of their pretreatment concentration. 
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The other two T 4BPs were unaffected. 
12. Administration of stilboestrol (10 mg/day) to adult 
ewes resulted in a marked decline in the level of 
plasma TBG. This was accompanied by an increase in the 
affinity of TBG for T 4 . Testosterone propionate 
(50 mg/day) appeared to have no effect on the concen-
tration of circulating T 4BPs in ewes. 
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APPENDIX 
Uncorrected [B] and [U] values taken from Figure 1 of 
Elewaut (1973). 
[BJ/ [U] 
9.14 
6.58 
5.38 
4.13 
2. 9 3 
2.20 
1.64 
[B] 
µg/100 ml 
9.6 
18.3 
2 7 .1 
41.0 
82.0 
143.0 
190.0 
[U] 
µg/100 ml 
1.05 
2.78 
5.04 
9.93 
2 8. 0 
65.0 
116.0 
